Using O VERB
the O DET
Quality O NOUN
Adjusted O VERB
Life O NOUN
Year O NOUN
outcome, O ADJ
the O DET
intervention O NOUN
was O VERB
not O ADV
cost O NOUN
effective O ADJ
from O ADP
an O DET
NHS/PSS O ADV
perspective. O ADJ

RESULTS: O NOUN
No O DET
statistical O ADJ
differences O NOUN
in O ADP
the O DET
implantation B-outcome NOUN
rate O NOUN
(42.6% O NOUN
vs O CCONJ
39.1%, O NUM
P O NOUN
= O SYM
.737, O NUM
rate O NOUN
ratio O NOUN
0.868, O NUM
95% O NOUN
confidence O NOUN
interval O NOUN
[CI]: O ADP
0.379-1.986) O ADP
and O CCONJ
the O DET
clinical B-outcome ADJ
pregnancy I-outcome NOUN
rate O NOUN
(23.4% O NUM
vs O CCONJ
26.1%, O NUM
P O NOUN
= O SYM
.764, O PUNCT
rate O NOUN
ratio O NOUN
1.155, O NOUN
95% O NOUN
CI: O NOUN
0.450-2.966) O NUM
were O VERB
detected O VERB
between O ADP
the O DET
placebo O NOUN
and O CCONJ
the O DET
treatment O NOUN
groups. O NOUN

The O DET
last O NOUN
date O NOUN
of O ADP
follow-up O NOUN
was O VERB
June O NOUN
12, O NUM
2018. O NUM

The O DET
return O NOUN
of O ADP
symmetrical B-outcome ADJ
pelvic I-outcome ADJ
floor I-outcome NOUN
muscles I-outcome NOUN
(PFM) I-outcome PUNCT
work O NOUN
after O ADP
pelvis O NOUN
reposition O NOUN
exercise O NOUN
was O VERB
observed O VERB
in O ADP
the O DET
experimental O ADJ
group. O VERB

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
This O DET
study O NOUN
was O VERB
a O DET
clinical O ADJ
trial O NOUN
in O ADP
which O ADP
80 O NUM
patients O NOUN
suffering O VERB
from O ADP
cancer O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
two O NUM
groups O NOUN
of O ADP
experimental O ADJ
and O CCONJ
control. O NOUN

CONCLUSIONS: O NOUN
Similar O ADJ
skeletal B-outcome ADJ
, O PUNCT
dental B-outcome ADJ
, O PUNCT
and O CCONJ
soft B-outcome NOUN
tissue I-outcome NOUN
changes O NOUN
were O VERB
obtained O VERB
in O ADP
both O CCONJ
groups O NOUN
after O ADP
Herbst O NOUN
therapy. O NOUN

PMID: O NOUN
31596411 O NUM

The O DET
PaCO(2) B-outcome ADV
in O ADP
group O NOUN
A O DET
was O VERB
(62.0+/-4.7) O PUNCT
mmHg O NOUN
, O PUNCT
which O ADP
was O VERB
significantly O ADV
higher O ADJ
than O ADP
group O NOUN
B O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
operation[(51.9+/-4.2) O NOUN
mmHg, O NOUN
t=2.432, O NUM
P<0.05]. O NOUN
The O DET
time B-outcome NOUN
spent I-outcome VERB
successfully I-outcome ADV
positioning I-outcome VERB
the Seperator DET
insertion I-outcome NOUN
in O ADP
group O NOUN
A O DET
and O CCONJ
group O NOUN
B O NOUN
were O VERB
(17.6+/-7.5), O NOUN
(29.8+/-13.6)s, O ADV
the O DET
endoscope B-outcome NOUN
indwelling I-outcome VERB
duration I-outcome NOUN
were(0.8+/-0.1), O NUM
(1.4+/-0.3)min, O NOUN
and O CCONJ
the O DET
operation B-outcome NOUN
time I-outcome NOUN
were(32.3+/-4.3), O NOUN
(46.8+/-4.8)min, O PUNCT
there O PRON
were O VERB
significantly O ADV
difference O NOUN
between O ADP
group O NOUN
A O DET
and O CCONJ
group O NOUN
B(t=2.670, O NOUN
2.214, O ADJ
2.166, O ADJ
all O DET
P<0.05). O NOUN

Title: O NOUN
Controlled O VERB
Trial O NOUN
of O ADP
Two O NUM
Incremental O ADJ
Milk-Feeding O VERB
Rates O NOUN
in O ADP
Preterm O NOUN
Infants. O NOUN

CONCLUSIONS: O NOUN
Contrast B-outcome NOUN
enhancement I-outcome NOUN
was O VERB
equivalent O ADJ
under O ADP
both O CCONJ
protocols. O NOUN

Conical O ADJ
implant O NOUN
interfaces, O NOUN
but O CCONJ
not O ADV
flat-to-flat O NOUN
or O CCONJ
platform-switched O VERB
implant O NOUN
interfaces, O NOUN
were O VERB
associated O VERB
with O ADP
no O DET
marginal B-outcome ADJ
bone I-outcome NOUN
level O NOUN
(MBL) O NOUN
changes O NOUN
over O ADP
3 O NUM
years. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Therefore, O NOUN
our O ADJ
results O NOUN
do O VERB
not O ADV
support O NOUN
the O DET
use O NOUN
of O ADP
antibiotic O ADJ
treatment O NOUN
for O ADP
chronic O ADJ
low O ADJ
back O ADP
pain O NOUN
and O CCONJ
Modic O NOUN
changes. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

This O DET
paper O NOUN
presents O NOUN
the O DET
MIM's O NOUN
intervention O NOUN
effect O NOUN
on O ADP
self-efficacy B-outcome NOUN
to O PART
cope O NOUN
with O ADP
stress, O NOUN
emotional O ADJ
coping B-outcome VERB
response, O NOUN
social B-outcome ADJ
support I-outcome NOUN
for O ADP
stress O NOUN
management, O NOUN
stress B-outcome NOUN
, O PUNCT
depressive B-outcome ADJ
symptoms I-outcome NOUN
, O PUNCT
and O CCONJ
positive B-outcome ADJ
and Seperator CCONJ
negative B-outcome ADJ
affect E1-outcome NOUN
. O PUNCT
METHODS: O NOUN
Participants O NOUN
(N O PUNCT
= O SYM
612) O NOUN
were O VERB
recruited O VERB
from O ADP
the O DET
Special O ADJ
Supplemental O ADJ
Nutrition O NOUN
Program O NOUN
for O ADP
Women, O NOUN
Infants, O NOUN
and O CCONJ
Children O NOUN
in O ADP
Michigan. O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
oncological O ADJ
benefits O NOUN
of O ADP
deep O ADJ
neuromuscular O ADJ
block O VERB
in O ADP
obese O NOUN
patients O NOUN
with O ADP
gastric O ADJ
cancer O NOUN
(DEBLOQS_GC O PUNCT
study): O NUM
A O DET
study O NOUN
protocol O NOUN
for O ADP
a O DET
double-blind, O NOUN
randomized O VERB
controlled O VERB
trial. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

This O DET
study O NOUN
evaluated O VERB
clinical O ADJ
and O CCONJ
radiographic O ADJ
twelve-month O NOUN
outcomes O NOUN
of O ADP
root O NOUN
canal O NOUN
treatments O NOUN
(CT) O NOUN
with O ADP
smear O NOUN
layer O NOUN
removal, O ADJ
performed O VERB
in O ADP
primary O ADJ
teeth, O NOUN
using O VERB
two O NUM
different O ADJ
root O NOUN
canal O NOUN
filling O VERB
materials. O NOUN

PC O NOUN
may O VERB
help O VERB
prevent O NOUN
dangerous O ADJ
hyperthermia O NOUN
in O ADP
athletes. O ADV

OBJECTIVE: O NOUN
One O NUM
of O ADP
the O DET
important O ADJ
aspects O NOUN
involved O VERB
in O ADP
achieving O VERB
optimal O ADJ
outcomes O NOUN
after O ADP
assisted O VERB
reproductive O ADJ
treatment O NOUN
(ART) O NOUN
is O VERB
the O DET
endometrium. O NOUN

Publication O NOUN
date: O NOUN
2019/01/15 O NOUN
06:00 O ADP
[medline] O NOUN

OBJECTIVE: O NOUN
to O PART
measure O NOUN
the O DET
effect O NOUN
of O ADP
an O DET
infant O NOUN
stimulation O NOUN
therapy O NOUN
(auditory, O NOUN
tactile, O NOUN
visual O ADJ
and O CCONJ
vestibular) O NOUN
on O ADP
the O DET
adaptation B-outcome NOUN
to I-outcome PART
postnatal I-outcome ADJ
life I-outcome NOUN
of O ADP
the O DET
mother-child O NOUN
dyad. O NOUN

A O DET
fragility B-outcome NOUN
fracture I-outcome NOUN
occurred O VERB
in O ADP
190 O NUM
women O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
and O CCONJ
in O ADP
122 O NUM
women O NOUN
in O ADP
the O DET
zoledronate O ADJ
group O NOUN
(hazard O PUNCT
ratio O NOUN
with O ADP
zoledronate, O NOUN
0.63; O NUM
95% O NOUN
confidence O NOUN
interval, O ADP
0.50 O NUM
to O PART
0.79; O NOUN
P<0.001). O NUM

OBJECTIVE: O NOUN
The O DET
aim O ADP
of O ADP
the O DET
study O NOUN
was O VERB
to O PART
test O NOUN
the O DET
applicability B-outcome NOUN
of O ADP
low-dose O NOUN
MDCT O NOUN
protocols O NOUN
for O ADP
decision-making O VERB
of O ADP
sinus O NOUN
surgeries O NOUN
of O ADP
patients O NOUN
with O ADP
uncontrolled O VERB
chronic O ADJ
rhinosinusitis. O SYM

The O DET
study O NOUN
compares O NOUN
the O DET
efficacy O NOUN
of O ADP
MCP O NOUN
using O VERB
the O DET
AIMhi O NOUN
Stay O NOUN
Strong O ADJ
App O NOUN
with O ADP
two O NUM
control O NOUN
groups O NOUN
(control O PUNCT
app O CCONJ
intervention O NOUN
and O CCONJ
treatment O NOUN
as O ADP
usual) O NOUN
on O ADP
participant-reported O VERB
psychological B-outcome ADJ
distress I-outcome NOUN
(the O NOUN
primary O ADJ
outcome) O PUNCT
using O VERB
the O DET
Kessler O NOUN
Distress O NOUN
Scale O NOUN
(K10)]; O NOUN
depressive B-outcome ADJ
symptoms I-outcome NOUN
using O VERB
the O DET
adapted O VERB
Patient O NOUN
Health B-outcome NOUN
Questionnaire O PROPN
(PHQ-9)]; O NOUN
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
using O VERB
the O DET
EuroQoL O NOUN
instrument O NOUN
( O NOUN
EQ5D]) O NOUN
and O CCONJ
adherence B-outcome NOUN
to O PART
dialysis O NOUN
treatment O NOUN
planning O VERB
through O ADP
file O NOUN
audit. O NOUN

Contrary O NOUN
to O PART
the O DET
progress O NOUN
in O ADP
the O DET
management O NOUN
of O ADP
severe O ADJ
AP, O NOUN
the O DET
MAP O NOUN
has O VERB
not O ADV
presented O VERB
significant O ADJ
changes O NOUN
in O ADP
recent O ADJ
years. O NOUN

Title: O NOUN
ED50 O NOUN
and O CCONJ
ED95 O NOUN
of O ADP
intrathecal O ADJ
hyperbaric O ADJ
ropivacaine O NOUN
for O ADP
parturients O NOUN
undergoing O VERB
cesarean O NOUN
section O NOUN
with O ADP
prophylactic O ADJ
infusion O NOUN
of O ADP
phenylephrine: O NOUN
A O DET
Prospective O ADJ
dose-finding O VERB
Study. O NOUN

RESULTS: O NOUN
The O DET
ED95 O NOUN
and O CCONJ
95% O NOUN
confidence O NOUN
intervals O NOUN
(95% O PUNCT
CI) O NOUN
of O ADP
spinal O ADJ
hyperbaric O ADJ
bupivacaine O NOUN
in O ADP
group O NOUN
D O NOUN
and O CCONJ
group O NOUN
C O NOUN
were O VERB
7.4 O NUM
mg O NOUN
(95% O PUNCT
CI, O NOUN
5.6-12.4 O NUM
mg) O NOUN
and O CCONJ
11.0 O NUM
mg O NOUN
(95% O PUNCT
CI, O NOUN
4.4-56.8 O NUM
mg), O NOUN
respectively. O NOUN

Here, O NOUN
we O PRON
present O ADJ
the O DET
impact O NOUN
of O ADP
the O DET
diet O NOUN
intervention O NOUN
on O ADP
cost-effectiveness O NOUN
and O CCONJ
explore O ADP
changes O NOUN
in O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
. O PUNCT
METHODS: O NOUN
A O DET
total O ADJ
of O ADP
110 O NUM
postpartum O NOUN
women O NOUN
with O ADP
overweight/obesity O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
diet O NOUN
(D-group) O PUNCT
or O CCONJ
control O NOUN
(C-group). O NOUN

Medical O ADJ
sciences O NOUN

A O DET
partial O ADJ
support O NOUN
of O ADP
the O DET
MAT O NOUN
and O CCONJ
of O ADP
ruminations O NOUN
reduction O NOUN
to O PART
the O DET
MBI's O NOUN
efficacy O NOUN
was O VERB
found. O NOUN

Title: O NOUN
Randomized O VERB
controlled O VERB
trial O NOUN
comparing O VERB
the O DET
efficacy O NOUN
of O ADP
daily O ADJ
and O CCONJ
every O DET
other O ADJ
day O NOUN
atorvastatin O NOUN
therapy O NOUN
and O CCONJ
its O ADJ
correlation O NOUN
with O ADP
serum O NOUN
hydroxymethylglutaryl-CoA B-outcome NOUN
reductase I-outcome NOUN
enzyme I-outcome NOUN
levels O NOUN
in O ADP
naive O ADJ
dyslipidemic O ADJ
patients. O NOUN

There O PRON
were O VERB
no O DET
Significant O ADJ
differences O NOUN
in O ADP
operation B-outcome NOUN
time I-outcome NOUN
, O PUNCT
liquid B-outcome ADV
input I-outcome NOUN
and O CCONJ
blood B-outcome NOUN
output I-outcome NOUN
between O ADP
group O NOUN
C O NOUN
and O CCONJ
group O NOUN
D(all O PUNCT
P>0.05). O NOUN

The O DET
intake O NOUN
of O ADP
CSO O NOUN
in O ADP
the O DET
CSO O NOUN
group, O NOUN
but O CCONJ
not O ADV
the O DET
increase O NOUN
in O ADP
plasma O NOUN
ALA O NOUN
proportions, O NOUN
correlated O VERB
inversely O ADV
with O ADP
the O DET
IFNG O NOUN
mRNA B-outcome NOUN
expression I-outcome NOUN
in O ADP
PBMCs O NOUN
(P O NUM
= O SYM
0.08). O NUM

The O DET
incidence O NOUN
of O ADP
severe B-outcome ADJ
disability I-outcome NOUN
in O ADP
the O DET
SBH O NOUN
treatment O NOUN
group O NOUN
was O VERB
significantly O ADV
lower O ADJ
than O ADP
that O ADP
in O ADP
the O DET
routine O ADJ
treatment O NOUN
group O NOUN
[5.6% O NOUN
(1/18) O PUNCT
vs. O CCONJ
44.4% O NUM
(8/18), O NUM
P O NOUN
< O SYM
0.05]. O NUM
There O PRON
was O VERB
1 O NUM
child O NOUN
death B-outcome NOUN
in O ADP
the O DET
routine O ADJ
treatment O NOUN
group O NOUN
and O CCONJ
no O DET
death O NOUN
in O ADP
the O DET
SBH O NOUN
treatment O NOUN
group. O VERB

There O PRON
is O VERB
currently O ADV
no O DET
standard O ADJ
therapeutic O ADJ
regimen O NOUN
available O ADJ
for O ADP
patients O NOUN
with O ADP
advanced O VERB
colorectal O ADJ
cancer O NOUN
in O ADP
whom O ADP
the O DET
disease O NOUN
continues O NOUN
to O PART
progress O NOUN
after O ADP
2 O NUM
or O CCONJ
more O ADV
lines O NOUN
of O ADP
chemotherapy. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
patients O NOUN
in O ADP
the O DET
experimental O ADJ
group O NOUN
and O CCONJ
control O NOUN
group O NOUN
will O VERB
take O NOUN
2.5 O NUM
g O NOUN
of O ADP
Bosinji O NOUN
granule O NOUN
(1.523 O PUNCT
g O NOUN
of O ADP
Bosinji O NOUN
extract) O NOUN
or O CCONJ
Loxonin O NOUN
tablet O NOUN
(60 O PUNCT
mg O NOUN
of O ADP
loxoprofen) O ADV
3 O NUM
times O NOUN
a O DET
day O NOUN
for O ADP
6 O NUM
weeks. O NOUN

At O ADP
the O DET
end O NOUN
of O ADP
an O DET
8-week O NOUN
consumption O NOUN
period, O NOUN
all O DET
subjects O NOUN
were O VERB
determined O VERB
serum O NOUN
bone B-outcome NOUN
markers O NOUN
including O VERB
calcium B-outcome NOUN
, O PUNCT
alkaline B-outcome ADJ
phosphatase I-outcome NOUN
, O PUNCT
osteocalcin B-outcome NOUN
, O PUNCT
and O CCONJ
beta B-outcome NOUN
CTX I-outcome NOUN
. O PUNCT
In O ADP
addition, O NOUN
the O DET
hematological B-outcome ADJ
and O CCONJ
blood O NOUN
clinical B-outcome ADJ
chemistry I-outcome NOUN
changes, O NOUN
and O CCONJ
total O ADJ
phenolic B-outcome NOUN
content O NOUN
in O ADP
the O DET
serum O NOUN
were O VERB
also O ADV
determined. O NOUN

Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT02241655. O ADP

Teachers O NOUN
assigned O VERB
to O PART
the O DET
waitlist O ADJ
control O NOUN
condition O NOUN
will O VERB
receive O VERB
an O DET
alternative O ADJ
training O VERB
on O ADP
how O ADP
to O PART
monitor O NOUN
physical O ADJ
functional O ADJ
capacity O NOUN
in O ADP
children O NOUN
with O ADP
special O ADJ
needs. O NOUN

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

Publication O NOUN
date: O NOUN
2019/01/17 O ADP
06:00 O ADP
[medline] O NOUN

Journal O ADJ
ID: O NOUN
8908809 O NUM

A O DET
heat B-outcome NOUN
stress I-outcome NOUN
test O NOUN
(120min, O NOUN
45% O ADJ
V O NUM
O2peak) O NOUN
before O ADP
(Pre O NUM
HA) O NOUN
and O CCONJ
after O ADP
HA O NOUN
(Post O PUNCT
HA) O NOUN
in O ADP
similar O ADJ
hot O ADJ
conditions O NOUN
assessed O VERB
heat B-outcome NOUN
acclimation I-outcome NOUN
status. O NOUN

Both O CCONJ
groups O NOUN
showed O VERB
significant O ADJ
gains O NOUN
at O ADP
the O DET
Fugl-Meyer O NOUN
motor B-outcome NOUN
assessment I-outcome NOUN
(FMA) O NOUN
(ST: O NOUN
5+/-4 O NOUN
points/FT: O NOUN
6+/-4 O NUM
points; O NOUN
P=0.04) O NOUN
and O CCONJ
Wolf O NOUN
motor B-outcome NOUN
function I-outcome NOUN
test O NOUN
(ST: O NOUN
0.4+/-0.3 O NOUN
points/FT: O NOUN
0.6+/-0.4 O NOUN
points; O NOUN
P=0.05), O NOUN
which O ADP
were O VERB
comparable O ADJ
between O ADP
groups O NOUN
(P>/=0.47). O PUNCT

METHODS: O NOUN
One O NUM
hundred O NUM
and O CCONJ
three O NUM
high O ADJ
school O NOUN
athletes O NOUN
completed O VERB
the O DET
study O NOUN
(M O NUM
age O NOUN
= O SYM
15.3, O NOUN
SD O NOUN
= O SYM
1.2; O NUM
70.9% O NUM
male; O NOUN
37.9% O NUM
Afr. O NOUN

Publication O NOUN
date: O NOUN
2019/03/09 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

Recovery B-outcome NOUN
conditions I-outcome NOUN
, O PUNCT
postoperative O ADJ
agitation B-outcome NOUN
were O VERB
also O ADV
recorded. O NOUN

Depression B-outcome NOUN
and O CCONJ
heart B-outcome NOUN
rate I-outcome NOUN
variability I-outcome NOUN
were O VERB
measured O VERB
using O VERB
the O DET
GDS O NOUN
and O CCONJ
digital O ADJ
electrocardiogram O NOUN
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
the O DET
24-week O NUM
intervention. O NOUN

On O ADP
each O DET
visit O NOUN
the O DET
participants O NOUN
consumed O VERB
either O CCONJ
a O DET
CA O NOUN
+ O SYM
C O NOUN
(100 O NUM
mg O NOUN
of O ADP
CA O NOUN
and O CCONJ
100 O NUM
mg O NOUN
of O ADP
C) O NOUN
or O CCONJ
placebo O NOUN
(dextrose) O NUM
capsule. O NUM

BACKGROUND: O NOUN
Alveolar O ADJ
osteitis O NOUN
is O VERB
a O DET
frequent O ADJ
postoperative O ADJ
complication O NOUN
of O ADP
third O ADJ
molar O ADJ
surgery. O VERB

INTERPRETATION: O CCONJ
Compared O VERB
with O ADP
ICSI, O NOUN
PICSI O NOUN
does O VERB
not O ADV
significantly O ADV
improve O VERB
term O NOUN
livebirth B-outcome ADJ
rates. O NOUN

DISCUSSION: O NOUN
This O DET
trial O NOUN
will O VERB
assess O NOUN
the O DET
effect O NOUN
of O ADP
selenium O NOUN
supplementation O NOUN
on O ADP
pregnancy B-outcome NOUN
outcome I-outcome NOUN
and O CCONJ
HIV B-outcome NOUN
disease I-outcome NOUN
progression I-outcome NOUN
among O ADP
HIV-infected O VERB
pregnant O ADJ
women O NOUN
in O ADP
Lagos. O NOUN

The O DET
success O NOUN
rates O NOUN
of O ADP
hemostasis B-outcome NOUN
for O ADP
3 O NUM
minutes O NOUN
and O CCONJ
5 O NUM
minutes, O NOUN
the O DET
time B-outcome NOUN
of I-outcome ADP
operation I-outcome NOUN
, O PUNCT
the O DET
amount O NOUN
of O ADP
intraoperative O ADJ
bleeding B-outcome VERB
, O PUNCT
the O DET
volume O NOUN
of O ADP
autogenously O ADV
blood B-outcome NOUN
transfusion I-outcome NOUN
, O PUNCT
the O DET
amount O NOUN
of O ADP
blood B-outcome NOUN
during O ADP
hemostasis, O NOUN
the O DET
amount O NOUN
of O ADP
blood B-outcome NOUN
transfusion I-outcome NOUN
, O PUNCT
and O CCONJ
BP B-outcome NOUN
, O PUNCT
red B-outcome ADJ
blood I-outcome NOUN
cell I-outcome NOUN
count I-outcome NOUN
(RBC) I-outcome NOUN
, O PUNCT
haematocrit B-outcome NOUN
(HCT) I-outcome PUNCT
, O PUNCT
haemoglobin B-outcome NOUN
(HB) I-outcome ADV
of O ADP
preoperative, O ADJ
2 O NUM
to O PART
3 O NUM
days, O NOUN
and O CCONJ
5 O NUM
to O PART
7 O NUM
days O NOUN
following O VERB
operation O NOUN
were O VERB
recorded O VERB
to O PART
compare. O NOUN

Publication O NOUN
date: O NOUN
2019/02/16 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSION: O NOUN
The O DET
results O NOUN
of O ADP
this O DET
study O NOUN
demonstrated O VERB
that O ADP
NES O NOUN
may O VERB
help O VERB
to O PART
relieve O NOUN
CINV O NOUN
in O ADP
patients O NOUN
with O ADP
AGC. O NOUN

OBJECTIVE: O NOUN
The O DET
aim O ADP
of O ADP
the O DET
present O ADJ
study O NOUN
was O VERB
to O PART
observe O NOUN
the O DET
feasibility B-outcome NOUN
and O CCONJ
effect O NOUN
of O ADP
cornea O NOUN
slice O NOUN
acquired O VERB
from O ADP
femtosecond O NOUN
laser O NOUN
surgery, O NOUN
small O ADJ
incision O NOUN
lenticule O NOUN
extraction O NOUN
(SMILE) O NUM
as O ADP
patch O NOUN
graft O NOUN
for O ADP
the O DET
prevention O NOUN
of O ADP
drainage B-outcome NOUN
tube I-outcome NOUN
exposure I-outcome NOUN
and O CCONJ
to O PART
compare O NOUN
with O ADP
the O DET
sclera. O NOUN

Journal O ADJ
ID: O NOUN
9435674 O NUM

Metabolomics O NOUN
was O VERB
employed O VERB
to O PART
investigate O NOUN
cellular B-outcome ADJ
metabolism I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
DKD O NOUN
patients O NOUN
had O VERB
decreased O VERB
mtDNA B-outcome ADJ
copy I-outcome NOUN
numbers O NOUN
and O CCONJ
increased O VERB
mtDNA B-outcome ADJ
damage I-outcome NOUN
compared O VERB
to O PART
DCs. O NOUN

Patient O NOUN
satisfaction B-outcome NOUN
at O ADP
24 O NUM
h O NOUN
postoperatively O ADV
was O VERB
filed O VERB
on O ADP
a O DET
11-point O NOUN
numeric O ADJ
rating O VERB
scale O NOUN
(SFS24; O PUNCT
0=fully O ADV
unsatisfied; O NOUN
10=fully O ADV
satisfied). O NUM

Lastly, O NOUN
EMLA O NOUN
lowered O VERB
overall B-outcome ADJ
pain I-outcome NOUN
score O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
first O ADV
analgesic O ADP
request O NOUN
in O ADP
ward O NOUN
compared O VERB
to O PART
control O NOUN
group O NOUN
(P O NUM
= O SYM
.02). O PUNCT

The O DET
menstrual O ADJ
disturbances O NOUN
as O ADP
a O DET
health O NOUN
problem O ADP
among O ADP
young O ADJ
girls O NOUN
affect O NOUN
not O ADV
only O ADV
reproductive, O NOUN
but O CCONJ
also O ADV
psychical O ADJ
health O NOUN
and O CCONJ
quality O NOUN
of O ADP
life. O NOUN

METHODS: O NOUN
We O PRON
evaluated O VERB
40 O NUM
patients O NOUN
aged O VERB
>/=18 O NOUN
years O NOUN
who O ADP
underwent O VERB
elective O ADJ
muscle O NOUN
sparing O VERB
thoracotomies. O NOUN

CONCLUSIONS: O NOUN
This O DET
study's O ADP
findings O NOUN
showed O VERB
that O ADP
an O DET
educational O ADJ
video O ADJ
can O VERB
be O VERB
as O ADP
beneficial O ADJ
as O ADP
expert O NOUN
proctoring, O NOUN
which O ADP
implies O NOUN
that O ADP
the O DET
development O NOUN
of O ADP
a O DET
standardized O VERB
educational O ADJ
video O ADJ
would O VERB
be O VERB
worthwhile. O VERB

Journal-Name:Hematology O NOUN
(Amsterdam, O NOUN
Netherlands) O ADJ

Title: O NOUN
Taping O VERB
to O PART
Improve O NOUN
Scapular B-outcome ADJ
Dyskinesis I-outcome NOUN
, O PUNCT
Scapular B-outcome ADJ
Upward I-outcome NOUN
Rotation I-outcome NOUN
, O PUNCT
and O CCONJ
Pectoralis B-outcome NOUN
Minor I-outcome ADJ
Length I-outcome NOUN
in O ADP
Overhead O ADP
Athletes. O NOUN

Before O ADP
and O CCONJ
after O ADP
the O DET
intervention O NOUN
anthropometric B-outcome ADP
parameters, O NOUN
serum O NOUN
lipid B-outcome NOUN
profile, O NOUN
serum O NOUN
concentrations O NOUN
of O ADP
alanine B-outcome NOUN
aminotransferase I-outcome NOUN
, O PUNCT
aspartate B-outcome NOUN
aminotransferase I-outcome NOUN
, O PUNCT
insulin B-outcome NOUN
, O PUNCT
glucose B-outcome NOUN
, O PUNCT
insulin-like B-outcome ADJ
growth I-outcome NOUN
factor-1 I-outcome NOUN
, O PUNCT
HOMA-IR B-outcome ADV
(homeostatic O PUNCT
model O NOUN
assessment), O NOUN
and O CCONJ
visceral B-outcome ADJ
adiposity I-outcome NOUN
index O NOUN
(VAI), O SYM
and O CCONJ
their O ADJ
changes O NOUN
were O VERB
registered. O NOUN

Comparison O NOUN
of O ADP
the O DET
mean O NOUN
differences O NOUN
at O ADP
the O DET
beginning O VERB
and O CCONJ
two O NUM
months O NOUN
after O ADP
the O DET
study O NOUN
in O ADP
the O DET
two O NUM
groups O NOUN
showed O VERB
that O ADP
the O DET
scores O NOUN
related O VERB
to O PART
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
dimensions O NOUN
in O ADP
the O DET
experimental O ADJ
group O NOUN
were O VERB
significantly O ADV
greater O ADJ
than O ADP
the O DET
control O NOUN
group O NOUN
(p</=0.05). O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
The O DET
study O NOUN
is O VERB
registered O VERB
at O ADP
EudraCT O NOUN
(2016-003017-10, O NOUN
date O NOUN
of O ADP
registration: O NOUN
22 O NUM
July O NOUN
2016) O NUM
and O CCONJ
( O PUNCT
NCT02868385 O NOUN
, O PUNCT
date O NOUN
of O ADP
registration: O NOUN
16 O NUM
August O NOUN
2016). O NOUN

Journal-Name:Journal O ADJ
of O ADP
shoulder O NOUN
and O CCONJ
elbow O NOUN
surgery O NOUN

OBJECTIVE: O NOUN
This O DET
study O NOUN
means O NOUN
to O PART
determine O NOUN
whether O ADP
Mg O NOUN
supplementation O NOUN
improves O NOUN
glycemic B-outcome ADJ
control I-outcome NOUN
indicators O NOUN
in O ADP
patients O NOUN
with O ADP
T2D. O NOUN
METHODS: O NOUN
After O ADP
one O NUM
week O NOUN
of O ADP
the O DET
dietary O ADJ
stabilization O NOUN
phase, O NOUN
42 O NUM
T2D O NOUN
patients O NOUN
were O VERB
stratified O VERB
according O ADJ
to O PART
sex, O NOUN
age, O NOUN
fasting O VERB
blood O NOUN
sugar O NOUN
(FBS) O PUNCT
and O CCONJ
Mg O NOUN
levels O NOUN
and O CCONJ
then O ADV
randomly O ADV
allocated O VERB
into O ADP
two O NUM
groups. O NOUN

Participants O NOUN
were O VERB
critically O ADV
ill O ADJ
patients O NOUN
who O ADP
regained O VERB
mental O ADJ
capacity O NOUN
following O VERB
receipt O NOUN
of O ADP
level O NOUN
3 O NUM
(intensive) O PUNCT
care. O NOUN

The O DET
primary O ADJ
and O CCONJ
secondary O ADJ
endpoints, O NOUN
excluding O VERB
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QoL) I-outcome NOUN
, O PUNCT
have O VERB
been O VERB
published. O NOUN

The O DET
patients O NOUN
were O VERB
randomly O ADV
assigned, O NOUN
in O ADP
a O DET
2:1 O ADP
ratio, O NOUN
to O PART
receive O VERB
a O DET
single O ADJ
300-mg O NUM
dose O NOUN
of O ADP
tafenoquine O NOUN
or O CCONJ
15 O NUM
mg O NOUN
of O ADP
primaquine O NOUN
once O ADP
daily O ADJ
for O ADP
14 O NUM
days O NOUN
(administered O PUNCT
under O ADP
supervision); O NOUN
all O DET
patients O NOUN
received O VERB
a O DET
3-day O NOUN
course O NOUN
of O ADP
chloroquine O NOUN
and O CCONJ
were O VERB
followed O VERB
for O ADP
180 O NUM
days. O NOUN

In O ADP
the O DET
current O ADJ
exploratory O ADJ
analysis, O NOUN
these O DET
ardms O NOUN
were O VERB
categorized O VERB
into O ADP
the O DET
moderate O ADJ
hypofractionated O VERB
(MHF) O PUNCT
group O NOUN
(52 O ADP
patients O NOUN
in O ADP
Arms O NOUN
1-3) O NOUN
and O CCONJ
the O DET
extreme O NOUN
hypofractionated O VERB
(EHF) O NOUN
group O NOUN
(30 O NOUN
patients O NOUN
in O ADP
Arms O NOUN
4-5). O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Intravenous O ADJ
boluses O NOUN
of O ADP
50 O NUM
mug O NUM
were O VERB
administered O VERB
for O ADP
breakthrough O NOUN
pain. O NOUN

Hence, O NOUN
the O DET
primary O ADJ
objective O ADP
was O VERB
to O PART
study O NOUN
the O DET
hypothesis O NOUN
that O ADP
methohexital O ADJ
confers O NOUN
a O DET
better O ADJ
hemodynamic B-outcome ADJ
profile O NOUN
than O ADP
propofol O NOUN
for O ADP
anesthetic O ADJ
induction, O NOUN
in O ADP
patients O NOUN
receiving O VERB
AAB. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Highly B-outcome ADV
sensitive I-outcome ADJ
troponin I-outcome NOUN
(HS-Tp) I-outcome NOUN
as O ADP
a O DET
biomarker O NOUN
of O ADP
irreversible O ADJ
damage O NOUN
to O PART
the O DET
myocardium O NOUN
was O VERB
evaluated O VERB
before O ADP
PCI O NOUN
and O CCONJ
after O ADP
PCI O NOUN
in O ADP
24 O NUM
hours. O DET

Incremental O ADJ
cost-effectiveness O NOUN
ratios O NOUN
were O VERB
calculated, O NOUN
with O ADP
uncertainty O NOUN
around O ADP
the O DET
values O NOUN
estimated O VERB
using O VERB
bootstrapping. O NOUN

Clear O ADJ
recommendations O NOUN
regarding O VERB
the O DET
dosage O NOUN
should O VERB
be O VERB
established. O NOUN

The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
right B-outcome ADJ
heart I-outcome NOUN
size I-outcome NOUN
and Seperator CCONJ
function S2-outcome NOUN
assessed O VERB
by O ADP
echocardiography O NOUN
during O ADP
long O ADV
term O NOUN
treatment O NOUN
with O ADP
riociguat. O NOUN

Publication O NOUN
date: O NOUN
2019/02/08 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:Einstein O NOUN
(Sao O ADV
Paulo, O NOUN
Brazil) O NOUN

2) O NOUN
Simulated O VERB
scuba O ADJ
results O NOUN
in O ADP
vitro: O ADP
under O ADP
VCV O NOUN
mode, O NOUN
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
monitored O VERB
by O ADP
respirator O NOUN
and O CCONJ
tidal B-outcome DET
volume I-outcome NOUN
showed O VERB
by O ADP
simulated O VERB
scuba O ADJ
in O ADP
different O ADJ
preset O NOUN
VT O NOUN
groups O NOUN
were O VERB
continuously O ADV
increased O VERB
with O ADP
the O DET
increase O NOUN
in O ADP
oxygen O NOUN
atomization O NOUN
flow, O NOUN
while O ADP
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
monitored O VERB
by O ADP
ventilator O NOUN
was O VERB
not O ADV
significantly O ADV
changed. O NOUN

METHODS: O NOUN
This O DET
pragmatic, O NOUN
randomized, O NOUN
controlled, O NOUN
parallel-group O NOUN
clinical O ADJ
trial O NOUN
will O VERB
compare O NOUN
the O DET
effectiveness O NOUN
of O ADP
the O DET
motivational O ADJ
interviewing O VERB
to O PART
an O DET
educational O ADJ
intervention, O ADP
including O VERB
the O DET
distribution O NOUN
of O ADP
an O DET
information O NOUN
flyer O NOUN
as O ADP
standard O ADJ
of O ADP
care O NOUN
on O ADP
vaccination O NOUN
coverage O NOUN
in O ADP
four O NUM
maternity O NOUN
wards O NOUN
across O ADP
the O DET
Province O NOUN
of O ADP
Quebec O NOUN
(PromovaQ). O NUM

Modified O VERB
classical O ADJ
pilates O NOUN
exercises O NOUN
were O VERB
performed O VERB
by O ADP
the O DET
experimental O ADJ
group O NOUN
three O NUM
times O NOUN
a O DET
week O NOUN
over O ADP
a O DET
12-week O NOUN
period. O NOUN

Publication O NOUN
date: O NOUN
2018/12/20 O ADJ
06:00 O ADP
[entrez] O ADP

CONCLUSION: O NOUN
RIPC O NOUN
does O VERB
not O ADV
result O VERB
in O ADP
significant O ADJ
reduction O NOUN
of O ADP
contrast B-outcome NOUN
induced I-outcome VERB
nephropathy I-outcome NOUN
. O PUNCT
However O ADV
RIPC O NOUN
helps O ADJ
in O ADP
the O DET
prevention O NOUN
of O ADP
post O ADV
procedural O ADJ
worsening O VERB
in O ADP
eGFR B-outcome NOUN
and O CCONJ
serum O NOUN
creatinine B-outcome NOUN
even O ADV
up O ADP
to O PART
6 O NUM
weeks. O NOUN

Effectiveness O NOUN
of O ADP
a O DET
national O ADJ
quality O NOUN
improvement O NOUN
programme O NOUN
to O PART
improve O VERB
survival O NOUN
after O ADP
emergency O NOUN
abdominal O ADJ
surgery O NOUN
(EPOCH): O NOUN
a O DET
stepped-wedge O NOUN
cluster-randomised O VERB
trial. O NOUN

Title: O NOUN
Vitamin O NOUN
D O NOUN
and O CCONJ
probiotic O ADJ
co-supplementation O NOUN
affects O NOUN
mental B-outcome ADJ
health I-outcome NOUN
, O PUNCT
hormonal B-outcome ADJ
, O PUNCT
inflammatory B-outcome ADJ
and O CCONJ
oxidative B-outcome ADJ
stress I-outcome NOUN
parameters O NOUN
in O ADP
women O NOUN
with O ADP
polycystic O ADJ
ovary O NOUN
syndrome. O NOUN

Thus, O NOUN
reasons O NOUN
for O ADP
engaging O VERB
in O ADP
weight O NOUN
loss O NOUN
interventions O NOUN
needs O NOUN
exploring, O NOUN
in O ADP
order O NOUN
to O PART
engage O NOUN
more O ADV
workplaces O NOUN
in O ADP
weight O NOUN
loss O NOUN
interventions. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

RESULTS: O NOUN
There O PRON
were O VERB
significant O ADJ
increases O NOUN
in O ADP
the O DET
scores O NOUN
of O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
dimensions O NOUN
in O ADP
the O DET
experimental O ADJ
group O NOUN
after O ADP
the O DET
intervention O NOUN
(p</=0.05). O NOUN

Publication O NOUN
date: O NOUN
2019/01/17 O ADP
06:00 O ADP
[medline] O NOUN

Level O NOUN
of O ADP
evidence O NOUN
II-2. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

OBJECTIVE: O NOUN
To O PART
compare O NOUN
the O DET
chest O NOUN
tube O NOUN
drainage O NOUN
by O ADP
the O DET
same O ADJ
thoracotomy O NOUN
intercostal O ADJ
space O NOUN
with O ADP
the O DET
traditional O ADJ
approach O NOUN
in O ADP
patients O NOUN
undergoing O VERB
muscle-sparing O VERB
thoracotomy. O NOUN

BACKGROUND: O NOUN
A O DET
high-fidelity O NOUN
task O NOUN
simulator O NOUN
for O ADP
cricothyroidotomy O NOUN
was O VERB
created O VERB
using O VERB
data O NOUN
from O ADP
a O DET
3-dimensional O ADJ
(3D) O NOUN
computed O VERB
tomography O NOUN
scan O NOUN
using O VERB
a O DET
3D O NOUN
printer. O NOUN

The O DET
visual O ADJ
analogue O NOUN
scale O NOUN
(VAS) O PUNCT
of O ADP
taste B-outcome NOUN
disturbance I-outcome NOUN
symptoms I-outcome NOUN
and O CCONJ
the O DET
gustatory B-outcome ADJ
tests O NOUN
were O VERB
assessed O VERB
before O ADP
and O CCONJ
8 O NUM
weeks O NOUN
after O ADP
treatment O NOUN
with O ADP
esomeprazole, O NOUN
a O DET
PPI O NOUN
(20 O PUNCT
patients, O NOUN
aged O VERB
50.0 O NUM
+/- O SYM
1.7 O NUM
years) O NOUN
or O CCONJ
famotidine, O NOUN
a O DET
H2 O NOUN
blocker O NOUN
(20 O PUNCT
patients, O NOUN
aged O VERB
47.1 O NUM
+/- O SYM
1.8 O NUM
years). O NOUN

The O DET
final O ADJ
follow-up O NOUN
visit O NOUN
was O VERB
April O NOUN
2017. O NUM

The O DET
scores O NOUN
of O ADP
unintentional O ADJ
injury O NOUN
risk B-outcome NOUN
behavior I-outcome NOUN
for O ADP
children O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
at O ADP
3 O NUM
and O CCONJ
6 O NUM
months O NOUN
after O ADP
intervention O NOUN
were O VERB
14.42+/-5.67 O NUM
and O CCONJ
14.14+/-8.95, O NOUN
respectively, O NOUN
lower O ADJ
than O ADP
those O DET
before O ADP
the O DET
intervention O NOUN
(16.85+/-8.48) O ADV
and O CCONJ
in O ADP
the O DET
control O NOUN
group O NOUN
(P=0.001). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Eradication B-outcome NOUN
failures O NOUN
were O VERB
not O ADV
associated O VERB
with O ADP
factors O NOUN
including O VERB
gender, O NOUN
age, O NOUN
body O NOUN
mass O NOUN
index, O NOUN
smoking, O NOUN
alcohol O NOUN
consumption, O NOUN
educational O ADJ
level, O NOUN
and O CCONJ
urban-rural O ADJ
distribution O NOUN
in O ADP
this O DET
observation O NOUN
(P O NUM
> O SYM
.05).Despite O NUM
increasing O VERB
drug B-outcome NOUN
resistance I-outcome NOUN
to O PART
CLA, O ADJ
Hp B-outcome NOUN
eradication I-outcome NOUN
rates O NOUN
in O ADP
FZD O NOUN
and O CCONJ
CLA O NOUN
groups O NOUN
have O VERB
no O DET
significant O ADJ
difference O NOUN
at O ADP
present; O NOUN
as O ADP
FZD-based O VERB
quadruple O ADJ
therapy O NOUN
is O VERB
more O ADV
cost-effective, O NOUN
we O PRON
recommend O NOUN
this O DET
regimen O NOUN
be O VERB
a O DET
first-line O NOUN
choice O NOUN
for O ADP
Hp O NOUN
eradication. O ADV

No O DET
other O ADJ
complications B-outcome NOUN
, O PUNCT
such O ADJ
as O ADP
infection B-outcome NOUN
or O CCONJ
deep B-outcome ADJ
vein I-outcome NOUN
thrombosis I-outcome NOUN
, O PUNCT
occurred O VERB
in O ADP
both O CCONJ
groups. O NOUN

Title: O NOUN
Hippotherapy O NOUN
in O ADP
Rehabilitation O NOUN
Care O NOUN
for O ADP
Children O NOUN
With O ADP
Neurological O ADJ
Impairments O NOUN
and O CCONJ
Developmental O ADJ
Delays: O NOUN
A O DET
Case O NOUN
Series. O NOUN

PMID: O NOUN
31613346 O NUM

METHODS: O NOUN
Cross-sectional O ADJ
analyses O NOUN
of O ADP
the O DET
PREDIMED-Plus O NOUN
trial. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Clinicaltrials.gov O NOUN
, O PUNCT
NCT03236961, O NOUN
retrospectively O ADV
registered O VERB
on O ADP
the O DET
2nd O ADJ
of O ADP
August O NOUN
2017. O NUM

Publication O NOUN
date: O NOUN
2018/12/29 O NOUN
00:00 O NOUN
[accepted] O ADV

Methods O NOUN
Sixty O NUM
older O ADJ
individuals O NOUN
with O ADP
depression O NOUN
score O NOUN
of O ADP
10 O NUM
or O CCONJ
above O ADP
(the O NOUN
Geriatric O NOUN
Depression O NOUN
Scale, O NOUN
GDS]) O NOUN
were O VERB
randomly O ADV
assigned O VERB
into O ADP
two O NUM
groups: O NOUN
TC O NOUN
(n O NOUN
= O SYM
30) O NOUN
and O CCONJ
control O NOUN
group O NOUN
(n O NOUN
= O SYM
30). O NOUN

Publication O NOUN
date: O NOUN
2019/03/05 O NOUN
06:00 O ADP
[medline] O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
patients O NOUN
with O ADP
MI, O NOUN
provision O NOUN
of O ADP
vouchers O NOUN
to O PART
offset O NOUN
medication O NOUN
co-payments O NOUN
for O ADP
P2Y12 O NOUN
inhibitors, O NOUN
compared O VERB
with O ADP
no O DET
vouchers, O NOUN
resulted O VERB
in O ADP
a O DET
3.3% O NOUN
absolute O ADJ
increase O NOUN
in O ADP
patient-reported O VERB
persistence B-outcome NOUN
with O ADP
P2Y12 O NOUN
inhibitors O NOUN
and O CCONJ
no O DET
significant O ADJ
reduction O NOUN
in O ADP
1-year O NOUN
major B-outcome ADJ
adverse I-outcome ADJ
cardiovascular I-outcome ADJ
events I-outcome NOUN
(MACE) I-outcome PUNCT
outcomes. O ADJ

Palo O NOUN
Alto, O NOUN
CA, O NOUN
USA. O NOUN

Children O NOUN
were O VERB
filmed O VERB
playing O VERB
pre-, O NOUN
mid-, O NOUN
and O CCONJ
postintervention, O NOUN
using O VERB
the O DET
Test O NOUN
of O ADP
Playfulness B-outcome ADV
(ToP) O ADV
to O PART
assess O NOUN
playfulness B-outcome ADV
. O PUNCT
The O DET
PICIHBI O NOUN
comprised O VERB
of O ADP
10 O NUM
monthly O ADV
sessions O NOUN
facilitated O VERB
by O ADP
an O DET
occupational O ADJ
therapist, O NOUN
involving O VERB
group O NOUN
discussions O NOUN
with O ADP
caregivers O NOUN
and O CCONJ
periods O NOUN
of O ADP
experiential O ADJ
play. O NOUN

Journal O ADJ
ID: O NOUN
101225531 O NUM

METHODS: O NOUN
Forty-four O NUM
children O NOUN
(27 O PUNCT
girls O NOUN
and O CCONJ
17 O NUM
boys) O NOUN
between O ADP
13 O NUM
and O CCONJ
17 O NUM
years O NOUN
of O ADP
age O NOUN
with O ADP
unilateral O ADJ
recurrent O ADP
patellar O ADJ
dislocation O NOUN
underwent O VERB
medial O ADJ
patellofemoral O ADJ
ligament O NOUN
(MPFL) O NOUN
reconstruction. O NOUN

The O DET
population O NOUN
studied O VERB
had O VERB
a O DET
mean O NOUN
age O NOUN
of O ADP
60.6 O NUM
years. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
success B-outcome NOUN
rate O NOUN
or O CCONJ
procedure B-outcome NOUN
time I-outcome NOUN
between O ADP
the O DET
2 O NUM
groups O NOUN
(success O ADV
rate: O NOUN
P O NOUN
= O SYM
.24, O ADP
procedure O NOUN
time: O NOUN
P O NOUN
= O SYM
.34). O ADP

Further O ADV
additional O ADJ
benefits O NOUN
are O VERB
better O ADJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QoL) I-outcome NOUN
and O CCONJ
shorter O ADJ
immunosuppressive B-outcome ADJ
treatment I-outcome NOUN
compared O VERB
with O ADP
standard O ADJ
GVHD O NOUN
prophylaxis O NOUN
without O ADP
ATLG. O NOUN

PURPOSE: O NOUN
While O ADP
some O DET
micro-organisms, O NOUN
such O ADJ
as O ADP
Staphylococcus O NOUN
aureus, O NOUN
are O VERB
clearly O ADV
implicated O VERB
in O ADP
causing O VERB
tissue O NOUN
damage O NOUN
in O ADP
diabetic O ADJ
foot O NOUN
ulcers O NOUN
(DFUs), O NOUN
our O ADJ
knowledge O NOUN
of O ADP
the O DET
contribution O NOUN
of O ADP
the O DET
entire O ADJ
microbiome O NOUN
to O PART
clinical O ADJ
outcomes O NOUN
is O VERB
limited. O NOUN

Journal-Name:JAMA O NOUN

Materials O NOUN
and O CCONJ
Methods: O NOUN
A O DET
total O ADJ
of O ADP
240 O NUM
(129 O NUM
females O NOUN
and O CCONJ
111 O NUM
male) O NOUN
aged O VERB
18 O NUM
- O PUNCT
65 O NUM
years O NOUN
were O VERB
referred O VERB
and O CCONJ
integrated O VERB
in O ADP
this O DET
clinical O ADJ
trial, O NOUN
All O DET
patients O NOUN
presented O VERB
with O ADP
a O DET
vital O ADJ
maxillary O ADJ
or O CCONJ
mandibular O ADJ
molar, O ADV
premolar O ADJ
or O CCONJ
front O NOUN
teeth O NOUN
designated O VERB
for O ADP
conventional O ADJ
root O NOUN
canal O NOUN
treatment O NOUN
for O ADP
prosthetic O ADJ
reasons O NOUN
detected O VERB
with O ADP
only O ADV
vital O ADJ
pulps. O NOUN

The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
compare O NOUN
the O DET
analgesic B-outcome ADP
benefits O NOUN
and O CCONJ
physiotherapy B-outcome NOUN
(PT) I-outcome NOUN
outcomes O NOUN
of O ADP
single-shot O NOUN
ACB O NOUN
to O PART
two O NUM
different O ADJ
regimens O NOUN
of O ADP
infusion O NOUN
of O ADP
the O DET
continuous O ADJ
ACB, O NUM
24-hour O NOUN
and O CCONJ
48-hour O NOUN
infusion. O NOUN

CONCLUSION: O NOUN
The O DET
strong O ADJ
efficacy O NOUN
and O CCONJ
favorable O ADJ
benefit-risk O NOUN
profile O NOUN
of O ADP
DMF O NOUN
extends O NOUN
to O PART
Japanese, O NOUN
and O CCONJ
more O ADV
broadly, O NOUN
East O ADV
Asian O ADJ
patients O NOUN
with O ADP
RRMS. O NOUN

Participants O NOUN
were O VERB
divided O VERB
into O ADP
groups O NOUN
that O ADP
received O VERB
16 O NUM
weeks O NOUN
of O ADP
either O CCONJ
usual O ADJ
care O NOUN
or O CCONJ
exercise O NOUN
intervention. O NOUN

Publication O NOUN
date: O NOUN
2018/03/20 O NOUN
00:00 O NOUN
[accepted] O ADV

At O ADP
late O ADJ
follow-up O NOUN
(24 O NOUN
to O PART
32 O NUM
days O NOUN
after O ADP
initiation O NOUN
of O ADP
therapy), O NOUN
fewer O ADJ
patients O NOUN
in O ADP
the O DET
plazomicin O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
meropenem O NOUN
group O NOUN
had O VERB
microbiologic B-outcome ADJ
recurrence I-outcome NOUN
(3.7% O PUNCT
vs. O CCONJ
8.1%) O NUM
or O CCONJ
clinical B-outcome ADJ
relapse I-outcome NOUN
(1.6% O NOUN
vs. O CCONJ
7.1%). O NOUN

Title: O NOUN
Gua O NOUN
Sha O NOUN
therapy O NOUN
for O ADP
chronic O ADJ
low O ADJ
back O ADP
pain: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Title: O NOUN
Contrast O NOUN
Material O ADJ
Injection O NOUN
Protocol O NOUN
With O ADP
the O DET
Dose O NOUN
Determined O VERB
According O ADJ
to O PART
Lean O ADJ
Body O NOUN
Weight O NOUN
at O ADP
Hepatic O ADJ
Dynamic O ADJ
Computed O VERB
Tomography: O ADP
Comparison O NOUN
Among O ADP
Patients O NOUN
With O ADP
Different O ADJ
Body O NOUN
Mass O NOUN
Indices. O NOUN

Visual O ADJ
impairment O NOUN
is O VERB
common O ADJ
among O ADP
rural O ADJ
Chinese O NOUN
children, O NOUN
but O CCONJ
fewer O ADJ
than O ADP
a O DET
quarter O NOUN
of O ADP
children O NOUN
who O ADP
need O NOUN
glasses O NOUN
actually O ADV
own O ADJ
and O CCONJ
use O NOUN
them. O NOUN

For O ADP
the O DET
secondary O ADJ
endpoint, O VERB
from O ADP
baseline O NOUN
to O PART
week O NOUN
24, O NUM
the O DET
total O ADJ
number O NOUN
of O ADP
new O ADJ
gadolinium-enhancing B-outcome VERB
(Gd(+)) I-outcome NUM
lesions I-outcome NOUN
was O VERB
reduced O VERB
by O ADP
75% O NUM
and O CCONJ
the O DET
mean O NOUN
number O NOUN
of O ADP
new/newly O ADV
enlarging O VERB
T2 B-outcome NOUN
hyperintense I-outcome NOUN
lesions I-outcome NOUN
was O VERB
reduced O VERB
by O ADP
63% O NOUN
(both O NOUN
p O NOUN
< O SYM
0.0001). O NUM

A O DET
mixed O VERB
analysis O NOUN
of O ADP
variance O NOUN
(ANOVA) O NUM
with O ADP
repeated O VERB
measures O NOUN
showed O VERB
no O DET
significant O ADJ
effects O NOUN
for O ADP
self-reported O VERB
pain B-outcome NOUN
perception. O NOUN

BACKGROUND: O NOUN
Persistent O ADJ
post-surgical O ADJ
pain O NOUN
and O CCONJ
associated O VERB
disability O NOUN
are O VERB
common O ADJ
after O ADP
a O DET
traumatic O ADJ
fracture O NOUN
repair. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

The O DET
surgical B-outcome ADJ
findings I-outcome NOUN
and O CCONJ
success B-outcome NOUN
rate O NOUN
in O ADP
two O NUM
subgroups O NOUN
were O VERB
compared. O NOUN

Results: O NOUN
Operative B-outcome ADJ
time I-outcome NOUN
of O ADP
the O DET
TAP O NOUN
group O NOUN
and O CCONJ
parecoxib O NOUN
+ O SYM
TAP O NOUN
group O NOUN
was O VERB
significantly O ADV
longer O ADJ
than O ADP
that O ADP
of O ADP
the O DET
parecoxib O NOUN
group O NOUN
and O CCONJ
control O NOUN
group. O VERB

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
trial O NOUN
was O VERB
conducted O VERB
at O ADP
seven O NUM
hospitals O NOUN
or O CCONJ
clinics O NOUN
in O ADP
Peru, O ADP
Brazil, O NOUN
Colombia, O NOUN
Vietnam, O NOUN
and O CCONJ
Thailand O NOUN
and O CCONJ
involved O VERB
patients O NOUN
with O ADP
normal O ADJ
glucose-6-phosphate O NOUN
dehydrogenase O NOUN
(G6PD) O PUNCT
enzyme O NOUN
activity O NOUN
and O CCONJ
female O NOUN
patients O NOUN
with O ADP
moderate O ADJ
G6PD O NOUN
enzyme O NOUN
deficiency; O NOUN
all O DET
patients O NOUN
had O VERB
confirmed O VERB
P. O NOUN
vivax O NOUN
parasitemia. O NOUN

CONCLUSION: O NOUN
Findings O NOUN
suggest O VERB
that O ADP
restricting O VERB
elite O ADP
sport O ADJ
sponsorship O NOUN
to O PART
healthier O ADJ
food O NOUN
brands O NOUN
that O ADP
meet O NOUN
set O NOUN
nutritional O ADJ
criteria O NOUN
could O VERB
help O VERB
promote O VERB
healthier O ADJ
eating O VERB
among O ADP
young O ADJ
adults. O NOUN

BACKGROUND: O NOUN
The O DET
aim O ADP
of O ADP
this O DET
analysis O NOUN
was O VERB
to O PART
ascertain O NOUN
the O DET
type O NOUN
of O ADP
relationship O NOUN
between O ADP
fish O NOUN
and O CCONJ
seafood O NOUN
consumption, O NOUN
omega-3 O NOUN
polyunsaturated O VERB
fatty O ADJ
acids O NOUN
(omega-3 O NUM
PUFA) O NOUN
intake, O NOUN
and O CCONJ
depression B-outcome NOUN
prevalence. O NOUN

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

Pain B-outcome NOUN
score O NOUN
in O ADP
the O DET
paracetamol O NOUN
group O NOUN
was O VERB
significantly O ADV
lower O ADJ
than O ADP
that O ADP
in O ADP
the O DET
dexmedetomidine O NOUN
group O NOUN
(P O NUM
= O SYM
.04); O NOUN
nevertheless, O NOUN
there O PRON
were O VERB
no O DET
group O NOUN
differences O NOUN
in O ADP
the O DET
mean O NOUN
scores O NOUN
of O ADP
pain B-outcome NOUN
during O ADP
these O DET
hours O NOUN
(P O NUM
> O SYM
.05). O NUM

Intranasal O ADJ
DEX O NOUN
2 O NUM
mug/kg O NOUN
is O VERB
an O DET
effective O ADJ
and O CCONJ
safe O ADJ
alternative O ADJ
for O ADP
premedication O NOUN
in O ADP
children. O NOUN

Assuming O VERB
null O ADJ
hypothesis, O NOUN
80% O NOUN
power O NOUN
and O CCONJ
5% O NOUN
alpha O NOUN
error, O NOUN
to O PART
detect O VERB
a O DET
10% O ADP
difference, O NOUN
adjusting O VERB
for O ADP
10% O ADP
loss O NOUN
of O ADP
follow O VERB
up, O NOUN
sample O NOUN
size O NOUN
was O VERB
204. O NUM

METHODS: O NOUN
The O DET
central B-outcome ADJ
corneal I-outcome ADJ
endothelium I-outcome NOUN
was O VERB
evaluated O VERB
by O ADP
serial O ADJ
specular O ADJ
microscopy O NOUN
at O ADP
0 O NUM
to O PART
24 O NUM
months. O NOUN

All O DET
included O VERB
patients O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
a O DET
treatment O NOUN
group O NOUN
(n O NOUN
= O SYM
43) O NOUN
or O CCONJ
a O DET
sham O NOUN
group O NOUN
(n O NOUN
= O SYM
43). O NUM

Journal-Name:Medicine O NOUN

Journal-Name:Nutrients O NOUN

The O DET
subjects, O NOUN
who O ADP
had O VERB
inclusion O NOUN
criteria, O NOUN
were O VERB
selected O VERB
through O ADP
convenience O NOUN
sampling O VERB
based O VERB
on O ADP
inclusion O NOUN
criteria O NOUN
and O CCONJ
randomly O ADV
allocated O VERB
into O ADP
three O NUM
groups. O NOUN

In O ADP
addition, O NOUN
no O DET
adverse B-outcome ADJ
events I-outcome NOUN
related O VERB
to O PART
the O DET
treatment O NOUN
were O VERB
recorded O VERB
in O ADP
either O CCONJ
group. O VERB

Approximately O ADV
6% O NOUN
of O ADP
galcanezumab-treated O VERB
patients O NOUN
maintained O VERB
>/=75% O NUM
response B-outcome NOUN
all O DET
6 O NUM
months O NOUN
versus O CCONJ
2% O NUM
of O ADP
placebo-treated O VERB
patients. O NOUN

During O ADP
the O DET
study O NOUN
period O NOUN
(0-12 O NOUN
months) O NOUN
mean O NOUN
total O ADJ
costs B-outcome NOUN
were O VERB
lowest O ADV
in O ADP
the O DET
Combined-arm O NUM
(euro476 O ADV
vs. O CCONJ
euro1062-euro1992, O NOUN
p O NOUN
< O SYM
0.001) O NUM
as O ADP
were O VERB
the O DET
mean O NOUN
number O NOUN
of O ADP
sickness B-outcome NOUN
absence I-outcome NOUN
days O NOUN
(0.15 O PUNCT
vs. O CCONJ
2.29-4.17, O NUM
p O NOUN
= O SYM
0.025). O NUM

METHODS: O NOUN
We O PRON
randomly O ADV
assigned O VERB
adults O NOUN
attending O VERB
U.K. O ADJ
National O ADJ
Health O NOUN
Service O NOUN
stop-smoking O VERB
services O NOUN
to O PART
either O CCONJ
nicotine-replacement O ADJ
products O NOUN
of O ADP
their O ADJ
choice, O NOUN
including O VERB
product O NOUN
combinations, O NOUN
provided O ADJ
for O ADP
up O ADP
to O PART
3 O NUM
months, O NOUN
or O CCONJ
an O DET
e-cigarette O NOUN
starter O NOUN
pack O NOUN
(a O PUNCT
second-generation O NOUN
refillable O ADJ
e-cigarette O NOUN
with O ADP
one O NUM
bottle O NOUN
of O ADP
nicotine O NOUN
e-liquid O NOUN
[18 O NUM
mg O NOUN
per O ADP
milliliter]), O NOUN
with O ADP
a O DET
recommendation O NOUN
to O PART
purchase O NOUN
further O ADV
e-liquids O NOUN
of O ADP
the O DET
flavor O NOUN
and O CCONJ
strength O NOUN
of O ADP
their O ADJ
choice. O NOUN

Participants O NOUN
who O ADP
underwent O VERB
SCTG+CAF+EMD O NOUN
application O NOUN
were O VERB
identified O VERB
as O ADP
the O DET
test O NOUN
group O NOUN
(n O NOUN
= O SYM
19) O NOUN
and O CCONJ
those O DET
who O ADP
underwent O VERB
SCTG+CAF O NUM
as O ADP
control O NOUN
group O NOUN
(n O NOUN
= O SYM
19). O ADJ

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

However, O ADV
its O ADJ
effectiveness O NOUN
is O VERB
controversial. O NOUN

We O PRON
found O VERB
significant O ADJ
positive O ADJ
correlations O NOUN
of O ADP
Delta O NOUN
insulin-like B-outcome ADJ
growth I-outcome NOUN
factor-1 I-outcome NOUN
with O ADP
initial O ADJ
and O CCONJ
Delta O NOUN
values O NOUN
of: O NOUN
HOMA-IR B-outcome ADV
, O PUNCT
triglyceride/high-density B-outcome NOUN
cholesterol I-outcome NOUN
ratio I-outcome NOUN
, O PUNCT
visceral B-outcome ADJ
adiposity I-outcome NOUN
index O NOUN
(VAI). O NOUN

Achaogen, O VERB
South O NOUN
San O NOUN
Francisco, O ADV
CA. O NOUN

Results: O NOUN
The O DET
age, O NOUN
sex O NOUN
ratio, O NOUN
body O NOUN
mass O NOUN
index O NOUN
(BMI) O PUNCT
and O CCONJ
ASA O NOUN
grading O VERB
ratio O NOUN
in O ADP
two O NUM
groups O NOUN
were O VERB
not O ADV
significantly O ADV
different(all O CCONJ
P>0.05). O NOUN

METHODS: O NOUN
This O DET
pilot O NOUN
randomized O VERB
controlled O VERB
trial O NOUN
compared O VERB
BZSF O NOUN
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
ceftriaxone O NOUN
with O ADP
ceftriaxone O NOUN
alone O ADJ
for O ADP
Chinese O NOUN
female O NOUN
patients O NOUN
with O ADP
uncomplicated O VERB
gonorrhea. O NOUN

All O DET
three O NUM
indicators O NOUN
of O ADP
CHW O NOUN
functioning O VERB
(as O PUNCT
measured O VERB
by O ADP
reports O NOUN
submitted O VERB
from O ADP
CHWs) O NOUN
improved O VERB
more O ADV
in O ADP
the O DET
intervention O NOUN
area O NOUN
relative O ADJ
to O PART
the O DET
comparison O NOUN
area, O NOUN
with O ADP
2 O NUM
out O ADP
of O ADP
3 O NUM
measures O NOUN
of O ADP
improvement O NOUN
reaching O VERB
statistical O ADJ
significance. O NOUN

Publication O NOUN
date: O NOUN
2019/03/07 O ADV
06:00 O ADP
[medline] O NOUN

Dietary O ADJ
carbohydrate O NOUN
reduction O NOUN
has O VERB
been O VERB
suggested O VERB
as O ADP
non-pharmacological O ADJ
therapy O NOUN
for O ADP
T2DM, O NOUN
but O CCONJ
the O DET
acute O ADJ
effects O NOUN
on O ADP
non-esterified B-outcome VERB
fatty I-outcome ADJ
acid I-outcome NOUN
(NEFA) I-outcome NUM
and O CCONJ
triglyceride B-outcome NOUN
(TG) I-outcome NOUN
during O ADP
subsequent O ADJ
meals O NOUN
remain O VERB
to O PART
be O VERB
investigated. O NOUN

However, O ADV
consistent O ADJ
with O ADP
previous O ADJ
research, O NOUN
we O PRON
present O ADJ
further O ADV
evidence O NOUN
of O ADP
a O DET
role O NOUN
for O ADP
active B-outcome ADJ
B12 I-outcome NOUN
, O PUNCT
HcY B-outcome NOUN
and O CCONJ
folate B-outcome NOUN
in O ADP
supporting O VERB
cognitive B-outcome ADJ
improvement O NOUN
in O ADP
adults O NOUN
with O ADP
low O ADJ
B O NOUN
vitamin O NOUN
status. O NOUN

Title: O NOUN
Role O NOUN
of O ADP
Lactobacillus O NOUN
rhamnosus O NOUN
(FloraActive) O NOUN
19070-2 O NUM
and O CCONJ
Lactobacillus O NOUN
reuteri O NOUN
(FloraActive) O NOUN
12246 O NUM
in O ADP
Infant O NOUN
Colic: O NOUN
A O DET
Randomized O VERB
Dietary O ADJ
Study. O NOUN

This O DET
trial O NOUN
began O VERB
in O ADP
January O NOUN
2013 O NUM
and O CCONJ
was O VERB
registered O VERB
with O ADP
the O DET
UMIN O NOUN
Clinical O ADJ
Trials O NOUN
Registry O NOUN
(UMIN000009634). O NUM

Journal O ADJ
ID: O NOUN
101281800 O NUM

316 O NUM
(29%) O NUM
of O ADP
1093 O NUM
infants O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
acquired O VERB
a O DET
late-onset O NOUN
infection B-outcome NOUN
versus O CCONJ
334 O NUM
(31%) O NUM
of O ADP
1089 O NUM
in O ADP
the O DET
control O NOUN
group. O VERB

Baseline O NOUN
characteristics O NOUN
were O VERB
comparable O ADJ
between O ADP
both O CCONJ
groups. O NOUN

CONCLUSIONS: O NOUN
This O DET
study O NOUN
concluded O VERB
that O ADP
if O ADP
targeting O VERB
the O DET
increasing O VERB
worldwide O ADJ
obesity O NOUN
problem O ADP
through O ADP
workplace O ADJ
initiated O VERB
weight O NOUN
loss O NOUN
programs, O NOUN
the O DET
sales O NOUN
pitch O NOUN
to O PART
managements O NOUN
and O CCONJ
employers O NOUN
have O VERB
to O PART
be O VERB
tailored O VERB
in O ADP
order O NOUN
to O PART
increase O NOUN
the O DET
participation O NOUN
and O CCONJ
the O DET
motivation O NOUN
for O ADP
the O DET
initiative. O PUNCT

In O ADP
conclusion, O NOUN
intraduodenal O ADJ
infusion O NOUN
of O ADP
L-valine, O ADJ
at O ADP
loads O NOUN
that O ADP
are O VERB
moderately O ADV
(3.3 O NOUN
g) O NOUN
or O CCONJ
substantially O ADV
(9.9 O PUNCT
g) O NOUN
above O ADP
World O NOUN
Health O NOUN
Organization O NOUN
valine O NOUN
requirement O NOUN
recommendations, O NOUN
does O VERB
not O ADV
appear O VERB
to O PART
have O VERB
energy B-outcome NOUN
intake I-outcome NOUN
- O PUNCT
or O CCONJ
blood B-outcome NOUN
glucose I-outcome NOUN
-lowering O VERB
effects. O NOUN

OBJECTIVES: O NOUN
To O PART
study O NOUN
if O ADP
four O NUM
cycles O NOUN
of O ADP
remote O ADV
ischemic O ADJ
preconditioning O VERB
(RIPC) O NUM
could O VERB
offer O VERB
protection O NOUN
against O ADP
contrast B-outcome NOUN
induced I-outcome VERB
nephropathy I-outcome NOUN
(CIN) I-outcome NOUN
and O CCONJ
post O ADV
procedural O ADJ
renal B-outcome ADJ
dysfunction I-outcome NOUN
in O ADP
high O ADJ
risk O NOUN
patients O NOUN
undergoing O VERB
percutaneous O ADJ
coronary O ADJ
intervention O NOUN
(PCI). O PUNCT

Journal O ADJ
ID: O NOUN
101521595 O NUM

A O DET
prenatal O ADJ
diet O NOUN
affects O NOUN
materno-foetal O ADJ
outcomes. O ADJ

Publication O NOUN
date: O NOUN
2019/01/20 O ADJ
06:00 O ADP
[entrez] O ADP

Journal O ADJ
ID: O NOUN
101234168 O NUM

DESIGN: O NOUN
A O DET
parallel-group O NOUN
randomized O VERB
controlled O VERB
trial. O NOUN

However, O ADV
blood O NOUN
loss O NOUN
and O CCONJ
fibrinolytic O ADJ
activity, O ADP
accounting O VERB
for O ADP
a O DET
poor O ADJ
prognosis O NOUN
following O VERB
TKA O NOUN
operation, O NOUN
were O VERB
relieved O VERB
by O ADP
fibrinolytic O ADJ
inhibitor O NOUN
tranexamic O ADJ
acid O NOUN
(TXA). O NOUN

108 O NUM
(27%) O NUM
of O ADP
394 O NUM
patients O NOUN
in O ADP
the O DET
ixazomib O NOUN
group O NOUN
and O CCONJ
51 O NUM
(20%) O NOUN
of O ADP
259 O NUM
patients O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
experienced O VERB
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
. O PUNCT
During O ADP
the O DET
treatment O NOUN
period, O NOUN
one O NUM
patient O NOUN
died B-outcome VERB
in O ADP
the O DET
ixazomib O NOUN
group O NOUN
and O CCONJ
none O NUM
died B-outcome VERB
in O ADP
the O DET
placebo O NOUN
group. O VERB

Participants O NOUN
were O VERB
randomized O VERB
in O ADP
a O DET
1:1 O ADJ
ratio O NOUN
to O PART
receive O VERB
either O CCONJ
800 O NUM
mug O NUM
of O ADP
misoprostol O NOUN
or O CCONJ
placebo O NOUN
sublingually O ADV
if O ADP
PPH O NOUN
was O VERB
diagnosed, O VERB
having O VERB
previously O ADV
received O VERB
a O DET
prophylactic O ADJ
oral O ADJ
dose O NOUN
of O ADP
600 O NUM
mug O NUM
misoprostol. O NOUN

RESULTS: O NOUN
the O DET
adaptive B-outcome ADJ
capacity I-outcome NOUN
was O VERB
measured O VERB
in O ADP
two O NUM
modes. O NOUN

The O DET
control O NOUN
group O NOUN
(n O NOUN
= O SYM
43) O NOUN
was O VERB
only O ADV
received O VERB
HRT. O NOUN

Title: O NOUN
Performance O NOUN
of O ADP
Litholyme O NOUN
compared O VERB
with O ADP
Sodasorb O ADV
carbon O NOUN
dioxide O NOUN
absorbents O NOUN
in O ADP
a O DET
standard O ADJ
clinical O ADJ
setting. O NOUN

Journal O ADJ
ID: O NOUN
101599229 O NUM

Journal O ADJ
ID: O NOUN
101521595 O NUM

Publication O NOUN
date: O NOUN
['2019/10/16 O NOUN
06:00' O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

CONCLUSION: O NOUN
Longitudinal O ADJ
profiling O VERB
is O VERB
an O DET
essential O ADJ
tool O NOUN
for O ADP
improving O VERB
our O ADJ
understanding O VERB
of O ADP
the O DET
microbiology O NOUN
of O ADP
chronic O ADJ
wounds, O ADV
as O ADP
community O NOUN
dynamics O NOUN
associated O VERB
with O ADP
clinical O ADJ
events O NOUN
can O VERB
only O ADV
be O VERB
identified O VERB
by O ADP
examining O VERB
changes O NOUN
over O ADP
multiple O ADJ
time O NOUN
points. O NOUN

The O DET
median O ADJ
opioid B-outcome NOUN
use I-outcome NOUN
in O ADP
24 O NUM
hours O NOUN
after O ADP
operation O NOUN
in O ADP
the O DET
paracetamol O NOUN
group O NOUN
was O VERB
lower O ADJ
when O ADP
compared O VERB
with O ADP
that O ADP
in O ADP
the O DET
dexmedetomidine O NOUN
group, O NOUN
and O CCONJ
the O DET
mean O NOUN
duration B-outcome NOUN
of I-outcome ADP
analgesia I-outcome NOUN
in O ADP
the O DET
paracetamol O NOUN
group O NOUN
was O VERB
higher O ADJ
when O ADP
comparing O VERB
with O ADP
dexmedetomidine O NOUN
group. O VERB

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

DISCUSSION: O NOUN
This O DET
trial O NOUN
is O VERB
designed O VERB
to O PART
confirm O NOUN
the O DET
effectiveness O NOUN
of O ADP
Simvastatin O NOUN
to O PART
protect O VERB
healthy O ADJ
and O CCONJ
steatotic O ADJ
livers O NOUN
undergoing O VERB
cold O NOUN
storage O NOUN
and O CCONJ
warm O ADP
reperfusion O NOUN
before O ADP
transplantation O NOUN
and O CCONJ
to O PART
evaluate O VERB
if O ADP
the O DET
addition O NOUN
of O ADP
Simvastatin O NOUN
translates O NOUN
into O ADP
improved O VERB
graft B-outcome NOUN
outcomes. O ADJ

The O DET
future O NOUN
researches O NOUN
with O ADP
longer O ADJ
pursuing O VERB
period's O NOUN
efficacy O NOUN
continuation O NOUN
are O VERB
suggested. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

METHODS: O NOUN
In O ADP
this O DET
experimental O ADJ
human O NOUN
laboratory O NOUN
study, O NOUN
participants O NOUN
(n O NOUN
= O SYM
128) O NOUN
were O VERB
randomised O VERB
to O PART
a O DET
self-affirmation O NOUN
or O CCONJ
control O NOUN
group. O VERB

Crossover O NOUN
to O PART
the O DET
sorafenib O NOUN
group O NOUN
was O VERB
permitted O VERB
for O ADP
patients O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
who O ADP
had O VERB
disease O NOUN
progression. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

INTERPRETATION: O CCONJ
Front-line O NOUN
treatment O NOUN
with O ADP
A+CHP O ADV
is O VERB
superior O ADJ
to O PART
CHOP O VERB
for O ADP
patients O NOUN
with O ADP
CD30-positive O ADJ
peripheral O ADJ
T-cell O NOUN
lymphomas O NOUN
as O ADP
shown O VERB
by O ADP
a O DET
significant O ADJ
improvement O NOUN
in O ADP
progression-free B-outcome ADJ
survival I-outcome NOUN
and O CCONJ
overall B-outcome ADJ
survival I-outcome NOUN
with O ADP
a O DET
manageable O ADJ
safety O NOUN
profile. O NOUN

Randomization O NOUN
began O VERB
on O ADP
November O NOUN
8, O NOUN
2010. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Patients O NOUN
were O VERB
tested O VERB
4 O NUM
weeks O NOUN
post-treatment O NOUN
to O PART
confirm O NOUN
eradication. O ADV

Journal-Name:Medicine O NOUN

Little O ADJ
is O VERB
known O VERB
regarding O VERB
the O DET
optimal O ADJ
method O NOUN
of O ADP
instruction O NOUN
for O ADP
this O DET
critical O ADJ
skill. O NOUN

Title: O NOUN
A O DET
Fully O ADV
Automated O VERB
Method O NOUN
for O ADP
the O DET
Determination O NOUN
of O ADP
Serum O NOUN
Belatacept O NOUN
and O CCONJ
Its O ADJ
Application O NOUN
in O ADP
a O DET
Pharmacokinetic O ADJ
Investigation O NOUN
in O ADP
Renal O ADJ
Transplant O NOUN
Recipients. O NOUN

Journal-Name:Zhonghua O NOUN
liu O NOUN
xing O VERB
bing O VERB
xue O NOUN
za O ADP
zhi O NUM
= O SYM
Zhonghua O NOUN
liuxingbingxue O NOUN
zazhi O NOUN

BACKGROUND: O NOUN
Observational O ADJ
data O NOUN
have O VERB
shown O VERB
that O ADP
slow O ADJ
advancement O ADJ
of O ADP
enteral O ADJ
feeding O VERB
volumes O NOUN
in O ADP
preterm O NOUN
infants O NOUN
is O VERB
associated O VERB
with O ADP
a O DET
reduced O VERB
risk O NOUN
of O ADP
necrotizing O VERB
enterocolitis O NOUN
but O CCONJ
an O DET
increased O VERB
risk O NOUN
of O ADP
late-onset O NOUN
sepsis. O NOUN

The O DET
haemoglobin B-outcome NOUN
and O CCONJ
hematocrit B-outcome NOUN
were O VERB
recorded; O NOUN
the O DET
total O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
and O CCONJ
intraoperative O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
were O VERB
calculated. O NOUN

However, O ADV
there O PRON
was O VERB
a O DET
statistically O ADV
significant O ADJ
improvement O NOUN
in O ADP
child O NOUN
and O CCONJ
parent O NOUN
reported O VERB
pain B-outcome NOUN
, O PUNCT
coordination B-outcome NOUN
and O CCONJ
grip B-outcome NOUN
strength I-outcome NOUN
in O ADP
both O CCONJ
groups. O NOUN

Systolic B-outcome ADJ
(SBP) I-outcome PUNCT
and X NUM
mean X NOUN
(MBP) X PUNCT
blood I-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
and O CCONJ
cardiac B-outcome ADJ
index O NOUN
(CI) O NOUN
were O VERB
related O VERB
to O PART
time O NOUN
after O ADP
polynomial O ADJ
transformation, O NOUN
and O CCONJ
showed O VERB
an O DET
increase O NOUN
after O ADP
intubation O NOUN
in O ADP
Group O NOUN
SM O NOUN
but O CCONJ
a O DET
decrease O NOUN
in O ADP
Group O NOUN
S O NOUN
(Ptime2*group<0.0001). O NOUN

RESULTS: O NOUN
The O DET
number O NOUN
of O ADP
task B-outcome NOUN
repetitions I-outcome NOUN
required O VERB
to O PART
reach O NOUN
the O DET
learning O VERB
curve O NOUN
plateau O NOUN
was O VERB
45, O NUM
42, O NUM
and O CCONJ
37 O NUM
repetitions O NOUN
in O ADP
groups O NOUN
I, O ADJ
II, O NOUN
and O CCONJ
III, O NOUN
which O ADP
means O NOUN
that O ADP
there O PRON
was O VERB
continuous O ADJ
improvement O NOUN
in O ADP
performing B-outcome VERB
the Seperator DET
task I-outcome NOUN
after O ADP
40 O NUM
repetitions O NOUN
only O ADV
in O ADP
groups O NOUN
I O NUM
and O CCONJ
II. O NUM

METHODS: O NOUN
In O ADP
this O DET
prospective, O NOUN
controlled O VERB
study, O NOUN
60 O NUM
age-related O VERB
cataract O NOUN
patients O NOUN
with O ADP
mild O ADJ
Meibomian O NOUN
gland O NOUN
dysfunction O NOUN
(MGD) O ADV
were O VERB
randomized O VERB
to O PART
treatment O NOUN
with O ADP
an O DET
ocular O ADJ
bandage O NOUN
contact O NOUN
lens O NOUN
(BCL) O PUNCT
(n O NOUN
= O SYM
30) O NOUN
or O CCONJ
to O PART
an O DET
untreated O VERB
control O NOUN
group O NOUN
(n O NOUN
= O SYM
30) O NOUN
after O ADP
phacoemulsification O NOUN
and O CCONJ
intraocular O ADJ
lens O NOUN
implantation. O NOUN

This O DET
study O NOUN
adds O NOUN
to O PART
a O DET
growing O VERB
body O NOUN
of O ADP
research O NOUN
showing O VERB
that O ADP
TC O NOUN
may O VERB
be O VERB
effective O ADJ
in O ADP
treating O VERB
depression O NOUN
of O ADP
the O DET
elderly. O NOUN

At O ADP
10 O NUM
minutes O NOUN
after O ADP
the O DET
beginning O VERB
of O ADP
atomization, O NOUN
the O DET
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
monitored O VERB
by O ADP
ventilator O NOUN
in O ADP
different O ADJ
preset O NOUN
suction O NOUN
pressure O NOUN
groups O NOUN
was O VERB
significantly O ADV
lower O ADJ
than O ADP
tidal B-outcome DET
volume I-outcome NOUN
showed O VERB
by O ADP
simulated O VERB
water O NOUN
lung O NOUN
(mL: O PUNCT
917.33+/-4.51 O NOUN
vs. O CCONJ
1 O NUM
103.33+/-5.77 O NOUN
at O ADP
20 O NUM
cmH2O O NOUN
of O ADP
preset O NOUN
suction O NOUN
pressure O NOUN
and O CCONJ
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow, O NOUN
P O NOUN
< O SYM
0.05), O NUM
and O CCONJ
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
was O VERB
significantly O ADV
higher O ADJ
than O ADP
tidal B-outcome DET
volume I-outcome NOUN
showed O VERB
by O ADP
simulated O VERB
water O NOUN
lung O NOUN
(mL: O PUNCT
1 O NUM
433.33+/-4.73 O NOUN
vs. O CCONJ
1 O NUM
103.33+/-5.77 O NOUN
at O ADP
20 O NUM
cmH2O O NOUN
of O ADP
preset O NOUN
suction O NOUN
pressure O NOUN
and O CCONJ
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow, O NOUN
P O NOUN
< O SYM
0.05). O NOUN

Background: O NOUN
Foot O NOUN
and O CCONJ
ankle O NOUN
characteristics O NOUN
and O CCONJ
dynamic O ADJ
knee O NOUN
valgus O NOUN
differ O VERB
in O ADP
people O NOUN
with O ADP
and O CCONJ
without O ADP
patellofemoral O ADJ
(PF) O NOUN
pain. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
Rectus O ADJ
Sheath O NOUN
Block O NOUN
(RSB) O NOUN
Analgesia O NOUN
Could O VERB
Enhance O NOUN
Significantly O ADV
the O DET
Patient O NOUN
Satisfaction B-outcome NOUN
Following O VERB
Midline O NOUN
Laparotomy O NOUN
in O ADP
Benign O ADV
Disease O NOUN
and O CCONJ
in O ADP
Cancer: O NOUN
A O DET
Prospective O ADJ
Study O NOUN
With O ADP
Special O ADJ
Reference O NOUN
to O PART
Nitrosative O ADJ
Stress O NOUN
Marker O NOUN
Nitrotyrosine B-outcome NOUN
(NT) I-outcome NOUN
Plasma O NOUN
Concentrations. O NOUN

Methods: O NOUN
Post O ADV
hoc O NOUN
analysis O NOUN
of O ADP
two O NUM
multicenter, O NOUN
randomized, O NOUN
double-blind, O NOUN
vehicle-controlled O VERB
Phase O NOUN
3 O NUM
studies O NOUN
in O ADP
moderate O ADJ
or O CCONJ
severe O ADJ
acne. O NOUN

These O DET
findings O NOUN
may O VERB
caution O NOUN
the O DET
use O NOUN
of O ADP
erythromycin O NOUN
as O ADP
empirical O ADJ
therapy O NOUN
in O ADP
these O DET
patients. O NOUN

Asthma O NOUN
and O CCONJ
body O NOUN
posture O ADJ
abnormalities O NOUN
in O ADP
children O NOUN
and O CCONJ
young O ADJ
people O NOUN
are O VERB
major O ADJ
epidemiological O ADJ
problems O NOUN
worldwide. O VERB

Journal-Name:Nutrients O NOUN

Other O ADJ
dentoalveolar B-outcome ADJ
changes O NOUN
in O ADP
both O CCONJ
groups O NOUN
were O VERB
intrusion B-outcome NOUN
of I-outcome ADP
the Seperator DET
maxillary I-outcome ADJ
first I-outcome ADV
molars I-outcome NOUN
, O PUNCT
and O CCONJ
extrusion B-outcome NOUN
of I-outcome ADP
the Seperator DET
mandibular I-outcome ADJ
first I-outcome ADV
molars I-outcome NOUN
and Seperator CCONJ
maxillary I-outcome ADJ
incisors S3-outcome NOUN
. O PUNCT
The O DET
mentolabial B-outcome ADJ
sulcus I-outcome NOUN
was O VERB
flattened, O NOUN
soft B-outcome NOUN
tissue I-outcome NOUN
convexity I-outcome NOUN
was O VERB
reduced, O VERB
and O CCONJ
forward O ADV
movement B-outcome NOUN
of I-outcome ADP
mandibular I-outcome ADJ
soft I-outcome NOUN
tissues I-outcome NOUN
was O VERB
seen O VERB
after O ADP
Herbst O NOUN
therapy. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Energy B-outcome NOUN
intake I-outcome NOUN
from O ADP
a O DET
buffet-meal O NOUN
immediately O ADV
after O ADP
the O DET
infusions O NOUN
was O VERB
quantified. O NOUN

Implants, O NOUN
titanium O NOUN
abutments, O NOUN
and O CCONJ
provisional O ADJ
crowns O VERB
were O VERB
placed O VERB
in O ADP
healed O VERB
ridges O NOUN
5 O NUM
months O NOUN
following O VERB
preservation O NOUN
after O ADP
tooth O NOUN
extraction O NOUN
with O ADP
recombinant O ADJ
human O NOUN
bone O NOUN
morphogenetic O ADJ
protein-2 O NOUN
(rhBMP-2). O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Antropyloroduodenal B-outcome ADJ
pressures I-outcome NOUN
, O PUNCT
plasma O NOUN
cholecystokinin B-outcome NOUN
, O PUNCT
blood B-outcome NOUN
glucose I-outcome NOUN
, O PUNCT
appetite B-outcome NOUN
perceptions I-outcome NOUN
and O CCONJ
gastrointestinal B-outcome ADJ
symptoms I-outcome NOUN
were O VERB
measured O VERB
during O ADP
90-min O NOUN
intraduodenal O ADJ
infusions O NOUN
of O ADP
L-valine O NOUN
at O ADP
0.15 O NUM
kcal/min O NOUN
(total: O NOUN
3.3 O NUM
g) O NOUN
or O CCONJ
0.45 O NUM
kcal/min O NOUN
(total: O NOUN
9.9 O NUM
g), O NOUN
or O CCONJ
0.9% O NOUN
saline O NOUN
(control). O NOUN

CONCLUSIONS: O NOUN
Amongst O ADP
patients O NOUN
undergoing O VERB
surgical O ADJ
repair O NOUN
of O ADP
open O ADJ
extremity O NOUN
fractures, O ADP
high O ADJ
SPOC O NOUN
questionnaire O NOUN
scores O NOUN
at O ADP
6 O NUM
weeks O NOUN
post-surgery O NOUN
were O VERB
predictive O ADJ
of O ADP
persistent B-outcome ADJ
pain I-outcome NOUN
, O PUNCT
reduced O VERB
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
and O CCONJ
pain B-outcome NOUN
interference I-outcome NOUN
at O ADP
1 O NUM
yr. O PUNCT

Journal O ADJ
ID: O NOUN
101225531 O NUM

White O ADP
sweet O ADJ
potato O NOUN
(WSP; O PUNCT
Ipomoea O NOUN
batatas O NOUN
L.), O NOUN
used O VERB
in O ADP
traditional O ADJ
medicine O NOUN
in O ADP
Brazil, O NOUN
Japan, O NOUN
and O CCONJ
Taiwan, O DET
is O VERB
a O DET
healthy O ADJ
carbohydrate O NOUN
source. O NOUN

Journal O ADJ
ID: O NOUN
101215359 O NUM

Journal O ADJ
ID: O NOUN
16210490R O NOUN

Publication O NOUN
date: O NOUN
2018/12/29 O NOUN
06:00 O ADP
[entrez] O ADP

During O ADP
induction O NOUN
chemotherapy, O NOUN
the O DET
incidence O NOUN
rates O NOUN
of O ADP
leukocytopenia B-outcome NOUN
(43.3% O PUNCT
vs. O CCONJ
80%, O NUM
P O NOUN
= O SYM
0.003), O NUM
thrombocytopenia B-outcome NOUN
(26.7% O NUM
vs. O CCONJ
56.7%, O NUM
P O NOUN
= O SYM
0.018), O NUM
and O CCONJ
nausea/vomiting B-outcome VERB
(40% O PUNCT
vs. O CCONJ
66.7%, O NUM
P O NOUN
= O SYM
0.038) O NUM
were O VERB
significantly O ADV
lower O ADJ
in O ADP
the O DET
CC O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
RC O NOUN
group. O VERB

Plasma O NOUN
vitamins B-outcome NOUN
and O CCONJ
phytonutrients B-outcome NOUN
were O VERB
significantly O ADV
correlated O VERB
with O ADP
ROS O NOUN
scavenging O VERB
and O CCONJ
DNA O NOUN
damage. O NOUN

Total O ADJ
180 O NUM
patients O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
Group O NOUN
A O DET
in O ADP
which O ADP
patients O NOUN
received O VERB
0.2% O NOUN
bio-adhesive O ADJ
chlorhexidine O NOUN
gel O NOUN
and O CCONJ
Group O NOUN
B O NOUN
where O ADP
patients O NOUN
received O VERB
placebo O NOUN
gel O NOUN
in O ADP
the O DET
extraction O NOUN
socket O NOUN
after O ADP
removal O NOUN
of O ADP
mandibular O ADJ
third O ADJ
molar. O NOUN

CONCLUSION: O NOUN
We O PRON
propose O NOUN
that O ADP
CSO O NOUN
intake O NOUN
may O VERB
partly O ADV
exert O NOUN
its O ADJ
benefits O NOUN
through O ADP
immuno-inflammatory O ADJ
molecular O ADJ
regulation O NOUN
in O ADP
PBMCs, O NOUN
while O ADP
modulation O NOUN
of O ADP
ICAM1 O NOUN
expression, O NOUN
an O DET
endothelial/vascular-related O VERB
gene, O ADJ
may O VERB
be O VERB
more O ADV
dependent O ADJ
on O ADP
the O DET
type O NOUN
of O ADP
fish O NOUN
consumed. O NOUN

RESULTS: O NOUN
After O ADP
6-week O NOUN
treatment O NOUN
and O CCONJ
2-week O NOUN
follow-up, O ADP
although O ADP
ET O NOUN
plus O CCONJ
montelukast O NOUN
did O VERB
not O ADV
show O VERB
better O ADJ
effectiveness O NOUN
in O ADP
improving O VERB
lung B-outcome NOUN
function I-outcome NOUN
, O PUNCT
as O ADP
evaluated O VERB
by O ADP
the O DET
forced B-outcome VERB
expiratory I-outcome ADJ
volume I-outcome NOUN
in Seperator ADP
1 I-outcome NUM
second I-outcome ADJ
(FEV1) I-outcome NOUN
(P O NUM
> O SYM
.05) O NOUN
and O CCONJ
FEV1/FVC B-outcome NOUN
(P O NUM
> O SYM
.05) O NOUN
than O ADP
montelukast O NOUN
alone, O NOUN
significant O ADJ
relief O NOUN
in O ADP
clinical B-outcome ADJ
symptoms I-outcome NOUN
(P O NUM
< O SYM
.01), O PUNCT
and O CCONJ
improvement O NOUN
in O ADP
Quality B-outcome NOUN
of I-outcome ADP
Life I-outcome NOUN
(P O NUM
< O SYM
.01) O PUNCT
have O VERB
achieved. O NOUN

The O DET
average O NOUN
available O ADJ
energy O NOUN
(calorie) O NOUN
content O NOUN
of O ADP
a O DET
28 O NUM
g O NOUN
serving O VERB
of O ADP
cashew O NOUN
nuts O NOUN
was O VERB
137 O NUM
kcal O NOUN
(+/-3.4 O NUM
kcal O NOUN
SEM) O NOUN
and O CCONJ
ranged O VERB
from O ADP
105 O NUM
to O PART
151 O NUM
kcal. O NOUN

The O DET
patients O NOUN
with O ADP
exercise O NOUN
habit O NOUN
(n O NOUN
= O SYM
31) O NOUN
showed O VERB
lower O ADJ
incidence O NOUN
of O ADP
pain B-outcome NOUN
than O ADP
patients O NOUN
without O ADP
exercise O NOUN
habit O NOUN
(n O NOUN
= O SYM
26) O NOUN
(P O NUM
= O SYM
.002, O ADP
P O NOUN
= O SYM
.005, O PUNCT
and O CCONJ
P O NOUN
= O SYM
.037 O NUM
in O ADP
overall, B-outcome NOUN
abdominal, B-outcome ADJ
and Seperator CCONJ
shoulder B-outcome NOUN
pain E1-outcome NOUN
, O PUNCT
respectively). O NOUN

This O DET
trial O NOUN
is O VERB
registered O VERB
with O ADP
ClinicalTrials.gov, O NOUN
number O NOUN
NCT01777152. O NOUN

The O DET
secondary O ADJ
outcomes O NOUN
consisted O VERB
of O ADP
shoulder B-outcome NOUN
disorder I-outcome ADP
, O PUNCT
measured O VERB
by O ADP
the O DET
score O NOUN
of O ADP
shoulder B-outcome NOUN
pain I-outcome NOUN
and O CCONJ
disability B-outcome NOUN
index O NOUN
(SPADI)]; O NOUN
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
assessed O VERB
by O ADP
the O DET
Short O NOUN
Form-36 O NOUN
questionnaire O NOUN
(SF-36)]; O NOUN
and O CCONJ
any O DET
adverse B-outcome ADJ
events I-outcome NOUN
(AEs) I-outcome NOUN
during O ADP
the O DET
treatment O NOUN
period. O NOUN

Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT01656278. O NOUN

This O DET
trial O NOUN
was O VERB
registered O VERB
with O ADP
ClinicalTrials.gov, O NOUN
number O NOUN
NCT02413372. O NOUN

Journal O ADJ
ID: O NOUN
8102988 O NUM

Pain B-outcome NOUN
scores O NOUN
and O CCONJ
the O DET
use B-outcome NOUN
of I-outcome ADP
rescue I-outcome NOUN
analgesics I-outcome NOUN
were O VERB
not O ADV
significantly O ADV
different O ADJ
between O ADP
2 O NUM
groups. O NOUN

Publication O NOUN
date: O NOUN
2019/02/12 O ADJ
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

We O PRON
enrolled O VERB
522 O NUM
patients O NOUN
with O ADP
microscopically O ADV
confirmed O VERB
P. O NOUN
vivax O NOUN
infection O NOUN
(>100 O NOUN
to O PART
<100,000 O NUM
parasites O NOUN
per O ADP
microliter) O NOUN
and O CCONJ
normal O ADJ
glucose-6-phosphate O NOUN
dehydrogenase O NOUN
(G6PD) O PUNCT
activity O NOUN
(with O PUNCT
normal O ADJ
activity O NOUN
defined O VERB
as O ADP
>/=70% O NUM
of O ADP
the O DET
median O ADJ
value O NOUN
determined O VERB
at O ADP
each O DET
trial O NOUN
site O NOUN
among O ADP
36 O NUM
healthy O ADJ
male O NOUN
volunteers O NOUN
who O ADP
were O VERB
otherwise O NOUN
not O ADV
involved O VERB
in O ADP
the O DET
trial). O NOUN

Publication O NOUN
date: O NOUN
2018/12/17 O NOUN
00:00 O NOUN
[accepted] O ADV

We O PRON
studied O VERB
whether O ADP
a O DET
DHA O NOUN
supply O NOUN
modified O VERB
plasma O NOUN
docosahexaenoic B-outcome VERB
acid I-outcome NOUN
(DHA) I-outcome NOUN
and O CCONJ
neurological B-outcome ADJ
and Seperator CCONJ
intellectual B-outcome ADJ
functioning E1-outcome VERB
in O ADP
PKU. O NOUN

ETHNOPHARMACOLOGICAL O ADJ
RELEVANCE: O NOUN
Polygala O NOUN
tenuifolia O NOUN
Willdenow O NOUN
root O NOUN
extract O NOUN
(BT-11) O NOUN
has O VERB
beneficial O ADJ
effects O NOUN
on O ADP
central O ADJ
nervous O ADJ
system O NOUN
disorders O NOUN
in O ADP
human. O NOUN

Journal O ADJ
ID: O NOUN
0374675 O NUM

Maternal B-outcome ADJ
outcomes O NOUN
and O CCONJ
other O ADJ
obstetric B-outcome ADP
interventions I-outcome NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
the O DET
strategies. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

The O DET
interventions O NOUN
were O VERB
conducted O VERB
by O ADP
means O NOUN
of O ADP
home O NOUN
visits O NOUN
over O ADP
6 O NUM
months. O NOUN

Publication O NOUN
date: O NOUN
2019/03/02 O ADJ
06:00 O ADP
[medline] O NOUN

During O ADP
the O DET
trial O NOUN
there O PRON
were O VERB
16 O NUM
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
for O ADP
infants O NOUN
in O ADP
the O DET
lactoferrin O NOUN
group O NOUN
and O CCONJ
10 O NUM
for O ADP
infants O NOUN
in O ADP
the O DET
control O NOUN
group. O VERB

At O ADP
6 O NUM
min, O NOUN
hemostasis B-outcome NOUN
was O VERB
achieved O NOUN
in O ADP
93.0% O NOUN
(238/256) O NOUN
of O ADP
the O DET
HP O NOUN
group O NOUN
compared O VERB
to O PART
77.3% O NUM
(102/132) O NOUN
of O ADP
the O DET
G O NOUN
+ O SYM
T O NOUN
group O NOUN
(non-inferiority O NUM
P O NOUN
< O SYM
0.0001, O NUM
superiority O NOUN
P O NOUN
< O SYM
0.0001). O NUM

The O DET
efficacy O NOUN
of O ADP
PZQ O NOUN
will O VERB
be O VERB
evaluated O VERB
in O ADP
stool O NOUN
samples O NOUN
using O VERB
the O DET
KK O NOUN
technique O NOUN
and O CCONJ
real-time O NOUN
PCR O NOUN
as O ADP
well O ADV
as O ADP
in O ADP
urine O NOUN
using O VERB
the O DET
point-of-care O NOUN
circulating O VERB
cathodic O ADJ
antigen O NOUN
test O NOUN
and O CCONJ
the O DET
up-converting O VERB
phosphor, O NOUN
lateral O ADJ
flow, O NOUN
circulating O VERB
anodic O NOUN
antigen O NOUN
assay. O NOUN

Journal-Name:Nutrients O NOUN

BACKGROUND: O NOUN
We O PRON
examined O VERB
whether O ADP
enhancing O VERB
self-affirmation O NOUN
among O ADP
a O DET
population O NOUN
of O ADP
drinkers, O NOUN
prior O ADJ
to O PART
viewing O VERB
threatening O VERB
alcohol O NOUN
pictorial O ADJ
health O NOUN
warning O VERB
labels, O NOUN
would O VERB
reduce O VERB
defensive B-outcome ADJ
reactions I-outcome NOUN
and O CCONJ
promote O VERB
reactions B-outcome NOUN
related O VERB
to O PART
behaviour O NOUN
change. O NOUN

For O ADP
observed O VERB
pain B-outcome NOUN
, O PUNCT
ANOVA O NOUN
results O NOUN
did O VERB
show O VERB
a O DET
significant O ADJ
interaction O NOUN
(p O PUNCT
< O SYM
.05) O NOUN
between O ADP
group O NOUN
and O CCONJ
study O NOUN
interval. O NOUN

The O DET
sterol B-outcome NOUN
regulatory I-outcome ADJ
element-binding I-outcome VERB
protein-1 I-outcome NOUN
(SREBP1) I-outcome NUM
expression I-outcome NOUN
in O ADP
endometrial O ADJ
tissues O NOUN
was O VERB
detected O VERB
by O ADP
qRT-PCR. O NOUN

This O DET
study O NOUN
was O VERB
performed O VERB
in O ADP
a O DET
double-blind, O NOUN
randomized O VERB
crossover O NOUN
fashion O NOUN
consisting O VERB
of O ADP
two O NUM
exhaustive O ADJ
exercise O NOUN
protocols. O NOUN

Electromyographic B-outcome ADJ
amplitude I-outcome ADJ
did O VERB
not O ADV
differ O VERB
between O ADP
limbs O NOUN
or O CCONJ
groups O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
intervention. O NOUN

Compared O VERB
to O PART
controls, O NOUN
subcutaneous B-outcome ADJ
and Seperator CCONJ
intra-abdominal B-outcome ADJ
fat E1-outcome NOUN
reduced O VERB
significantly O ADV
with O ADP
both O CCONJ
diet O NOUN
(- O NOUN
12.5% O NUM
and O CCONJ
- O PUNCT
12.0%) O NOUN
and O CCONJ
exercise O NOUN
plus O CCONJ
diet O NOUN
(- O NOUN
16.0% O NUM
and O CCONJ
- O PUNCT
14.6%). O NUM

FINDINGS: O ADJ
Between O ADP
Feb O NOUN
1, O NOUN
2014, O NUM
and O CCONJ
Aug O NOUN
31, O NUM
2016, O NUM
2772 O NUM
couples O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
receive O VERB
PICSI O NOUN
(n=1387) O NUM
or O CCONJ
ICSI O NOUN
(n=1385), O PUNCT
of O ADP
whom O ADP
2752 O NUM
(1381 O PUNCT
in O ADP
the O DET
PICSI O NOUN
group O NOUN
and O CCONJ
1371 O NUM
in O ADP
the O DET
ICSI O NOUN
group) O ADJ
were O VERB
included O VERB
in O ADP
the O DET
primary O ADJ
analysis. O NOUN

In O ADP
patients O NOUN
with O ADP
episodic O NOUN
migraine, O ADJ
>/=50% O ADV
response O NOUN
was O VERB
maintained O VERB
in O ADP
41.5 O NUM
and O CCONJ
41.1% O NOUN
of O ADP
galcanezumab-treated O VERB
patients O NOUN
(120 O NUM
mg O NOUN
and O CCONJ
240 O NUM
mg, O NOUN
respectively) O NOUN
for O ADP
>/=3 O NOUN
consecutive O ADJ
months O NOUN
(until O NOUN
patient's O NOUN
endpoint) O NOUN
and O CCONJ
19.0 O NUM
and O CCONJ
20.5%, O NUM
respectively, O NOUN
for O ADP
6 O NUM
consecutive O ADJ
months O NOUN
and O CCONJ
was O VERB
significantly O ADV
greater O ADJ
than O ADP
the O DET
21.4 O NUM
and O CCONJ
8.0% O NOUN
of O ADP
placebo-treated O VERB
patients O NOUN
at O ADP
>/=3 O NOUN
and O CCONJ
6 O NUM
months O NOUN
consecutively O ADV
(P O NUM
< O SYM
0.001). O NUM

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
Independent O ADJ
coprimary O ADJ
outcomes O NOUN
were O VERB
patient-reported O VERB
persistence B-outcome NOUN
with O ADP
P2Y12 O NOUN
inhibitor O NOUN
(defined O NUM
as O ADP
continued O NOUN
treatment O NOUN
without O ADP
gap O NOUN
in O ADP
use O NOUN
>/=30 O NOUN
days) O NOUN
and O CCONJ
major B-outcome ADJ
adverse I-outcome ADJ
cardiovascular I-outcome ADJ
events I-outcome NOUN
(MACE) I-outcome PUNCT
( O PUNCT
death B-outcome NOUN
, O PUNCT
recurrent B-outcome ADP
MI I-outcome NOUN
, O PUNCT
or O CCONJ
stroke B-outcome NOUN
) O PUNCT
at O ADP
1 O NUM
year O NOUN
among O ADP
patients O NOUN
discharged O VERB
with O ADP
a O DET
prescription O NOUN
for O ADP
clopidogrel O NOUN
or O CCONJ
ticagrelor. O NUM

Journal O ADJ
ID: O NOUN
101213819 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Department O NOUN
of O ADP
Pharmacy O NOUN
Practice, O NOUN
Sri O NOUN
Adichunchanagiri O NOUN
College O NOUN
of O ADP
Pharmacy, O NOUN
B. O NOUN
G. O NOUN
Nagara, O NOUN
Karnataka, O NOUN
India. O NOUN

RESULTS: O NOUN
After O ADP
treatment, O NOUN
patients O NOUN
in O ADP
the O DET
Gua O NOUN
Sha O NOUN
group O NOUN
reported O VERB
lower O ADJ
pain B-outcome NOUN
intensity I-outcome NOUN
(p<0.001) O PUNCT
and O CCONJ
better O ADJ
overall O ADJ
health B-outcome NOUN
status O NOUN
(p=0.002) O NOUN
compared O VERB
to O PART
the O DET
waitlist O ADJ
group. O VERB

In O ADP
logistic O ADJ
regression O NOUN
models, O NOUN
treatment O NOUN
group O NOUN
membership O NOUN
was O VERB
significantly O ADV
associated O VERB
with O ADP
spectacle B-outcome NOUN
ownership I-outcome NOUN
(Odds O NOUN
Ratio O NOUN
[OR] O NOUN
= O SYM
11.9, O VERB
p O NOUN
< O SYM
0.001) O NUM
and O CCONJ
wearing B-outcome VERB
behavior I-outcome NOUN
(OR O NOUN
= O SYM
7.2, O NOUN
p O NOUN
< O SYM
0.001). O NUM

Journal-Name:Lancet O NOUN
(London, O PUNCT
England) O NOUN

Electromyographic B-outcome ADJ
amplitude I-outcome ADJ
and Seperator CCONJ
median X NOUN
frequency S1-outcome NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
limbs O NOUN
at O ADP
the O DET
start O NOUN
of O ADP
the O DET
intervention. O NOUN

The O DET
EMID O NOUN
study O NOUN
is O VERB
a O DET
randomized O VERB
and O CCONJ
controlled O VERB
clinical O ADJ
trial O NOUN
with O ADP
two O NUM
parallel O ADJ
groups O NOUN
and O CCONJ
a O DET
12-month O NOUN
follow-up O NOUN
period. O NOUN

RESULTS: O NOUN
A O DET
2 O NUM
(group) O PUNCT
x O SYM
2 O NUM
(time) O PUNCT
repeated O VERB
measures O NOUN
ANOVA O NOUN
showed O VERB
there O PRON
was O VERB
a O DET
significant O ADJ
main O ADJ
effect O NOUN
on O ADP
time O NOUN
for O ADP
increase O NOUN
in O ADP
the O DET
composite O NOUN
strength B-outcome NOUN
score O NOUN
(p O PUNCT
= O SYM
.002, O ADP
engp2 O NOUN
= O SYM
.18). O NUM

Hops, O NOUN
the O DET
immature O ADJ
inflorescences O NOUN
of O ADP
the O DET
female O NOUN
hop O NOUN
plant O NOUN
(Humulus O NOUN
lupulus O NOUN
L.) O ADP
are O VERB
one O NUM
of O ADP
the O DET
main O ADJ
components O NOUN
of O ADP
beer O NOUN
and O CCONJ
provides O NOUN
flavor O NOUN
and O CCONJ
bitterness. O NOUN

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

Publication O NOUN
Type: O NOUN
Clinical O ADJ
Trial, O NOUN
Phase O NOUN
III O NUM

No O DET
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
occurred. O NOUN

Journal-Name:JAMA O NOUN

Journal-Name: O NOUN
Lin O NOUN
chuang O NOUN
er O NOUN
bi O ADP
yan O NOUN
hou O VERB
tou O NOUN
jing O VERB
wai O CCONJ
ke O NOUN
za O ADP
zhi O NUM
= O SYM
Journal O ADJ
of O ADP
clinical O ADJ
otorhinolaryngology, O NOUN
head, O ADJ
and O CCONJ
neck O NOUN
surgery O NOUN

Journal-Name:Medicine O NOUN

The O DET
7-year O NOUN
biochemical B-outcome ADJ
failure-free I-outcome ADJ
survival I-outcome NOUN
(BCFFS) I-outcome NUM
of O ADP
the O DET
MHF O NOUN
and O CCONJ
EHF O NOUN
groups O NOUN
were O VERB
90.5 O NUM
and O CCONJ
57.1% O NUM
in O ADP
the O DET
low-risk O NOUN
group O NOUN
(p O PUNCT
= O SYM
0.154); O NOUN
83.5 O NUM
and O CCONJ
42.9% O NUM
in O ADP
the O DET
intermediate O ADJ
risk O NOUN
group O NOUN
(p O PUNCT
= O SYM
0.018); O NUM
and O CCONJ
41.7 O NUM
and O CCONJ
40.0% O NUM
in O ADP
the O DET
high O ADJ
risk O NOUN
group O NOUN
(p O PUNCT
= O SYM
0.786), O NUM
respectively. O NOUN

At O ADP
Month O NOUN
6, O NOUN
there O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
groups O NOUN
(P O NUM
= O SYM
.85) O NUM
with O ADP
regard O NOUN
to O PART
analgesics B-outcome NOUN
and O CCONJ
social B-outcome ADJ
impact. O NOUN

Meanwhile, O NOUN
active B-outcome ADJ
flexional I-outcome ADJ
angle I-outcome NOUN
and O CCONJ
passive B-outcome ADJ
flexional I-outcome ADJ
angle I-outcome NOUN
in O ADP
preoperative O ADJ
analgesia O NOUN
group O NOUN
were O VERB
larger O ADJ
than O ADP
that O ADP
in O ADP
postoperative O ADJ
analgesia O NOUN
group O NOUN
at O ADP
72 O NUM
hours O NOUN
post O ADV
operation. O ADV

Title: O NOUN
Baltimore O NOUN
CONNECT: O NOUN
A O DET
Randomized O VERB
Trial O NOUN
to O PART
Build O NOUN
Partnership O NOUN
Between O ADP
Community O NOUN
Organizations O NOUN
and O CCONJ
a O DET
Local O ADJ
Health O NOUN
System. O NOUN

Both O CCONJ
PPI O NOUN
and O CCONJ
H2 O NOUN
blocker O NOUN
could O VERB
inhibit O NOUN
acid B-outcome NOUN
reflux I-outcome NOUN
. O PUNCT
LPR O NOUN
was O VERB
diagnosed O VERB
with O ADP
reflux O NOUN
finding O VERB
score O NOUN
and O CCONJ
reflux O NOUN
symptom O NOUN
index. O NOUN

Journal O ADJ
ID: O NOUN
101249598 O NUM

This O DET
was O VERB
a O DET
post O ADV
hoc O NOUN
investigation O NOUN
of O ADP
serum O NOUN
noggin B-outcome NOUN
levels O NOUN
among O ADP
TDT O NOUN
patients O NOUN
with O ADP
osteoporosis O NOUN
who O ADP
participated O VERB
in O ADP
a O DET
randomized, O NOUN
placebo-control, O NOUN
phase O NOUN
2b O NOUN
study. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Journal O ADJ
ID: O NOUN
0374675 O NUM

Journal-Name:Medicine O NOUN

OBJECTIVE: O NOUN
To O PART
evaluate O VERB
the O DET
effect O NOUN
of O ADP
lacrimal O ADJ
duct O NOUN
probing O VERB
combined O VERB
with O ADP
tobramycin/dexamethasone O NOUN
eye O NOUN
drops O NOUN
or O CCONJ
ointment O NOUN
on O ADP
persistent O ADJ
CNLDO O NOUN
in O ADP
children O NOUN
older O ADJ
than O ADP
1-year-old. O ADV

Yi O NOUN
xue O NOUN
ban O NOUN
= O SYM
Journal O ADJ
of O ADP
Peking O VERB
University. O NOUN

Extracorporeal O PUNCT
magnetic O ADJ
innervation O NOUN
(ExMI) O NUM
is O VERB
a O DET
relatively O ADV
new O ADJ
conservative O ADJ
treatment O NOUN
method O NOUN
for O ADP
UI. O NOUN

Journal O ADJ
ID: O NOUN
101126433 O NUM

CONCLUSIONS: O NOUN
Omadacycline O NOUN
was O VERB
noninferior O ADJ
to O PART
linezolid O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
acute O ADJ
bacterial O ADJ
skin O NOUN
and O CCONJ
skin-structure O NOUN
infections O NOUN
and O CCONJ
had O VERB
a O DET
similar O ADJ
safety O NOUN
profile. O NOUN
( O PUNCT

The O DET
mean O NOUN
increase O NOUN
in O ADP
peak B-outcome NOUN
oxygen I-outcome NOUN
uptake I-outcome NOUN
, O PUNCT
relative O ADJ
to O PART
control, O NOUN
was O VERB
greater O ADJ
following O VERB
HIIT O NOUN
than O ADP
MICT O NOUN
(2.4 O NOUN
vs. O CCONJ
0.7 O NUM
mL/kg/min). O NOUN

In O ADP
terms O NOUN
of O ADP
adverse B-outcome ADJ
reactions I-outcome NOUN
, O PUNCT
the O DET
incidence O NOUN
of O ADP
bone B-outcome NOUN
marrow I-outcome NOUN
suppression I-outcome NOUN
, O PUNCT
gastrointestinal B-outcome ADJ
reaction I-outcome NOUN
and O CCONJ
low-protein B-outcome NOUN
reaction I-outcome NOUN
was O VERB
significantly O ADV
lower O ADJ
in O ADP
group O NOUN
A O DET
than O ADP
that O ADP
in O ADP
group O NOUN
BP<0.05. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
intraoperative O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
, O PUNCT
total O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
, O PUNCT
hemoglobin B-outcome NOUN
and O CCONJ
hematocrit B-outcome NOUN
before O ADP
operation O NOUN
and O CCONJ
at O ADP
1 O NUM
and O CCONJ
3 O NUM
days O NOUN
after O ADP
operation, O NOUN
and O CCONJ
C-reactive B-outcome ADJ
protein I-outcome NOUN
and O CCONJ
erythrocyte B-outcome NOUN
sedimentation I-outcome NOUN
rate I-outcome NOUN
before O ADP
operation O NOUN
and O CCONJ
at O ADP
1, O NOUN
3, O NOUN
and O CCONJ
14 O NUM
days O NOUN
between O ADP
2 O NUM
groups O NOUN
( O PUNCT
P>0.05). O NOUN

Global B-outcome NOUN
health I-outcome NOUN
status O NOUN
showed O VERB
a O DET
more O ADV
favourable O ADJ
time O NOUN
course O NOUN
in O ADP
the O DET
ATLG O NOUN
group O NOUN
compared O VERB
with O ADP
the O DET
non-ATLG O NOUN
group O NOUN
(p=0.02; O NOUN
treatment O NOUN
by O ADP
visit O NOUN
interaction). O NOUN

Journal-Name:Medicine O NOUN

Mean O NOUN
steps/day B-outcome NOUN
were O VERB
significantly O ADV
lower O ADJ
in O ADP
the O DET
intervention O NOUN
vs O CCONJ
control O NOUN
group O NOUN
(adjusted O PUNCT
mean O NOUN
difference O NOUN
= O SYM
- O PUNCT
336, O NOUN
95% O NOUN
CI: O NOUN
-612 O NUM
to O PART
- O PUNCT
60, O NOUN
p O NOUN
= O SYM
0.02) O NUM
at O ADP
6 O NUM
months. O NOUN

Methods: O NOUN
A O DET
total O ADJ
of O ADP
52 O NUM
women O NOUN
were O VERB
included O VERB
in O ADP
the O DET
analysis: O NOUN
28 O NUM
participants O NOUN
were O VERB
allocated O VERB
to O PART
the O DET
experimental O ADJ
group O NOUN
(EG) O NOUN
and O CCONJ
24 O NUM
to O PART
the O DET
control O NOUN
group O NOUN
(CG). O NUM

RESULTS: O NOUN
Improved O VERB
physical B-outcome ADJ
fitness I-outcome ADP
was O VERB
demonstrated O VERB
in O ADP
the O DET
exercise O NOUN
group O NOUN
by O ADP
increases O NOUN
in O ADP
median O ADJ
estimated O VERB
VO2max O NOUN
(Baseline: O PUNCT
43.41mls/kg/min; O PUNCT
post-intervention: O NOUN
46.01mls/kg/min; O NOUN
p O NOUN
= O SYM
0.03). O NUM

SUBJECTS/METHODS: O NOUN
Samples O NOUN
from O ADP
72 O NUM
participants O NOUN
randomized O VERB
to O PART
one O NUM
of O ADP
the O DET
following O VERB
12-week O NOUN
intervention O NOUN
groups, O NOUN
FF O NOUN
(n O NOUN
= O SYM
19), O NUM
LF O NOUN
(n O NOUN
= O SYM
19), O NUM
CSO O NOUN
(n O NOUN
= O SYM
17) O NOUN
or O CCONJ
a O DET
control O NOUN
group O NOUN
(n O NOUN
= O SYM
17), O NUM
were O VERB
available O ADJ
for O ADP
the O DET
PBMC O NOUN
study. O NOUN

A O DET
sample O NOUN
of O ADP
210 O NUM
pregnant O ADJ
women O NOUN
within O ADP
gestational O ADJ
ages O NOUN
of O ADP
16-24 O NUM
wk O NOUN
were O VERB
recruited O VERB
at O ADP
antenatal O ADJ
clinics O NOUN
and O CCONJ
equally O ADV
randomized O VERB
to O PART
either O CCONJ
a O DET
two-dose O NOUN
SP O NOUN
or O CCONJ
three-dose O NOUN
SP O NOUN
group. O VERB

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
Participants O NOUN
requiring O VERB
replacement O NOUN
of O ADP
single O ADJ
maxillary O ADJ
anterior O ADJ
and O CCONJ
first O ADV
premolar O ADJ
teeth O NOUN
were O VERB
recruited O VERB
and O CCONJ
treated O VERB
under O ADP
an O DET
institutional O ADJ
review O NOUN
board O ADP
(IRB)-approved O PUNCT
protocol. O NOUN

However, O ADV
Kruskal O NOUN
Wallis O NOUN
test O NOUN
did O VERB
not O ADV
show O VERB
a O DET
significant O ADJ
relationship O NOUN
between O ADP
the O DET
three O NUM
positions O NOUN
under O ADP
study O NOUN
and O CCONJ
the O DET
mean O NOUN
gastric B-outcome ADJ
residual I-outcome ADJ
volume I-outcome NOUN
. O PUNCT
CONCLUSION: O NOUN
Prone O NOUN
position O NOUN
was O VERB
featured O VERB
with O ADP
the O DET
lowest O ADV
gastric B-outcome ADJ
residual I-outcome ADJ
volume I-outcome NOUN
and O CCONJ
highest O ADP
possibility O NOUN
of O ADP
absorbing B-outcome VERB
nutrient I-outcome NOUN
. O PUNCT
Still, O NOUN
given O VERB
the O DET
fact O NOUN
that O ADP
no O DET
significant O ADJ
difference O NOUN
was O VERB
found O VERB
in O ADP
the O DET
three O NUM
groups, O NOUN
further O ADV
and O CCONJ
deeper O NOUN
studies O NOUN
are O VERB
needed. O NOUN

Rectal B-outcome ADJ
temperature I-outcome NOUN
, O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
, O PUNCT
thermal B-outcome ADJ
sensation I-outcome NOUN
, O PUNCT
and O CCONJ
ratings O NOUN
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
were O VERB
measured O VERB
at O ADP
various O ADJ
times O NOUN
before, O NOUN
during, O NOUN
and O CCONJ
after O ADP
exercise. O NOUN

CONCLUSIONS/SIGNIFICANCE: O NOUN
The O DET
extended O VERB
treatment O NOUN
strategy O NOUN
with O ADP
the O DET
combination O NOUN
regimen O NOUN
showed O VERB
the O DET
highest O ADP
documented O VERB
efficacy O NOUN
in O ADP
HIV-VL O NOUN
patients; O NOUN
these O DET
results O NOUN
support O NOUN
a O DET
recommendation O NOUN
of O ADP
this O DET
regimen O NOUN
as O ADP
first-line O NOUN
treatment O NOUN
strategy O NOUN
for O ADP
HIV-VL O NOUN
patients O NOUN
in O ADP
eastern O NOUN
Africa. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Treatment B-outcome NOUN
failure I-outcome NOUN
occurred O VERB
in O ADP
74 O NUM
of O ADP
506 O NUM
participants O NOUN
(14.6%) O ADV
in O ADP
the O DET
intravenous O ADJ
group O NOUN
and O CCONJ
67 O NUM
of O ADP
509 O NUM
participants O NOUN
(13.2%) O PUNCT
in O ADP
the O DET
oral O ADJ
group. O VERB

Furthermore, O NOUN
trends O NOUN
for O ADP
sex O NOUN
differences O NOUN
were O VERB
discovered O VERB
in O ADP
urinary, O ADJ
but O CCONJ
not O ADV
salivary, O ADJ
hydration B-outcome NOUN
markers, O NOUN
with O ADP
discrepancies O NOUN
in O ADP
kinetics O NOUN
between O ADP
fluid O NOUN
compartments O NOUN
both O CCONJ
warranting O VERB
further O ADV
study. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
This O DET
trial O NOUN
is O VERB
registered O VERB
on O ADP
ClinicalTrials.gov O NOUN
(identifier: O NOUN
NCT01838668 O NOUN
), O NUM
April O NOUN
20, O NUM
2013 O NUM
(retrospectively O ADV
registered). O ADP

4) O NOUN
Conclusion: O NOUN
The O DET
effects O NOUN
found O VERB
in O ADP
the O DET
present O ADJ
study O NOUN
agree O ADJ
with O ADP
antihypertensive O ADJ
and O CCONJ
antioxidant O NOUN
effects O NOUN
previously O ADV
reported O VERB
for O ADP
Spirulina O NOUN
maxima. O NOUN

CONCLUSIONS:: O NOUN
We O PRON
suggest O VERB
that O ADP
after O ADP
reposition O NOUN
exercises, O NOUN
the O DET
pelvis O NOUN
was O VERB
more O ADV
symmetrically O ADV
aligned O VERB
in O ADP
relation O NOUN
to O PART
body O NOUN
axis; O NOUN
therefore, O NOUN
the O DET
muscles O NOUN
of O ADP
the O DET
pelvic O ADJ
floor O NOUN
have O VERB
functional O ADJ
length O NOUN
and O CCONJ
did O VERB
not O ADV
shorten O NOUN
or O CCONJ
lengthen O ADV
due O ADJ
to O PART
pelvis O NOUN
rotation. O NOUN

Title: O NOUN
Rehydrating B-outcome VERB
efficacy O NOUN
of O ADP
maple O NOUN
water O NOUN
after O ADP
exercise-induced O VERB
dehydration. O ADV

Publication O NOUN
date: O NOUN
2018/10/29 O NOUN
00:00 O NOUN
[accepted] O ADV

At O ADP
D58, O NOUN
the O DET
adjusted O VERB
efficacy O NOUN
was O VERB
55% O NOUN
(95% O PUNCT
CI O NOUN
32-78%) O PUNCT
in O ADP
the O DET
monotherapy O NOUN
arm, O ADJ
and O CCONJ
88% O VERB
(95% O PUNCT
CI O NOUN
79-98%) O NUM
in O ADP
the O DET
combination O NOUN
arm. O NOUN

Title: O NOUN
The O DET
impact O NOUN
of O ADP
unhealthy O NOUN
food O NOUN
sponsorship O NOUN
vs. O CCONJ
pro-health O ADJ
sponsorship O NOUN
models O NOUN
on O ADP
young O ADJ
adults' O NOUN
food B-outcome NOUN
preferences I-outcome NOUN
: O PUNCT
a O DET
randomised O VERB
controlled O VERB
trial. O NOUN

Following O VERB
a O DET
16-week O NOUN
washout O ADV
phase, O NOUN
they O PRON
consumed O VERB
the O DET
alternative O ADJ
supplement. O NOUN

However, O ADV
it O PRON
was O VERB
confirmed O VERB
that O ADP
they O PRON
were O VERB
not O ADV
associated O VERB
with O ADP
the O DET
test O NOUN
product. O NOUN

Greater O ADJ
proclination B-outcome NOUN
and Seperator CCONJ
more X NOUN
protrusion B-outcome NOUN
of I-outcome ADP
mandibular I-outcome ADJ
incisors E3-outcome NOUN
were O VERB
found O VERB
in O ADP
the O DET
IA O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
101273480 O NUM

Journal-Name:Nutrients O NOUN

We O PRON
found O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
the O DET
overall O ADJ
experience, O NOUN
helpfulness O ADV
of O ADP
the O DET
meeting, O ADP
or O CCONJ
stress O NOUN
levels O NOUN
of O ADP
the O DET
meeting O VERB
between O ADP
those O DET
who O ADP
met O VERB
via O ADP
videoconference O NOUN
vs. O CCONJ
in-person O NOUN
(p=0.9909; O NUM
p=0.8420; O NOUN
p=0.2352, O NOUN
respectively). O NOUN

2.1% O NOUN
reported O VERB
thinking O VERB
they O PRON
would O VERB
be O VERB
better O ADJ
off O ADP
dead O ADP
or O CCONJ
of O ADP
hurting O VERB
themselves O PRON
in O ADP
some O DET
way O NOUN
in O ADP
the O DET
past O NOUN
2 O NUM
weeks. O NOUN

Title: O NOUN
Corneal B-outcome ADJ
Endothelial I-outcome ADJ
Cell I-outcome NOUN
Density I-outcome NOUN
and Seperator CCONJ
Morphology S3-outcome NOUN
After O ADP
Phacoemulsification O NOUN
in O ADP
Patients O NOUN
With O ADP
Primary O ADJ
Open-Angle O NOUN
Glaucoma O NOUN
and O CCONJ
Cataracts: O NOUN
2-Year O NUM
Results O NOUN
of O ADP
a O DET
Randomized O VERB
Multicenter O NOUN
Trial. O NOUN

Significant O ADJ
differences O NOUN
were O VERB
not O ADV
observed O VERB
in O ADP
the O DET
remaining O VERB
Makoto O NOUN
tests. O NOUN

Our O ADJ
results O NOUN
support O NOUN
the O DET
efficacy O NOUN
of O ADP
vitamin O NOUN
D3 O NOUN
given O VERB
monthly O ADV
both O CCONJ
for O ADP
correcting O VERB
hypovitaminosis B-outcome NOUN
and O CCONJ
for O ADP
maintaining O VERB
vitamin O NOUN
D O NOUN
levels. O NOUN

BACKGROUND: O NOUN
This O DET
pilot O NOUN
study O NOUN
aimed O VERB
to O PART
investigate O NOUN
the O DET
feasible O ADJ
effectiveness O NOUN
and O CCONJ
safety O NOUN
of O ADP
Bazhengsan O NOUN
formula O NOUN
(BZSF) O NUM
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
ceftriaxone O NOUN
for O ADP
female O NOUN
patients O NOUN
with O ADP
uncomplicated O VERB
gonorrhea. O NOUN

Follow-up O NOUN
was O VERB
completed O VERB
December O NOUN
2017. O NUM

Publication O NOUN
date: O NOUN
2019/02/14 O NOUN
06:00 O ADP
[entrez] O ADP

At O ADP
T3, O NOUN
the O DET
intervention O NOUN
group O NOUN
still O ADV
reported O VERB
significantly O ADV
higher O ADJ
self-efficacy B-outcome NOUN
to O PART
cope O NOUN
with O ADP
stress O NOUN
(d O NOUN
= O SYM
0.32) O NUM
and O CCONJ
better O ADJ
emotional O ADJ
coping B-outcome VERB
response O NOUN
(d O NOUN
= O SYM
0.34) O NUM
than O ADP
the O DET
comparison O NOUN
group O NOUN
but O CCONJ
did O VERB
not O ADV
report O NOUN
significantly O ADV
higher O ADJ
social B-outcome ADJ
support I-outcome NOUN
for O ADP
stress O NOUN
management, O NOUN
stress B-outcome NOUN
, O PUNCT
depressive B-outcome ADJ
symptoms I-outcome NOUN
, O PUNCT
and O CCONJ
positive B-outcome ADJ
and Seperator CCONJ
negative B-outcome ADJ
affect E1-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
To O PART
help O VERB
young, O NOUN
low-income O NOUN
women O NOUN
with O ADP
overweight O NUM
or O CCONJ
obesity O NOUN
manage O NOUN
stress, O NOUN
researchers O NOUN
and O CCONJ
program O NOUN
planners O NOUN
may O VERB
consider O NOUN
focusing O VERB
on O ADP
building O VERB
self-efficacy B-outcome NOUN
to O PART
cope O NOUN
with O ADP
stress. O NOUN

Objective: O NOUN
To O PART
determine O NOUN
whether O ADP
a O DET
therapeutic O ADJ
strategy O NOUN
involving O VERB
low-dose O NOUN
intracoronary O ADJ
fibrinolytic O ADJ
therapy O NOUN
with O ADP
alteplase O NOUN
infused O VERB
early O ADJ
after O ADP
coronary O ADJ
reperfusion O NOUN
will O VERB
reduce O VERB
microvascular B-outcome ADJ
obstruction I-outcome NOUN
. O PUNCT
Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Between O ADP
March O NOUN
17, O NUM
2016, O NUM
and O CCONJ
December O NOUN
21, O NUM
2017, O NUM
440 O NUM
patients O NOUN
presenting O VERB
at O ADP
11 O NUM
hospitals O NOUN
in O ADP
the O DET
United O VERB
Kingdom O NOUN
within O ADP
6 O NUM
hours O NOUN
of O ADP
STEMI O NOUN
due O ADJ
to O PART
a O DET
proximal-mid-vessel O NOUN
occlusion O NOUN
of O ADP
a O DET
major O ADJ
coronary O ADJ
artery O NOUN
were O VERB
randomized O VERB
in O ADP
a O DET
1:1:1 O ADJ
dose-ranging O VERB
trial O NOUN
design. O NOUN

Simulation O NOUN
has O VERB
been O VERB
shown O VERB
in O ADP
similar O ADJ
settings O NOUN
to O PART
enhance O NOUN
performance O NOUN
and O CCONJ
knowledge. O NOUN

Journal O ADJ
ID: O NOUN
101476450 O NUM

Journal O ADJ
ID: O NOUN
101479826 O NUM

The O DET
differences O NOUN
of O ADP
morbidity B-outcome NOUN
, O PUNCT
pulmonary B-outcome ADJ
function I-outcome NOUN
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
were O VERB
compared O VERB
between O ADP
the O DET
two O NUM
groups. O NOUN

Eighteen O NUM
healthy O ADJ
adults O NOUN
were O VERB
enrolled O VERB
in O ADP
a O DET
randomized, O NOUN
crossover O NOUN
study O NOUN
with O ADP
two O NUM
treatment O NOUN
periods. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/02/28 O NOUN
06:00 O ADP
[medline] O NOUN

Outcome O NOUN
measures O NOUN
used O VERB
were O VERB
Barthel O PROPN
index O NOUN
(BI)], O NOUN
modified O VERB
Ashworth O NOUN
scale], O NUM
manual O ADJ
muscle O NOUN
testing, O NOUN
and O CCONJ
goniometry O NOUN
for O ADP
range B-outcome NOUN
of I-outcome ADP
motion I-outcome NOUN
(ROM) I-outcome NOUN
assessment. O NOUN

Journal O ADJ
ID: O NOUN
101479826 O NUM

All O DET
analyses O NOUN
were O VERB
performed O VERB
with O ADP
the O DET
use O NOUN
of O ADP
proportional-hazards O NOUN
models O NOUN
in O ADP
the O DET
per-protocol O NOUN
population O NOUN
(all O PUNCT
participants O NOUN
who O ADP
underwent O VERB
randomization, O NOUN
met O VERB
the O DET
inclusion O NOUN
criteria, O NOUN
and O CCONJ
survived O VERB
beyond O ADP
the O DET
recruitment O NOUN
hospitalization) O NOUN
and O CCONJ
as-treated O VERB
population O NOUN
(participants O NOUN
stratified O VERB
according O ADJ
to O PART
adherence). O NOUN

There O PRON
was O VERB
no O DET
difference O NOUN
in O ADP
FPPA O NOUN
(knee O NUM
valgus O NOUN
angle) O NOUN
between O ADP
groups O NOUN
(15, O PUNCT
0.63-377.99). O NUM

Likely O ADV
due O ADJ
to O PART
greater O ADJ
beverage O ADP
osmolality O NOUN
(81 O PUNCT
+/- O SYM
1.4 O NUM
vs. O CCONJ
11 O NUM
+/- O SYM
0.7 O NUM
mOsmol/kg), O NOUN
thirst B-outcome ADV
sensation I-outcome NOUN
remained O VERB
12% O NUM
higher O ADJ
with O ADP
MW O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

There O PRON
were O VERB
no O DET
statistical O ADJ
differences O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
adverse B-outcome ADJ
reactions I-outcome NOUN
between O ADP
the O DET
two O NUM
groups. O NOUN

The O DET
patient O NOUN
satisfaction B-outcome NOUN
scores O NOUN
were O VERB
significantly O ADV
higher O ADJ
in O ADP
the O DET
sedation O NOUN
group O NOUN
(Z=2.07, O PUNCT
P O NOUN
&lt; O NOUN
0.05). O NOUN

In O ADP
acute, O NOUN
the O DET
maximum O NOUN
levels O NOUN
of O ADP
resveratrol B-outcome NOUN
(RSV) I-outcome PUNCT
were O VERB
detected O VERB
both O CCONJ
in O ADP
serum O NOUN
and O CCONJ
whole O ADJ
blood O NOUN
60 O NUM
min O NOUN
after O ADP
the O DET
administration O NOUN
of O ADP
Taurisolo((R)); O NOUN
in O ADP
chronic, O NOUN
a O DET
significant O ADJ
increase O NOUN
of O ADP
resveratrol B-outcome NOUN
(RSV) I-outcome PUNCT
was O VERB
detected O VERB
in O ADP
serum O NOUN
after O ADP
the O DET
4-week O NOUN
treatment. O NOUN

Methods: O NOUN
Participants O NOUN
(n O NOUN
= O SYM
30) O NOUN
came O NOUN
to O PART
the O DET
lab O NOUN
on O ADP
three O NUM
consecutive O ADJ
days O NOUN
after O ADP
being O VERB
overnight O ADV
smoking O VERB
abstinent. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
Menthol O NOUN
chewing O VERB
gum O NOUN
on O ADP
preoperative O ADJ
thirst B-outcome ADV
management: O NOUN
randomized O VERB
clinical O ADJ
trial. O NOUN

Publication O NOUN
date: O NOUN
2019/02/26 O VERB
06:00 O ADP
[medline] O NOUN

Patients O NOUN
with O ADP
clinically O ADV
diagnosed O VERB
osteoarthritis O NOUN
of O ADP
knee O NOUN
were O VERB
injected O VERB
either O CCONJ
Triamcinolone O NOUN
or O CCONJ
Placebo O NOUN
after O ADP
recording O VERB
the O DET
baseline O NOUN
scores O NOUN
of O ADP
the O DET
knee O NOUN
by O ADP
Knee O NOUN
injury O NOUN
and O CCONJ
Osteoarthritis O NOUN
Outcome O NOUN
Score O NOUN
(KOOS) O PUNCT
- O PUNCT
Physical O ADJ
Function O NOUN
Short O NOUN
form O NOUN
(KOOS-PS), O NUM
the O DET
Western O NOUN
Ontario O NOUN
and O CCONJ
McMaster O NOUN
Universities O NOUN
Osteoarthritis O NOUN
Index O NOUN
(WOMAC) O NUM
and O CCONJ
Visual O ADJ
Analogue O NOUN
Scale O NOUN
(VAS). O NOUN

Vaping O VERB
did O VERB
not O ADV
affect O NOUN
exhaled B-outcome VERB
CO I-outcome NOUN
. O PUNCT
Cigarette B-outcome NOUN
craving I-outcome VERB
reduced O VERB
significantly O ADV
after O ADP
product O NOUN
use, O NOUN
with O ADP
the O DET
decline O NOUN
being O VERB
stronger O ADJ
for O ADP
smoking O VERB
than O ADP
for O ADP
e-cigarettes O NOUN
or O CCONJ
IQOS(TM). O NOUN

CONCLUSION: O NOUN
This O DET
study O NOUN
demonstrated O VERB
the O DET
potential O ADJ
benefits O NOUN
and O CCONJ
high O ADJ
clinical O ADJ
relevance O NOUN
of O ADP
exercise O NOUN
programs O NOUN
to O PART
improve O VERB
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
in O ADP
older O ADJ
breast O NOUN
cancer O NOUN
survivors O NOUN
undergoing O VERB
aromatase O NOUN
inhibitor O NOUN
therapy. O NOUN

Department O NOUN
of O ADP
Pharmacy O NOUN
Practice, O NOUN
Sri O NOUN
Adichunchanagiri O NOUN
College O NOUN
of O ADP
Pharmacy, O NOUN
B. O NOUN
G. O NOUN
Nagara, O NOUN
Karnataka, O NOUN
India O PROPN
- O PUNCT
rajesh.venkyresearch01@gmail.com. O NOUN

Objective: O NOUN
To O PART
evaluate O VERB
the O DET
effect O NOUN
of O ADP
postoperative O ADJ
intravenous O ADJ
(IV) O NUM
acetaminophen O ADV
(paracetamol) O NUM
vs O CCONJ
placebo O NOUN
combined O VERB
with O ADP
IV O NUM
propofol O NOUN
vs O CCONJ
dexmedetomidine O NOUN
on O ADP
postoperative O ADJ
delirium B-outcome NOUN
among O ADP
older O ADJ
patients O NOUN
undergoing O VERB
cardiac O ADJ
surgery. O VERB

Journal-Name:Medicine O NOUN

Osteoporosis O NOUN
is O VERB
a O DET
common O ADJ
complication O NOUN
of O ADP
transfusion O NOUN
dependent O ADJ
beta-thalassemia O NOUN
(TDT) O NOUN
and O CCONJ
denosumab O NOUN
has O VERB
been O VERB
recently O ADV
emerged O VERB
as O ADP
a O DET
promising O VERB
therapeutic O ADJ
option. O NOUN

Journal O ADJ
ID: O NOUN
101215702 O NUM

Title: O NOUN
"We O NOUN
find O ADP
what O DET
we O PRON
look O PUNCT
for, O NOUN
and O CCONJ
we O PRON
look O PUNCT
for O ADP
what O DET
we O PRON
know": O NOUN
factors O NOUN
interacting O VERB
with O ADP
a O DET
mental O ADJ
health O NOUN
training O VERB
program O NOUN
to O PART
influence O NOUN
its O ADJ
expected O VERB
outcomes O NOUN
in O ADP
Tunisia. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

All O DET
biomarkers O NOUN
of O ADP
metabolic B-outcome ADJ
recovery I-outcome NOUN
were O VERB
equivalent O ADJ
when O ADP
evaluating O VERB
R1 O NOUN
v O NUM
R2. O NOUN

Stratified O VERB
by O ADP
country, O NOUN
patients O NOUN
were O VERB
randomized O VERB
1:1 O ADJ
to O PART
receive O VERB
DMF O NOUN
240 O NUM
mg O NOUN
twice O ADV
daily O ADJ
or O CCONJ
placebo. O NOUN

Qualitative O ADJ
data O NOUN
was O VERB
analyzed O VERB
using O VERB
thematic O ADJ
analysis. O NOUN

CLINICAL O ADJ
SIGNIFICANCE: O NOUN
Curcumin O NOUN
gel O NOUN
as O ADP
an O DET
adjunct O ADP
to O PART
SRP O NOUN
showed O VERB
a O DET
marked O VERB
improvement O NOUN
in O ADP
restoring O VERB
gingival B-outcome ADJ
health I-outcome NOUN
by O ADP
an O DET
improvement O NOUN
in O ADP
clinical O ADJ
parameters. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
a O DET
short-term O NOUN
low O ADJ
fermentable O ADJ
oligiosaccharide, O NOUN
disaccharide, O NOUN
monosaccharide O NOUN
and O CCONJ
polyol O NOUN
(FODMAP) O PUNCT
diet O NOUN
on O ADP
exercise-related O VERB
gastrointestinal B-outcome ADJ
symptoms I-outcome NOUN
. O PUNCT

Journal O ADJ
ID: O NOUN
0255562 O NUM

BACKGROUND: O NOUN
Although O ADP
conventional O ADJ
60 O NUM
mg O NOUN
of O ADP
prasugrel O NOUN
allows O NOUN
for O ADP
rapid O ADJ
and O CCONJ
potent O ADJ
platelet O NOUN
inhibition O NOUN
within O ADP
30 O NUM
min O NOUN
after O ADP
loading O VERB
dose, O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
lower O ADJ
doses O NOUN
of O ADP
prasugrel O NOUN
in O ADP
Indian O NOUN
patients O NOUN
has O VERB
not O ADV
yet O ADV
been O VERB
investigated. O NOUN

Journal-Name:Zhong O ADJ
nan O VERB
da O NOUN
xue O NOUN
xue O NOUN
bao. O ADP

Whether O ADP
positive-pressure O NOUN
ventilation O NOUN
with O ADP
a O DET
bag-mask O ADJ
device O NOUN
(bag-mask O NUM
ventilation) O NOUN
during O ADP
tracheal O ADJ
intubation O NOUN
of O ADP
critically O ADV
ill O ADJ
adults O NOUN
prevents O NOUN
hypoxemia O NOUN
without O ADP
increasing O VERB
the O DET
risk O NOUN
of O ADP
aspiration O NOUN
remains O NOUN
controversial. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Objective: O NOUN
To O PART
assess O NOUN
whether O ADP
EEG-guided O VERB
anesthetic O ADJ
administration O NOUN
decreases O NOUN
the O DET
incidence O NOUN
of O ADP
postoperative O ADJ
delirium B-outcome NOUN
. O PUNCT
Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Randomized O VERB
clinical O ADJ
trial O NOUN
of O ADP
1232 O NUM
adults O NOUN
aged O VERB
60 O NUM
years O NOUN
and O CCONJ
older O ADJ
undergoing O VERB
major O ADJ
surgery O NOUN
and O CCONJ
receiving O VERB
general O ADJ
anesthesia O NOUN
at O ADP
Barnes-Jewish O NOUN
Hospital O NOUN
in O ADP
St O NOUN
Louis. O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

RESULTS: O NOUN
All O DET
mandibular B-outcome ADJ
skeletal I-outcome ADJ
dimensions O NOUN
increased, O NOUN
and O CCONJ
improvements O NOUN
of O ADP
the O DET
sagittal B-outcome ADJ
maxillomandibular I-outcome ADJ
parameters O NOUN
were O VERB
found O VERB
in O ADP
both O CCONJ
groups. O NOUN

Journal-Name:Medicine O NOUN

Most O DET
subjects O NOUN
were O VERB
vitD(3) O NOUN
deficient O ADJ
at O ADP
enrolment, O NOUN
but O CCONJ
a O DET
gradual O ADJ
and O CCONJ
significant O ADJ
improvement O NOUN
of O ADP
vitD(3) B-outcome NOUN
status O NOUN
was O VERB
demonstrated O VERB
in O ADP
the O DET
vitD(3) O NOUN
+ O SYM
PBA O NOUN
group O NOUN
compared O VERB
with O ADP
placebo O NOUN
(p O PUNCT
< O SYM
0.0001) O NUM
from O ADP
week O NOUN
0 O NUM
to O PART
16 O NUM
(median O PUNCT
37.5 O NUM
versus O CCONJ
115.5 O NUM
nmol/L). O NOUN

In O ADP
the O DET
current O ADJ
clinical O ADJ
trial, O NOUN
we O PRON
examined O VERB
the O DET
antioxidant B-outcome NOUN
and O CCONJ
DNA B-outcome NOUN
protection I-outcome NOUN
capacity O NOUN
of O ADP
a O DET
plant-based, O NOUN
multi-vitamin/mineral, O NOUN
and O CCONJ
phytonutrient O NOUN
(PMP) O NOUN
supplementation O NOUN
in O ADP
healthy O ADJ
adults O NOUN
who O ADP
were O VERB
habitually O ADV
low O ADJ
in O ADP
the O DET
consumption O NOUN
of O ADP
fruits O NOUN
and O CCONJ
vegetables. O PUNCT

BACKGROUND: O NOUN
Registered O VERB
healthcare O NOUN
workers O NOUN
worldwide O ADJ
have O VERB
a O DET
high O ADJ
prevalence O NOUN
of O ADP
work-related O VERB
musculoskeletal O ADJ
disorders, O NOUN
particularly O ADV
of O ADP
the O DET
back. O NOUN

Conclusion: O NOUN
Supraglottic O ADJ
tracheal O ADJ
tube O NOUN
ventilation O NOUN
for O ADP
painless O NOUN
fiberbronchoscopy O NOUN
is O VERB
a O DET
safe O ADJ
and O CCONJ
effective O ADJ
procedure. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

At O ADP
baseline, O NOUN
mean O NOUN
(SD) O NOUN
duration O NOUN
of O ADP
cry B-outcome NOUN
and Seperator CCONJ
fuss B-outcome NOUN
time E1-outcome NOUN
was O VERB
comparable O ADJ
in O ADP
the O DET
probiotic O ADJ
and O CCONJ
control O NOUN
groups: O NOUN
305 O NUM
(81) O NOUN
vs. O CCONJ
315 O NUM
(90) O PUNCT
min., O NUM

Journal-Name:Oncology O NOUN
reports O NOUN

Title: O NOUN
The O DET
use O NOUN
of O ADP
ETView O NOUN
endotracheal O ADJ
tube O NOUN
for O ADP
surveillance O NOUN
after O ADP
tube O NOUN
positioning O VERB
in O ADP
patients O NOUN
undergoing O VERB
lobectomy, O NOUN
randomized O VERB
trial. O NOUN

To O PART
this O DET
end, O NOUN
we O PRON
tested O VERB
the O DET
effects O NOUN
of O ADP
two O NUM
commercially-available O ADJ
drinks O NOUN
on O ADP
strength O NOUN
in O ADP
a O DET
field-based O VERB
setting O VERB
with O ADP
both O CCONJ
male O NOUN
and O CCONJ
female O NOUN
high O ADJ
school O NOUN
athletes O NOUN
completing O VERB
a O DET
summer O NOUN
training O VERB
program. O NOUN

METHODS: O NOUN
We O PRON
randomly O ADV
assigned O VERB
609 O NUM
patients O NOUN
with O ADP
complicated O VERB
urinary O ADJ
tract O NOUN
infections O NOUN
(UTIs), O PUNCT
including O VERB
acute O ADJ
pyelonephritis, O NOUN
in O ADP
a O DET
1:1 O ADJ
ratio O NOUN
to O PART
receive O VERB
intravenous O ADJ
plazomicin O NOUN
(15 O PUNCT
mg O NOUN
per O ADP
kilogram O NOUN
of O ADP
body O NOUN
weight O NOUN
once O ADP
daily) O CCONJ
or O CCONJ
meropenem O NOUN
(1 O NOUN
g O NOUN
every O DET
8 O NUM
hours), O NOUN
with O ADP
optional O ADJ
oral O ADJ
step-down O VERB
therapy O NOUN
after O ADP
at O ADP
least O ADV
4 O NUM
days O NOUN
of O ADP
intravenous O ADJ
therapy, O NOUN
for O ADP
a O DET
total O ADJ
of O ADP
7 O NUM
to O PART
10 O NUM
days O NOUN
of O ADP
therapy. O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

The O DET
ETView O NOUN
single O ADJ
lumen O NOUN
endotracheal O ADJ
tube O NOUN
had O VERB
fewer O ADJ
associated O VERB
complications B-outcome NOUN
and O CCONJ
is O VERB
superior O ADJ
to O PART
the O DET
2 O NUM
double-lumen O NOUN
tubes. O NOUN

DISCUSSION: O NOUN
Halitosis O NOUN
treatment O NOUN
is O VERB
a O DET
topic O ADJ
that O ADP
still O ADV
needs O NOUN
attention. O NOUN

Journal O ADJ
ID: O NOUN
0374675 O NUM

This O DET
tendency O NOUN
of O ADP
the O DET
improvement O NOUN
was O VERB
maintained, O NOUN
in O ADP
favour O NOUN
of O ADP
the O DET
IG, O NOUN
at O ADP
the O DET
12-month O NOUN
follow-up O NOUN
visit. O NOUN

There O PRON
was O VERB
a O DET
significant O ADJ
interaction O NOUN
of O ADP
composite O NOUN
strength B-outcome NOUN
score O NOUN
between O ADP
groups, O NOUN
(p O PUNCT
= O SYM
.04, O PUNCT
engp2 O NOUN
= O SYM
.08). O PUNCT

Journal O ADJ
ID: O NOUN
2985213R O NOUN

They O PRON
were O VERB
randomly O ADV
assigned O VERB
to O PART
either O CCONJ
neoadjuvant O ADJ
chemotherapy O NOUN
or O CCONJ
upfront O ADP
surgery. O VERB

REGISTRATION: O NOUN
This O DET
trial O NOUN
was O VERB
registered O VERB
at O ADP
ClinicalTrials.govNCT01925924. O NOUN

Secondary O ADJ
endpoints O NOUN
include O VERB
symptomatic B-outcome ADJ
malaria I-outcome NOUN
, O PUNCT
Polymerase O NOUN
Chain O NOUN
Reaction O NOUN
(PCR)-detectable O ADJ
Plasmodium B-outcome NOUN
spp I-outcome NOUN
Infections I-outcome NOUN
, O PUNCT
molecular O ADJ
markers O NOUN
of O ADP
drug B-outcome NOUN
resistance I-outcome NOUN
and O CCONJ
antibodies B-outcome NOUN
specific I-outcome ADJ
for Seperator ADP
Plasmodium I-outcome NOUN
spp I-outcome NOUN
Parasites I-outcome NOUN
. O PUNCT
DISCUSSION: O NOUN
This O DET
study O NOUN
has O VERB
been O VERB
approved O VERB
by O ADP
relevant O ADJ
institutional O ADJ
ethics O NOUN
committees O NOUN
in O ADP
Myanmar O ADJ
and O CCONJ
Australia. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

BACKGROUND: O NOUN
Mothers O NOUN
of O ADP
preterm O NOUN
infants O NOUN
often O ADV
have O VERB
symptoms O NOUN
of O ADP
anxiety O NOUN
and O CCONJ
depression, O NOUN
recognized O VERB
as O ADP
risk O NOUN
factors O NOUN
for O ADP
the O DET
development O NOUN
of O ADP
cardiovascular O ADJ
diseases O NOUN
and O CCONJ
associated O VERB
with O ADP
low O ADJ
rates O NOUN
of O ADP
heart O NOUN
rate O NOUN
variability O NOUN
(HRV). O NOUN

Participants O NOUN
recovered O VERB
in O ADP
a O DET
similar O ADJ
time-dependent O ADJ
manner O NOUN
in O ADP
all O DET
markers O NOUN
of O ADP
metabolism B-outcome NOUN
following O VERB
the O DET
PLA O NOUN
and O CCONJ
CA O NOUN
+ O SYM
C O NOUN
trials. O NOUN

Results: O NOUN
A O DET
total O ADJ
of O ADP
240 O NUM
of O ADP
279 O NUM
patients O NOUN
(129 O NUM
females O NOUN
and O CCONJ
111 O NUM
male) O NOUN
aged O VERB
18 O NUM
- O PUNCT
65 O NUM
years O NOUN
were O VERB
referred O VERB
and O CCONJ
integrated O VERB
in O ADP
this O DET
clinical O ADJ
trial, O NOUN
whereas O ADP
29 O NUM
were O VERB
rejected O VERB
as O ADP
not O ADV
completing O VERB
the O DET
requirements O NOUN
needed. O NOUN

PATIENT O NOUN
AND O CCONJ
METHODS: O NOUN
We O PRON
propose O NOUN
a O DET
prospective, O NOUN
double-blinded, O NOUN
randomized O VERB
phase O NOUN
2 O NUM
study O NOUN
of O ADP
2 O NUM
parallel O ADJ
groups O NOUN
of O ADP
eligible O ADJ
adult O NOUN
patients. O NOUN

Methods: O NOUN
A O DET
feasibility O NOUN
randomized O VERB
control O NOUN
trial O NOUN
allowed O VERB
for O ADP
comparison O NOUN
of O ADP
PICIHBI O NOUN
and O CCONJ
conventional O ADJ
one-on-one O NUM
occupational O ADJ
therapy O NOUN
interventions. O NOUN

Study O NOUN
1 O NUM
tested O VERB
8-week O NOUN
group-based O VERB
Monitor O NOUN
+ O SYM
Accept O ADV
and O CCONJ
Monitor O NOUN
Only O ADV
interventions O NOUN
compared O VERB
with O ADP
a O DET
no O DET
treatment O NOUN
control O NOUN
group. O VERB

Title: O NOUN
Effect O NOUN
of O ADP
the O DET
soft-tissue O NOUN
techniques O NOUN
in O ADP
the O DET
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
Crohn's O NOUN
disease: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Tai O NOUN
Chi O NOUN
as O ADP
a O DET
mild O ADJ
to O PART
moderate O ADJ
mind-body O NOUN
exercise O NOUN
is O VERB
suitable O ADJ
for O ADP
older O ADJ
individuals O NOUN
who O ADP
suffer O NOUN
from O ADP
depression. O NOUN

CONCLUSION: O NOUN
While O ADP
methohexital O ADJ
was O VERB
shown O VERB
to O PART
confer O VERB
greater O ADJ
hemodynamic B-outcome ADJ
stability O NOUN
in O ADP
patients O NOUN
taking O VERB
ACEi/ARB, O NOUN
the O DET
measured O VERB
hormone B-outcome NOUN
levels O NOUN
could O VERB
not O ADV
explain O NOUN
the O DET
mechanism O NOUN
for O ADP
this O DET
effect. O NOUN

RESULTS: O NOUN
In O ADP
the O DET
modified O VERB
intention-to-treat O NOUN
population, O NOUN
omadacycline O NOUN
(316 O NUM
patients) O NOUN
was O VERB
noninferior O ADJ
to O PART
linezolid O NOUN
(311 O NOUN
patients) O NOUN
with O ADP
respect O NOUN
to O PART
early O ADJ
clinical O ADJ
response O NOUN
(rate O NOUN
of O ADP
response, O NOUN
84.8% O NUM
and O CCONJ
85.5%, O NUM
respectively; O NOUN
difference, O NOUN
-0.7 O NOUN
percentage O NOUN
points; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
-6.3 O CCONJ
to O PART
4.9). O NOUN

Therefore, O NOUN
we O PRON
conducted O VERB
this O DET
study O NOUN
to O PART
determine O NOUN
the O DET
95% O NOUN
effective O ADJ
dose B-outcome NOUN
(ED95) O PUNCT
of O ADP
intrathecal O ADJ
hyperbaric O ADJ
ropivacaine O NOUN
for O ADP
cesarean O NOUN
section O NOUN
in O ADP
parturients O NOUN
receiving O VERB
prophylactic O ADJ
infusion O NOUN
of O ADP
phenylephrine O NOUN
to O PART
prevent O NOUN
spinal-induced O VERB
hypotension. O NOUN

The O DET
view O NOUN
from O ADP
the O DET
tip O NOUN
appears O NOUN
continuously O ADV
on O ADP
a O DET
portable O ADJ
monitor O NOUN
in O ADP
the O DET
anesthesia O NOUN
area. O NOUN

Journal-Name:Therapeutic O ADJ
drug O NOUN
monitoring O VERB

BACKGROUND O NOUN
AND O CCONJ
PURPOSE: O NOUN
There O PRON
is O VERB
a O DET
need O NOUN
to O PART
investigate O NOUN
the O DET
effects O NOUN
of O ADP
pilates O NOUN
exercises O NOUN
on O ADP
the O DET
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
of O ADP
patients O NOUN
with O ADP
chronic O ADJ
kidney O NOUN
diseases O NOUN
(CKD). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[medline] O NOUN

Bilateral O ADJ
strength O NOUN
training O VERB
did O VERB
not O ADV
correct O ADJ
the O DET
unilateral O ADJ
strength B-outcome NOUN
deficit I-outcome ADP
observed O VERB
in O ADP
this O DET
group O NOUN
of O ADP
survivors O NOUN
of O ADP
breast O NOUN
cancer. O NOUN

RESULTS: O NOUN
Overall, O NOUN
834 O NUM
patients O NOUN
with O ADP
minor O ADJ
stroke O NOUN
were O VERB
included O VERB
in O ADP
this O DET
subgroup, O NOUN
553 O NUM
SAI O NOUN
(381 O PUNCT
lacunar O NOUN
infarction, O ADP
172 O NUM
non-lacunar O NOUN
infarction) O NOUN
and O CCONJ
281 O NUM
MAIs. O NOUN

Publication O NOUN
date: O NOUN
2018/12/04 O ADP
00:00 O NOUN
[accepted] O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Complication B-outcome NOUN
rates O NOUN
in O ADP
all O DET
strategy O NOUN
groups O NOUN
were O VERB
significantly O ADV
lower O ADJ
than O ADP
in O ADP
the O DET
control O NOUN
group; O ADJ
however, O ADV
no O DET
significant O ADJ
difference O NOUN
was O VERB
found O VERB
among O ADP
the O DET
strategy O NOUN
groups. O NOUN

Resting O VERB
blood O NOUN
samples O NOUN
were O VERB
collected O VERB
prior O ADJ
to O PART
and O CCONJ
on O ADP
completion O NOUN
of O ADP
each O DET
diet O NOUN
to O PART
determine O NOUN
plasma O NOUN
intestinal B-outcome ADJ
fatty I-outcome ADJ
acid I-outcome NOUN
binding I-outcome VERB
protein I-outcome NOUN
(I-FABP) I-outcome ADV
as O ADP
a O DET
marker O NOUN
of O ADP
acute B-outcome ADJ
GI I-outcome NOUN
injury I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
Overall O ADV
Irritable B-outcome ADJ
Bowel I-outcome NOUN
Syndrome-Severity I-outcome NOUN
Scoring O VERB
System O NOUN
(IBS-SSS) O PUNCT
score O NOUN
significantly O ADV
reduced O VERB
in O ADP
the O DET
LOWFODMAP O NOUN
condition O NOUN
from O ADP
81.1 O NUM
+/- O SYM
16.4 O NUM
to O PART
31.3 O NUM
+/- O SYM
9.2 O NUM
(arbitrary O PUNCT
units; O ADJ
P O NOUN
= O SYM
0.004). O NUM

Title: O NOUN
Using O VERB
the O DET
Borg O ADJ
rating O VERB
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
scale O NOUN
to O PART
grade O NOUN
the O DET
intensity B-outcome NOUN
of O ADP
a O DET
functional O ADJ
training O VERB
program O NOUN
of O ADP
the O DET
affected O VERB
upper O ADJ
limb O NOUN
after O ADP
a O DET
stroke: O NOUN
a O DET
feasibility O NOUN
study. O NOUN

Journal-Name:BMC O NOUN
ophthalmology O NOUN

FUNDING: O NOUN
Seattle O ADJ
Genetics O NOUN
Inc, O NOUN
Millennium O NOUN
Pharmaceuticals O NOUN
Inc, O NOUN
a O DET
wholly O ADV
owned O VERB
subsidiary O NOUN
of O ADP
Takeda O NOUN
Pharmacuetical O NOUN
Company O DET
Limited, O VERB
and O CCONJ
National O ADJ
Institutes O NOUN
of O ADP
Health O NOUN
National O ADJ
Cancer O NOUN
Institute O NOUN
Cancer O NOUN
Center. O NOUN

A O DET
noninferiority O NOUN
margin O ADP
of O ADP
10 O NUM
percentage O NOUN
points O NOUN
was O VERB
used. O NOUN

Efficacy O NOUN
was O VERB
evaluated O VERB
again O ADV
at O ADP
day O NOUN
58, O NUM
after O ADP
completion O NOUN
of O ADP
treatment. O NOUN

Journal-Name:International O ADJ
journal O ADJ
of O ADP
environmental O ADJ
research O NOUN
and O CCONJ
public O ADJ
health O NOUN

TPI O NOUN
group O NOUN
received O VERB
TPIs O NOUN
with O ADP
2 O NUM
mL O NOUN
of O ADP
0.2% O NOUN
ropivacaine, O ADJ
and O CCONJ
EMLA O NOUN
group O NOUN
received O VERB
an O DET
occlusive O ADJ
dressing O VERB
with O ADP
EMLA O NOUN
cream O NOUN
2 O NUM
g O NOUN
on O ADP
both O CCONJ
shoulders. O NOUN

METHODS: O NOUN
We O PRON
conducted O VERB
a O DET
case O NOUN
study O NOUN
with O ADP
a O DET
purposeful O ADJ
sample O NOUN
of O ADP
18 O NUM
trained O VERB
PCPs. O NOUN

The O DET
most O DET
common O ADJ
adverse B-outcome ADJ
event I-outcome NOUN
was O VERB
mucocutaneous B-outcome ADJ
bleeding I-outcome VERB
, O PUNCT
which O ADP
was O VERB
reported O VERB
in O ADP
65% O NUM
of O ADP
the O DET
patients O NOUN
in O ADP
the O DET
caplacizumab O NOUN
group O NOUN
and O CCONJ
in O ADP
48% O ADP
in O ADP
the O DET
placebo O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2019/01/29 O NOUN
06:00 O ADP
[medline] O NOUN

Anticoagulants O NOUN
are O VERB
effective O ADJ
as O ADP
venous O ADJ
thromboprophylaxis, O NOUN
but O CCONJ
with O ADP
an O DET
increased O VERB
risk O NOUN
of O ADP
bleeding. O NOUN

Publication O NOUN
date: O NOUN
2019/03/01 O NOUN
06:00 O ADP
[medline] O NOUN

After O ADP
4 O NUM
weeks, O NOUN
the O DET
levels O NOUN
of O ADP
Trimethylamine B-outcome NOUN
N-oxide I-outcome NOUN
(TMAO) I-outcome NOUN
were O VERB
significantly O ADV
decreased O VERB
in O ADP
the O DET
treatment O NOUN
group O NOUN
compared O VERB
to O PART
placebo O NOUN
(63.6% O NOUN
vs. O CCONJ
0.54%, O NUM
respectively, O NOUN
P O NOUN
< O SYM
0.0001). O NUM

The O DET
potential O ADJ
role O NOUN
of O ADP
the O DET
clinical O ADJ
assessment O NOUN
of O ADP
peripheral O ADJ
perfusion O NOUN
as O ADP
a O DET
target O NOUN
during O ADP
resuscitation O NOUN
in O ADP
early O ADJ
septic O ADJ
shock O NOUN
has O VERB
not O ADV
been O VERB
established. O NOUN

Pulpectomy O NOUN
was O VERB
performed O VERB
on O ADP
27 O NUM
primary O ADJ
teeth O NOUN
with O ADP
necrosis O NOUN
or O CCONJ
irreversible O ADJ
pulpitis, O NOUN
caused O VERB
by O ADP
dental O ADJ
caries O NOUN
or O CCONJ
trauma, O NOUN
in O ADP
23 O NUM
children O NOUN
(2-7 O NOUN
years O NOUN
old). O PUNCT

Funded O VERB
by O ADP
Ablynx; O NOUN
HERCULES O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02553317 O ADJ
.). O NOUN

3) O NOUN
Compared O VERB
with O ADP
combination O NOUN
group, O NOUN
improvement O NOUN
of O ADP
sleep B-outcome NOUN
onset I-outcome NOUN
latency I-outcome NOUN
(SOL) I-outcome NOUN
and O CCONJ
sleep B-outcome NOUN
efficiency I-outcome NOUN
(SE) I-outcome NOUN
in O ADP
CBT-i O NOUN
group O NOUN
was O VERB
superior O ADJ
(both O NOUN
P=0.01). O NOUN

The O DET
median O ADJ
intervention O NOUN
period O NOUN
was O VERB
3.34 O NUM
years. O NOUN

RESULTS: O NOUN
Sixty-five O ADJ
patients O NOUN
completed O VERB
the O DET
study, O NOUN
including O VERB
33 O NUM
in O ADP
the O DET
control O NOUN
group O NOUN
and O CCONJ
32 O NUM
in O ADP
the O DET
treatment O NOUN
group. O VERB

For O ADP
all O DET
analyses O NOUN
a O DET
level O NOUN
of O ADP
significance O NOUN
of O ADP
95% O NOUN
(P O NUM
< O SYM
.05) O NOUN
will O VERB
be O VERB
considered. O NOUN

The O DET
Delta O NOUN
heart B-outcome NOUN
rate I-outcome NOUN
and O CCONJ
Delta O NOUN
cardiac B-outcome ADJ
output O NOUN
values O NOUN
were O VERB
lower O ADJ
in O ADP
the O DET
Group O NOUN
R O NOUN
(P O NUM
= O SYM
.02 O NUM
and O CCONJ
P O NOUN
= O SYM
.04, O PUNCT
respectively). O NOUN

Because O ADP
of O ADP
the O DET
time O NOUN
spent O VERB
at O ADP
the O DET
workplace, O ADP
workplaces O NOUN
can O VERB
be O VERB
optimal O ADJ
arenas O NOUN
for O ADP
weight O NOUN
loss O NOUN
programs O NOUN
and O CCONJ
these O DET
programs O NOUN
have O VERB
been O VERB
effective O ADJ
to O PART
decrease O NOUN
body O NOUN
weight. O NOUN

This O DET
could O VERB
fill O NOUN
the O DET
gap O NOUN
between O ADP
devices O NOUN
that O ADP
fully O ADV
compensate O NOUN
for O ADP
walking O VERB
and O CCONJ
those O DET
which O ADP
allow O ADP
patients O NOUN
to O PART
maintain O NOUN
residual O ADJ
mobility. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

This O DET
study O NOUN
was O VERB
an O DET
exploratory O ADJ
analysis O NOUN
to O PART
investigate O NOUN
the O DET
secondary O ADJ
end-point O NOUN
of O ADP
biochemical B-outcome ADJ
failure-free I-outcome ADJ
survival I-outcome NOUN
(BCFFS) I-outcome NUM
of O ADP
patients O NOUN
with O ADP
long-term O NOUN
follow-up. O PUNCT

TRIAL O NOUN
REGISTRATION: O NOUN
Clinicaltrials.gov O NOUN
Identifier: O NOUN
NCT03173339. O NOUN

The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
assess O NOUN
the O DET
prevalence O NOUN
and O CCONJ
correlates O NOUN
of O ADP
different O ADJ
indicators O NOUN
of O ADP
psychological O ADJ
distress O NOUN
among O ADP
13-14 O NUM
year O NOUN
old O ADJ
low O ADJ
caste O NOUN
girls O NOUN
in O ADP
rural, O ADJ
south O NOUN
India. O NOUN

Title: O NOUN
How O ADP
mindfulness O ADV
training O VERB
promotes O NOUN
positive B-outcome ADJ
emotions I-outcome NOUN
: O PUNCT
Dismantling O VERB
acceptance O NOUN
skills O NOUN
training O VERB
in O ADP
two O NUM
randomized O VERB
controlled O VERB
trials. O NOUN

The O DET
curative O ADJ
effect O NOUN
was O VERB
compared O VERB
before O ADP
and O CCONJ
after O ADP
treatment, O NOUN
including O VERB
ulcer B-outcome NOUN
surface I-outcome NOUN
pain I-outcome NOUN
(VAS O PUNCT
score), O NOUN
time B-outcome NOUN
of I-outcome ADP
ulcer I-outcome NOUN
healing I-outcome VERB
, O PUNCT
and O CCONJ
the O DET
changes O NOUN
of O ADP
T B-outcome NOUN
cell I-outcome NOUN
subsets I-outcome NOUN
( O PUNCT
CD3(+) B-outcome NOUN
, O PUNCT
CD4(+) B-outcome NOUN
, O PUNCT
CD8(+) B-outcome NOUN
and O CCONJ
CD4(+)/CD8(+) B-outcome NOUN
) O PUNCT
before O ADP
and O CCONJ
after O ADP
treatment O NOUN
were O VERB
compared O VERB
by O ADP
SPSS O ADV
22 O NUM
software O NOUN
package. O ADJ

All O DET
outcomes O NOUN
were O VERB
measured O VERB
at O ADP
baseline, O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
6-week O NOUN
treatment O NOUN
and O CCONJ
2-week O NOUN
follow-up O NOUN
after O ADP
the O DET
treatment. O NOUN

METHODS: O NOUN
In O ADP
a O DET
multicenter, O NOUN
double-blind, O NOUN
placebo-controlled, O NOUN
delayed-start O NOUN
trial, O NOUN
we O PRON
randomly O ADV
assigned O VERB
patients O NOUN
with O ADP
early O ADJ
Parkinson's O NOUN
disease O NOUN
to O PART
receive O VERB
levodopa O NOUN
(100 O NUM
mg O NOUN
three O NUM
times O NOUN
per O ADP
day) O NOUN
in O ADP
combination O NOUN
with O ADP
carbidopa O NOUN
(25 O NOUN
mg O NOUN
three O NUM
times O NOUN
per O ADP
day) O NOUN
for O ADP
80 O NUM
weeks O NOUN
(early-start O NOUN
group) O ADJ
or O CCONJ
placebo O NOUN
for O ADP
40 O NUM
weeks O NOUN
followed O VERB
by O ADP
levodopa O NOUN
in O ADP
combination O NOUN
with O ADP
carbidopa O NOUN
for O ADP
40 O NUM
weeks O NOUN
(delayed-start O NOUN
group). O NOUN

PATIENTS O NOUN
AND O CCONJ
METHODS: O NOUN
A O DET
multicentre, O NOUN
prospective, O NOUN
randomized, O NOUN
double-blind, O NOUN
placebo-controlled O VERB
trial O NOUN
was O VERB
undertaken O VERB
involving O VERB
229 O NUM
patients O NOUN
undergoing O VERB
primary O ADJ
cementless O NOUN
THA O NOUN
using O VERB
a O DET
posterior O ADJ
approach, O NOUN
whose O ADP
extended O VERB
rivaroxaban O ADJ
thromboprophylaxis O NOUN
started O VERB
on O ADP
the O DET
day O NOUN
of O ADP
surgery. O VERB

Journal-Name:JAMA O NOUN

Conclusions: O NOUN
Our O ADJ
study O NOUN
demonstrates O NOUN
that O ADP
NCH O NOUN
gel O NOUN
appears O NOUN
to O PART
be O VERB
able O ADJ
to O PART
reduce O VERB
the O DET
formation O NOUN
of O ADP
intrauterine B-outcome ADJ
adhesions I-outcome NOUN
in O ADP
women O NOUN
who O ADP
undergo O NOUN
curettage O NOUN
in O ADP
the O DET
second O ADJ
trimester, O ADV
although O ADP
larger O ADJ
controlled, O NOUN
randomized, O NOUN
multicenter O NOUN
studies O NOUN
are O VERB
needed O VERB
to O PART
confirm O NOUN
these O DET
results. O NOUN

BACKGROUND: O NOUN
Many O ADJ
men O NOUN
have O VERB
limited O VERB
knowledge O NOUN
about O ADV
reproductive O ADJ
health O NOUN
and O CCONJ
fertility. O NOUN

CONCLUSIONS: O NOUN
Ecabet O NOUN
sodium O NOUN
had O VERB
a O DET
preventive O ADJ
effect O NOUN
on O ADP
low-dose O NOUN
aspirin-induced O VERB
small O ADJ
intestinal O ADJ
mucosal O ADJ
injury O NOUN
in O ADP
the O DET
upper O ADJ
part O NOUN
of O ADP
the O DET
small O ADJ
intestine. O NOUN

General O NOUN
fertility B-outcome NOUN
awareness I-outcome ADV
increased O VERB
from O ADP
a O DET
mean O NOUN
score O NOUN
of O ADP
4.6 O NUM
to O PART
5.5 O NUM
out O ADP
of O ADP
12 O NUM
(P O NUM
= O SYM
0.004) O NOUN
in O ADP
the O DET
IG. O NOUN

CONCLUSION: O NOUN
The O DET
findings O NOUN
demonstrated O VERB
that O ADP
both O CCONJ
regimens O NOUN
of O ADP
drugs O NOUN
can O VERB
control O NOUN
the O DET
hemodynamic B-outcome ADJ
status O NOUN
of O ADP
patients O NOUN
during O ADP
laparoscopic O ADJ
cholecystectomy, O NOUN
which O ADP
provides O NOUN
effective O ADJ
postoperative O ADJ
analgesia O NOUN
for O ADP
pain B-outcome NOUN
management. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Statistical O ADJ
analyses O NOUN
will O VERB
be O VERB
conducted O VERB
under O ADP
the O DET
intention-to-treat O NOUN
principle. O NOUN

Although O ADP
the O DET
concentration B-outcome NOUN
of I-outcome ADP
fentanyl I-outcome NOUN
was O VERB
higher O ADJ
than O ADP
those O DET
of O ADP
previous O ADJ
researches, O NOUN
there O PRON
was O VERB
no O DET
respiratory B-outcome ADJ
depression I-outcome NOUN
. O PUNCT
But, O NOUN
there O PRON
was O VERB
no O DET
advantage O NOUN
of O ADP
reducing O VERB
pain B-outcome NOUN
score O NOUN
and O CCONJ
the O DET
use B-outcome NOUN
of I-outcome ADP
rescue I-outcome NOUN
analgesics I-outcome NOUN
. O PUNCT
CLINICAL O ADJ
TRIAL O NOUN
REGISTRATION: O NOUN
(available O ADP
at: O NOUN
http://cris.nih.go.kr, O NOUN
KCT0002221). O NOUN

METHODS: O NOUN
WISDOM O NOUN
was O VERB
a O DET
multinational, O ADJ
randomized, O NOUN
double-blind, O NOUN
active-controlled, O NOUN
52-week O NOUN
study O NOUN
in O ADP
patients O NOUN
with O ADP
severe-to-very O NOUN
severe O ADJ
COPD. O NOUN

Fourteen O NUM
patients O NOUN
in O ADP
both O CCONJ
the O DET
placebo-dexmedetomidine O NOUN
and O CCONJ
acetaminophen-propofol O NOUN
groups O NOUN
(46% O NUM
and O CCONJ
45%) O NOUN
and O CCONJ
7 O NUM
in O ADP
the O DET
acetaminophen-dexmedetomidine O NOUN
and O CCONJ
placebo-propofol O NOUN
groups O NOUN
(24% O NUM
and O CCONJ
23%) O NUM
had O VERB
hypotension B-outcome NOUN
. O PUNCT
Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
older O ADJ
patients O NOUN
undergoing O VERB
cardiac O ADJ
surgery, O NOUN
postoperative O ADJ
scheduled O VERB
IV O NUM
acetaminophen, O NOUN
combined O VERB
with O ADP
IV O NUM
propofol O NOUN
or O CCONJ
dexmedetomidine, O ADP
reduced O VERB
in-hospital O NOUN
delirium B-outcome NOUN
vs O CCONJ
placebo. O NOUN

CONCLUSION: O NOUN
Intrathecal O ADJ
5 O NUM
mug O NUM
Dex O NOUN
enhances O NOUN
the O DET
efficacy O NOUN
of O ADP
spinal O ADJ
bupivacaine O NOUN
by O ADP
24% O NOUN
in O ADP
patients O NOUN
undergoing O VERB
cesarean O NOUN
section O NOUN
with O ADP
spinal O ADJ
anesthesia. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
7511141 O NUM

The O DET
studyPeden O NOUN
CJ, O NOUN
Stephens O NOUN
T, O NOUN
Martin O NOUN
G O NOUN
et O NOUN
al. O NOUN

Data O NOUN
was O VERB
analyzed O VERB
by O ADP
repeated O VERB
measures O NOUN
analysis O NOUN
of O ADP
variance O NOUN
(rANOVA) O NOUN
and O CCONJ
chi-squared O NOUN
test O NOUN
(chi O PUNCT
test). O NOUN

Journal-Name:Nutrients O NOUN

CONCLUSIONS: O NOUN
This O DET
double O ADV
blinded, O NOUN
randomized, O NOUN
and O CCONJ
placebo-controlled O VERB
trial O NOUN
demonstrated O VERB
that O ADP
the O DET
single O ADJ
use O NOUN
of O ADP
20 O NUM
mg O NOUN
nifedipine O NOUN
given O VERB
30 O NUM
minutes O NOUN
before O ADP
embryo O NOUN
transfer O NOUN
did O VERB
not O ADV
improve O VERB
the O DET
implantation B-outcome NOUN
rate O NOUN
or O CCONJ
the O DET
clinical B-outcome ADJ
pregnancy I-outcome NOUN
rate O NOUN
of O ADP
the O DET
infertility O NOUN
treatment. O NOUN

Analyses O NOUN
were O VERB
done O NOUN
according O ADJ
to O PART
the O DET
intention-to-treat O NOUN
principle. O NOUN

The O DET
registration O NOUN
can O VERB
be O VERB
found O VERB
at O ADP
the O DET
following O VERB
URL: O NOUN
https://clinicaltrials.gov/ct2/show/NCT01838668. O NOUN

METHODS: O NOUN
Sixty-seven O NUM
stable O ADJ
COPD O NOUN
patients O NOUN
were O VERB
enrolled O VERB
and O CCONJ
assigned O VERB
to O PART
the O DET
experiment O NOUN
group O NOUN
(n O NOUN
= O SYM
36) O NOUN
and O CCONJ
the O DET
control O NOUN
group O NOUN
(n O NOUN
= O SYM
31). O ADP

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Using O VERB
this O DET
approach, O NOUN
repellent O NOUN
(N,N-diethyl-benzamide O NOUN
- O PUNCT
12% O NUM
w/w, O NOUN
cream) O NOUN
is O VERB
distributed O VERB
by O ADP
VHVs O NOUN
in O ADP
villages O NOUN
sequentially O ADV
throughout O ADV
the O DET
malaria O NOUN
transmission O NOUN
season. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Exercise-related O VERB
GI O NOUN
issues O NOUN
are O VERB
a O DET
common O ADJ
cause O ADP
of O ADP
underperformance, O NOUN
with O ADP
current O ADJ
evidence O NOUN
focusing O VERB
on O ADP
the O DET
use O NOUN
of O ADP
FODMAP O ADV
approaches O NOUN
with O ADP
recreationally O ADV
competitive O ADJ
or O CCONJ
highly O ADV
trained O VERB
athletes. O ADV

Journal-Name:Aerospace O NOUN
medicine O NOUN
and O CCONJ
human O NOUN
performance O NOUN

CONCLUSION: O NOUN
This O DET
is O VERB
the O DET
first O ADV
randomised O VERB
controlled O VERB
trial O NOUN
to O PART
compare O NOUN
a O DET
structured O VERB
multidisciplinary, O NOUN
multisite O NOUN
intervention O NOUN
with O ADP
standard O ADJ
care O NOUN
in O ADP
symptomatic O ADJ
childhood O NOUN
hypermobility. O NUM

Band O NOUN
ligation O NOUN
is O VERB
the O DET
main O ADJ
therapeutic O ADJ
option, O NOUN
but O CCONJ
it O PRON
may O VERB
be O VERB
technically O ADV
difficult O ADJ
to O PART
perform O NOUN
in O ADP
active O ADJ
bleeders. O NOUN

CONTEXT: O NOUN
Deviations O NOUN
in O ADP
scapular O ADJ
motions O NOUN
and O CCONJ
subsequent O ADJ
alterations O NOUN
in O ADP
associated O VERB
soft O NOUN
tissues O NOUN
are O VERB
thought O VERB
to O PART
contribute O NOUN
to O PART
overuse O ADP
shoulder O NOUN
injuries O NOUN
in O ADP
overhead O ADP
athletes. O ADV

The O DET
trained O VERB
nodal O NOUN
teachers O NOUN
reported O VERB
children O NOUN
with O ADP
symptoms O NOUN
of O ADP
acute O ADJ
pharyngitis O NOUN
and O CCONJ
or O CCONJ
RF/RHD O NOUN
in O ADP
intervention O NOUN
arm O NOUN
and O CCONJ
children O NOUN
taken O VERB
to O PART
hospitals O NOUN
by O ADP
parents O NOUN
for O ADP
symptoms O NOUN
of O ADP
acute O ADJ
pharyngitis O NOUN
and O CCONJ
or O CCONJ
RF/RHD O NOUN
under O ADP
control O NOUN
arm O NOUN
through O ADP
mobile O ADJ
phone O NOUN
to O PART
coordinating O VERB
centre. O NOUN

The O DET
linear O ADJ
mixed O VERB
model O NOUN
was O VERB
used O VERB
for O ADP
data O NOUN
analysis, O NOUN
in O ADP
which O ADP
a O DET
5% O NOUN
significance O NOUN
level O NOUN
was O VERB
adopted. O NOUN

CONCLUSION: O NOUN
There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
clinical O ADJ
outcomes O NOUN
between O ADP
the O DET
two O NUM
trial O NOUN
arms. O ADJ

No O DET
adverse B-outcome ADJ
events I-outcome NOUN
related O VERB
to O PART
test O NOUN
beverage O ADP
ingestion O NOUN
were O VERB
observed. O NOUN

TRIAL O NOUN
REGISTRATION O NOUN
NUMBER: O NOUN
NCT03386149 O NOUN
(clinicaltrials.gov) O NOUN
and O CCONJ
KCT0002848 O NOUN
(Clinical O ADJ
Research O NOUN
Information O NOUN
Service O NOUN
of O ADP
the O DET
Republic O ADJ
of O ADP
Korea). O NOUN

RESULTS: O NOUN
There O PRON
were O VERB
in O ADP
total O ADJ
80 O NUM
reported O VERB
adverse B-outcome ADJ
events I-outcome NOUN
during O ADP
the O DET
follow-up; O ADP
50 O NUM
in O ADP
placebo O NOUN
and O CCONJ
30 O NUM
in O ADP
krill O NOUN
powder O NOUN
group. O VERB

Title: O NOUN
Exercise O NOUN
training O VERB
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
montelukast O NOUN
in O ADP
children O NOUN
with O ADP
mild O ADJ
asthma: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
In O ADP
this O DET
randomized O VERB
clinical O ADJ
trial, O NOUN
83 O NUM
women O NOUN
with O ADP
poor O ADJ
endometrial O ADJ
response O NOUN
to O PART
standard O ADJ
hormone O NOUN
replacement O NOUN
therapy O NOUN
(HRT) O ADV
(endometrium O PUNCT
thickness O NOUN
< O SYM
7 O NUM
mm) O NOUN
in O ADP
the O DET
13th O ADJ
day O NOUN
of O ADP
the O DET
cycle O NOUN
in O ADP
a O DET
frozen-thawed O VERB
embryo O NOUN
transfer O NOUN
(FET) O PUNCT
were O VERB
entered O VERB
in O ADP
two O NUM
groups. O NOUN

The O DET
Taurisolo((R)) O NOUN
polyphenol O NOUN
content O NOUN
was O VERB
evaluated O VERB
by O ADP
a O DET
High O ADJ
Performance O NOUN
Liquid O NOUN
Chromatography-diode-array O NOUN
detector O NOUN
(HPLC-DAD) O NOUN
method, O NOUN
and O CCONJ
RSV O NOUN
was O VERB
monitored O VERB
as O ADP
an O DET
indicative O ADJ
marker. O NOUN

Results: O NOUN
(1)Compared O PUNCT
with O ADP
the O DET
results O NOUN
at O ADP
baseline, O NOUN
the O DET
total O ADJ
scores O NOUN
of O ADP
Pittsburgh O NOUN
sleep B-outcome NOUN
quality I-outcome NOUN
index O NOUN
(PSQI)], O NOUN
Beck O NOUN
depression B-outcome NOUN
index O NOUN
(BDI) O NOUN
, O PUNCT
Beck O NOUN
anxiety B-outcome NOUN
inventory O ADJ
(BAI) O NOUN
in O ADP
both O CCONJ
groups O NOUN
significantly O ADV
decreased O VERB
at O ADP
the O DET
end O NOUN
of O ADP
treatment: O NOUN
CBT-i O NOUN
group, O NOUN
PSQI O NOUN
(4.7+/-2.5) O NUM
vs. O CCONJ
(12.9+/-3.5); O NOUN
BDI O NOUN
(3.2+/-4.4) O NOUN
vs. O CCONJ
(9.7+/-6.4); O NOUN
BAI O NOUN
(4.2+/-5.6) O NOUN
vs. O CCONJ
(10.7+/-8.1); O PUNCT
and O CCONJ
combination O NOUN
group, O NOUN
PSQI O NOUN
(5.8+/-2.8) O NUM
vs. O CCONJ
(13.9+/-3.1); O NOUN
BDI O NOUN
(4.5+/-4.8) O PUNCT
vs. O CCONJ
(13.8+/-8.7); O PUNCT
BAI O NOUN
(4.4+/-4.0) O NOUN
vs. O CCONJ
(14.1+/-6.3) O PUNCT
(all O PUNCT
P<0.01). O NOUN
( O PUNCT

The O DET
mean O NOUN
value O NOUN
of O ADP
137 O NUM
kcal/serving O VERB
is O VERB
16% O NUM
lower O ADJ
(p O PUNCT
< O SYM
0.0001) O NUM
than O ADP
what O DET
is O VERB
typically O ADV
found O VERB
on O ADP
food O NOUN
labels. O NOUN

Journal O ADJ
ID: O NOUN
101230586 O NUM

Over O ADP
the O DET
36-month O NOUN
period, O NOUN
there O PRON
were O VERB
no O DET
significant O ADJ
changes O NOUN
in O ADP
the O DET
location B-outcome NOUN
of I-outcome ADP
mesial I-outcome ADJ
or Seperator CCONJ
distal I-outcome ADJ
papilla I-outcome NOUN
in O ADP
any O DET
group. O VERB

Publication O NOUN
date: O NOUN
2018/12/19 O NOUN
06:00 O ADP
[entrez] O ADP

Several O ADJ
studies O NOUN
demonstrated O VERB
that O ADP
polyphenols O NOUN
are O VERB
able O ADJ
to O PART
inhibit O NOUN
the O DET
growth O NOUN
of O ADP
TMA-producing O VERB
bacterial O ADJ
strains, O NOUN
and O CCONJ
resveratrol O NOUN
(RSV) O PUNCT
reduced O VERB
TMAO O NOUN
levels O NOUN
in O ADP
mice. O NOUN

Incidence O NOUN
of O ADP
treatment-related B-outcome VERB
AEs I-outcome NOUN
with O ADP
tretinoin O NOUN
0.05% O NUM
lotion O NOUN
was O VERB
lower O ADJ
than O ADP
in O ADP
the O DET
overall O ADJ
study O NOUN
population; O NOUN
the O DET
most O DET
frequently O ADV
were O VERB
application O NOUN
site O NOUN
pain B-outcome NOUN
(2.0%), O NOUN
dryness B-outcome ADV
(1.4%), O NOUN
and O CCONJ
erythema B-outcome NOUN
(1.2%). O PUNCT

DISCUSSION: O NOUN
The O DET
evidence O NOUN
provided O ADJ
will O VERB
inform O NOUN
program O NOUN
investment O ADJ
and O CCONJ
design, O NOUN
and O CCONJ
contribute O NOUN
to O PART
the O DET
literature O NOUN
on O ADP
the O DET
effect O NOUN
of O ADP
menstrual O ADJ
health-based O VERB
interventions O NOUN
on O ADP
girls' O NOUN
agency B-outcome NOUN
, O PUNCT
safety O NOUN
and O CCONJ
life B-outcome NOUN
outcomes. O ADJ

Title: O NOUN
Single-Dose O NOUN
Tafenoquine O NOUN
to O PART
Prevent O NOUN
Relapse B-outcome NOUN
of O ADP
Plasmodium O NOUN
vivax O NOUN
Malaria. O NOUN

Title: O NOUN
The O DET
Effects O NOUN
of O ADP
Oral O ADJ
Magnesium O NOUN
Supplementation O NOUN
on O ADP
Glycemic B-outcome ADJ
Response I-outcome NOUN
among O ADP
Type O NOUN
2 O NUM
Diabetes O NOUN
Patients. O NOUN

Title: O NOUN
Prevalence O NOUN
and O CCONJ
correlates O NOUN
of O ADP
psychological O ADJ
distress O NOUN
among O ADP
13-14 O NUM
year O NOUN
old O ADJ
adolescent O NOUN
girls O NOUN
in O ADP
North O NOUN
Karnataka, O NOUN
South O NOUN
India: O NOUN
a O DET
cross-sectional O ADJ
study. O NOUN

Final O ADJ
irrigation O NOUN
was O VERB
done O NOUN
with O ADP
cold O NOUN
(4 O NOUN
degrees O NOUN
C, O NOUN
2.5 O NUM
degrees O NOUN
C, O NOUN
and O CCONJ
room O NOUN
temperature) O NOUN
17% O NUM
EDTA O NOUN
and O CCONJ
10 O NUM
mL O NOUN
of O ADP
cold O NOUN
saline O NOUN
solution. O NOUN

CONCLUSIONS: O NOUN
In O ADP
this O DET
study O NOUN
on O ADP
patients O NOUN
with O ADP
chronic O ADJ
low O ADJ
back O ADP
pain O NOUN
and O CCONJ
Modic O NOUN
changes O NOUN
at O ADP
the O DET
level O NOUN
of O ADP
a O DET
previous O ADJ
disc O NOUN
herniation, O NOUN
three O NUM
months O NOUN
of O ADP
treatment O NOUN
with O ADP
amoxicillin O NOUN
did O VERB
not O ADV
provide O VERB
a O DET
clinically O ADV
important O ADJ
benefit O NUM
compared O VERB
with O ADP
placebo. O NOUN

Title: O NOUN
Can O VERB
autologous O ADJ
platelet O NOUN
rich O ADJ
plasma O NOUN
expand O NOUN
endometrial B-outcome ADJ
thickness I-outcome NOUN
and O CCONJ
improve O VERB
pregnancy B-outcome NOUN
rate O NOUN
during O ADP
frozen-thawed O VERB
embryo O NOUN
transfer O NOUN
cycle? O VERB

Major B-outcome ADP
adverse I-outcome ADJ
cardiac I-outcome ADJ
events I-outcome NOUN
( O PUNCT
cardiac B-outcome ADJ
death I-outcome NOUN
, O PUNCT
nonfatal B-outcome ADJ
MI I-outcome NOUN
, O PUNCT
unplanned B-outcome VERB
hospitalization I-outcome NOUN
for Seperator ADP
heart I-outcome NOUN
failure I-outcome NOUN
) O PUNCT
occurred O VERB
in O ADP
15 O NUM
patients O NOUN
(10.1%) O NOUN
in O ADP
the O DET
placebo O NOUN
group, O NOUN
18 O NUM
(12.9%) O NOUN
in O ADP
the O DET
10-mg O NOUN
alteplase O NOUN
group, O NOUN
and O CCONJ
12 O NUM
(8.2%) O NUM
in O ADP
the O DET
20-mg O NOUN
alteplase O NOUN
group. O VERB

Title: O NOUN
beta-Eudesmol, O NOUN
an O DET
Oxygenized O VERB
Sesquiterpene, O NOUN
Reduces O NOUN
the O DET
Increase O NOUN
in O ADP
Saliva O ADJ
3-Methoxy-4-Hydroxyphenylglycol B-outcome NOUN
After O ADP
the O DET
"Trier O ADP
Social O ADJ
Stress O NOUN
Test" O NOUN
in O ADP
Healthy O NOUN
Humans: O NOUN
A O DET
Randomized, O NOUN
Double-Blind, O NOUN
Placebo-Controlled O VERB
Cross-Over O NOUN
Study. O NOUN

The O DET
intervention O NOUN
was O VERB
scheduled O VERB
to O PART
occur O VERB
early O ADJ
during O ADP
the O DET
primary O ADJ
PCI O NOUN
procedure, O NOUN
after O ADP
reperfusion O NOUN
of O ADP
the O DET
infarct-related O VERB
coronary O ADJ
artery O NOUN
and O CCONJ
before O ADP
stent O NOUN
implant. O ADJ

Title: O NOUN
Oral O ADJ
versus O CCONJ
Intravenous O ADJ
Antibiotics O NOUN
for O ADP
Bone O NOUN
and O CCONJ
Joint O NOUN
Infection. O NOUN

In O ADP
the O DET
MRI-guided O VERB
group, O NOUN
the O DET
treatment O NOUN
goal O NOUN
was O VERB
absence B-outcome NOUN
of I-outcome ADP
MRI I-outcome NOUN
bone I-outcome NOUN
marrow I-outcome NOUN
edema I-outcome NOUN
combined I-outcome VERB
with Seperator ADP
clinical I-outcome ADJ
remission I-outcome NOUN
, O PUNCT
defined O VERB
as O ADP
DAS28-CRP O NOUN
of O ADP
3.2 O NUM
or O CCONJ
less O ADV
and O CCONJ
no O DET
swollen O NOUN
joints. O NOUN

Publication O NOUN
date: O NOUN
2018/10/16 O NOUN
00:00 O NOUN
[accepted] O ADV

In O ADP
experimental O ADJ
group O NOUN
one, O NOUN
a O DET
15-minute O NOUN
trial O NOUN
of O ADP
pelvis O NOUN
reposition O NOUN
exercise O NOUN
was O VERB
carried O VERB
out. O NOUN
[ O PUNCT

Retrospectively O ADV
registered O VERB
12 O NUM
March O NOUN
2018. O NUM

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Interventions: O NOUN
Participants O NOUN
were O VERB
randomized O VERB
to O PART
an O DET
intervention O NOUN
group O NOUN
that O ADP
encouraged O VERB
an O DET
energy-reduced O VERB
Mediterranean O NOUN
diet, O ADV
promoted O VERB
physical O ADJ
activity, O ADP
and O CCONJ
provided O ADJ
behavioral O ADJ
support O NOUN
(n O NOUN
= O SYM
3406) O NOUN
or O CCONJ
to O PART
a O DET
control O NOUN
group O NOUN
that O ADP
encouraged O VERB
an O DET
energy-unrestricted O VERB
Mediterranean O NOUN
diet O NOUN
(n O NOUN
= O SYM
3468). O NOUN

Title: O NOUN
Denosumab O NOUN
effects O NOUN
on O ADP
serum O NOUN
levels O NOUN
of O ADP
the O DET
bone O NOUN
morphogenetic O ADJ
proteins O NOUN
antagonist O NOUN
noggin B-outcome NOUN
in O ADP
patients O NOUN
with O ADP
transfusion-dependent O ADJ
thalassemia O ADP
and O CCONJ
osteoporosis. O NOUN

Conclusion: O NOUN
Compared O VERB
with O ADP
conventional O ADJ
chemotherapy, O NOUN
induction O NOUN
chrono-chemotherapy O NOUN
seemed O VERB
to O PART
reduce O VERB
chemotherapy-related O VERB
toxicities B-outcome NOUN
and O CCONJ
improve O VERB
average O NOUN
local O ADJ
relapse O NOUN
time O NOUN
in O ADP
patients O NOUN
treated O VERB
with O ADP
combined O VERB
chemoradiotherapy O NOUN
for O ADP
NPC. O NOUN

The O DET
aim O ADP
of O ADP
the O DET
present O ADJ
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
preoperative O ADJ
celecoxib O NOUN
administration O NOUN
in O ADP
alleviating O VERB
postoperative O ADJ
pain B-outcome NOUN
in O ADP
knee O NOUN
osteoarthritis O NOUN
(OA) O NOUN
patients O NOUN
undergoing O VERB
total O ADJ
knee O NOUN
arthroplasty O NOUN
(TKA).A O NOUN
total O ADJ
of O ADP
226 O NUM
knee O NOUN
OA O NOUN
patients O NOUN
underwent O VERB
TKA O NOUN
were O VERB
consecutively O ADV
recruited O VERB
and O CCONJ
randomized O VERB
into O ADP
preoperative O ADJ
analgesia O NOUN
group O NOUN
and O CCONJ
postoperative O ADJ
analgesia O NOUN
group O NOUN
as O ADP
1:1 O ADJ
ratio. O NOUN

Moreover, O NOUN
results O NOUN
prove O NOUN
that O ADP
participants O NOUN
positively O ADV
respond B-outcome VERB
to O PART
health-related O VERB
information, O NOUN
whereas O ADP
information O NOUN
on O ADP
bitterness-taste O NOUN
generates O NOUN
lower O ADJ
preferences B-outcome NOUN
. O PUNCT

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
Music-instruction O NOUN
intervention O NOUN
for O ADP
treatment O NOUN
of O ADP
post-traumatic O ADJ
stress O NOUN
disorder: O NOUN
a O DET
randomized O VERB
pilot O NOUN
study. O NOUN

At O ADP
4-weeks O NOUN
post-baseline O NOUN
there O PRON
were O VERB
significant O ADJ
increases O NOUN
in O ADP
identified B-outcome VERB
regulation I-outcome NOUN
, O PUNCT
integrated B-outcome VERB
regulation I-outcome NOUN
, O PUNCT
intrinsic B-outcome ADJ
motivation I-outcome NOUN
, O PUNCT
social B-outcome ADJ
norms I-outcome NOUN
and O CCONJ
intentions B-outcome NOUN
in O ADP
intervention O NOUN
compared O VERB
to O PART
control O NOUN
participants. O NOUN

Journal O ADJ
ID: O NOUN
8205248 O NUM

Title: O NOUN
Decolonization O NOUN
to O PART
Reduce O NOUN
Postdischarge O NOUN
Infection B-outcome NOUN
Risk O NOUN
among O ADP
MRSA O NOUN
Carriers. O NOUN

We O PRON
compared O VERB
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
a O DET
modified O VERB
FOLFIRINOX O NOUN
regimen O NOUN
with O ADP
gemcitabine O NOUN
as O ADP
adjuvant O NOUN
therapy O NOUN
in O ADP
patients O NOUN
with O ADP
resected O VERB
pancreatic O ADJ
cancer. O NOUN

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

Our O ADJ
results O NOUN
suggest O VERB
that O ADP
a O DET
HIIT O NOUN
training O VERB
program O NOUN
with O ADP
TRX O NOUN
have O VERB
benefits O NOUN
in O ADP
BMI B-outcome NOUN
, O PUNCT
handgrip B-outcome NOUN
strength I-outcome NOUN
, O PUNCT
gait B-outcome NOUN
speed I-outcome NOUN
, O PUNCT
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
in O ADP
older O ADJ
adults. O NOUN

Although O ADP
none O NUM
of O ADP
our O ADJ
patient O NOUN
had O VERB
significant O ADJ
elevation O NOUN
of O ADP
CPK B-outcome NOUN
. O PUNCT
CONCLUSION: O NOUN
This O DET
study O NOUN
concluded O VERB
that O ADP
both O CCONJ
doses O NOUN
of O ADP
atorvastatin O NOUN
(40 O NOUN
& O CCONJ
80mg) O NUM
are O VERB
equally O ADV
efficacious O ADJ
in O ADP
improving O VERB
dyslipidemia B-outcome NOUN
but O CCONJ
higher O ADJ
dose O NOUN
leads O NOUN
to O PART
more O ADV
incidence O NOUN
of O ADP
myalgia B-outcome NOUN
. O PUNCT

Hispanic O ADJ
subjects O NOUN
(aged O PUNCT
11 O NUM
to O PART
50 O NUM
years, O NOUN
N=766) O NOUN
were O VERB
randomized O VERB
(1:1) O NOUN
to O PART
receive O VERB
tretinoin O NOUN
0.05% O NUM
lotion O NOUN
or O CCONJ
vehicle, O NOUN
once-daily O ADV
for O ADP
12 O NUM
weeks. O NOUN

This O DET
study O NOUN
was O VERB
an O DET
eight-week, O NOUN
double-blind, O NOUN
randomized, O NOUN
parallel-arm, O NOUN
and O CCONJ
placebo-controlled O VERB
trial. O NOUN

Publication O NOUN
date: O NOUN
2019/02/06 O ADJ
06:00 O ADP
[entrez] O ADP

In O ADP
part O NOUN
C, O NOUN
patients O NOUN
who O ADP
had O VERB
recurrent O ADP
attacks O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
receive O VERB
injections O NOUN
of O ADP
one O NUM
of O ADP
two O NUM
doses O NOUN
of O ADP
givosiran O NOUN
(2.5 O PUNCT
or O CCONJ
5.0 O NUM
mg O NOUN
per O ADP
kilogram) O NOUN
or O CCONJ
placebo O NOUN
once O ADP
monthly O ADV
(total O ADJ
of O ADP
four O NUM
injections) O NOUN
or O CCONJ
once O ADP
quarterly O ADV
(total O ADJ
of O ADP
two O NUM
injections) O NOUN
during O ADP
a O DET
12-week O NOUN
period, O NOUN
starting O VERB
on O ADP
day O NOUN
0. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Blood B-outcome NOUN
lactate I-outcome VERB
([La-]b O PUNCT
mmol. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:BMC O NOUN
gastroenterology O NOUN

Achaogen, O VERB
South O NOUN
San O NOUN
Francisco, O ADV
CA. O NOUN

The O DET
goal O NOUN
of O ADP
the O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
results O NOUN
of O ADP
medial O ADJ
patellofemoral O ADJ
ligament O NOUN
reconstruction O NOUN
in O ADP
children. O NOUN

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
This O DET
is O VERB
a O DET
double-blind, O NOUN
randomized O VERB
controlled O VERB
multicenter O NOUN
prospective O ADJ
trial. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHODS: O NOUN
Prospective O ADJ
randomized O VERB
clinical O ADJ
trial O NOUN
including O VERB
21 O NUM
mothers O NOUN
of O ADP
preterms O NOUN
admitted O VERB
to O PART
the O DET
Neonatal O ADJ
Intensive O ADJ
Care O NOUN
Unit O NOUN
of O ADP
a O DET
tertiary O ADJ
hospital, O ADJ
recruited O VERB
from O ADP
August O NOUN
2015 O NUM
to O PART
September O NOUN
2017, O NUM
and O CCONJ
divided O VERB
into O ADP
control O NOUN
group O NOUN
(CG; O NOUN
n O NOUN
= O SYM
11) O NOUN
and O CCONJ
music O ADJ
therapy O NOUN
group O NOUN
(MTG; O NOUN
n O NOUN
= O SYM
10). O NOUN

Purpose: O NOUN
The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
efficacy O NOUN
and O CCONJ
toxicities B-outcome NOUN
of O ADP
induction O NOUN
chronomodulated O VERB
chemotherapy O NOUN
in O ADP
comparison O NOUN
with O ADP
conventional O ADJ
induction O NOUN
chemotherapy O NOUN
for O ADP
nasopharyngeal O ADJ
carcinoma O NOUN
(NPC). O NOUN

RESULTS: O NOUN
After O ADP
treatment, O NOUN
patients O NOUN
in O ADP
both O CCONJ
groups O NOUN
achieved O NOUN
promising O VERB
effectiveness. O NOUN

Daily O ADJ
drainage B-outcome NOUN
and O CCONJ
all O DET
adverse B-outcome ADJ
events I-outcome NOUN
after O ADP
operation O NOUN
were O VERB
also O ADV
compared. O NOUN

The O DET
primary O ADJ
outcome O NOUN
measurement O NOUN
was O VERB
the O DET
headache B-outcome NOUN
intensity I-outcome NOUN
. O PUNCT
Secondary O ADJ
outcomes O NOUN
were O VERB
frequency O NOUN
and O CCONJ
duration B-outcome NOUN
of I-outcome ADP
headache B-outcome NOUN
, O PUNCT
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
assessed O VERB
by O ADP
the O DET
Short O NOUN
Form-36. O NOUN

Journal-Name:Nutrients O NOUN

Title: O NOUN
A O DET
Pilot O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN
of O ADP
Transcutaneous O ADJ
Electrical O ADJ
Nerve O NOUN
Stimulation O NOUN
for O ADP
Patients O NOUN
With O ADP
Acute O ADJ
Tinnitus. O NOUN

The O DET
study O NOUN
involves O NOUN
140 O NUM
public O ADJ
primary O ADJ
schools O NOUN
in O ADP
three O NUM
rural O ADJ
sub-counties O NOUN
(Magarini, O NOUN
Kaloleni O NOUN
and O CCONJ
Ganze) O NOUN
of O ADP
Kilifi O ADV
County O NOUN
in O ADP
the O DET
Coastal O ADJ
area O NOUN
of O ADP
Kenya. O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

DISCUSSION: O NOUN
To O PART
our O ADJ
knowledge, O NOUN
APPAC O NOUN
II O NUM
trial O NOUN
is O VERB
the O DET
first O ADV
randomised O VERB
controlled O VERB
trial O NOUN
comparing O VERB
per O ADP
oral O ADJ
antibiotic O ADJ
monotherapy O NOUN
with O ADP
intravenous O ADJ
antibiotic O ADJ
therapy O NOUN
continued O NOUN
by O ADP
per O ADP
oral O ADJ
antibiotics O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
uncomplicated O VERB
acute O ADJ
appendicitis. O NOUN

CONCLUSION: O NOUN
The O DET
results O NOUN
of O ADP
this O DET
study O NOUN
revealed O VERB
that O ADP
oral O ADJ
Mg O NOUN
supplementation O NOUN
reduces O NOUN
insulin B-outcome NOUN
resistance I-outcome NOUN
and O CCONJ
improves O NOUN
the O DET
glycemic B-outcome ADJ
control I-outcome NOUN
indicators O NOUN
among O ADP
T2D O NOUN
patients. O NOUN

METHODS: O NOUN
The O DET
BabyGel O NOUN
pilot O NOUN
was O VERB
a O DET
cluster O NOUN
randomised O VERB
trial O NOUN
that O ADP
assessed O VERB
the O DET
post-partum O NOUN
use O NOUN
of O ADP
alcohol-based O VERB
hand O NOUN
rub O NOUN
(ABHR) O NUM
to O PART
prevent O NOUN
neonatal B-outcome ADJ
infections I-outcome NOUN
in O ADP
Mbale, O ADV
Uganda. O NOUN

Interventions: O NOUN
Hospitals O NOUN
randomized O VERB
to O PART
the O DET
intervention O NOUN
(n O NOUN
= O SYM
131 O NUM
[6436 O NOUN
patients]) O NUM
provided O ADJ
patients O NOUN
with O ADP
co-payment O NOUN
vouchers O NOUN
for O ADP
clopidogrel O NOUN
or O CCONJ
ticagrelor O ADV
for O ADP
1 O NUM
year O NOUN
(median O PUNCT
voucher O ADV
value O NOUN
for O ADP
a O DET
30-day O NOUN
supply, O NOUN
$137 O NOUN
[25th-75th O SYM
percentile, O NOUN
$20-$339]). O NOUN

In O ADP
the O DET
low-dose O NOUN
remifentanil O NOUN
(LR) O NOUN
group O NOUN
(n O NOUN
= O SYM
46), O NOUN
remifentanil O NOUN
was O VERB
infused O VERB
at O ADP
a O DET
rate O NOUN
of O ADP
0.05 O NUM
mug/kg/min. O NOUN

There O PRON
was O VERB
no O DET
statistically O ADV
significant O ADJ
difference O NOUN
between O ADP
the O DET
bracket O NOUN
adhesives O NOUN
in O ADP
the O DET
numbers O NOUN
with O ADP
at O ADP
least O ADV
1 O NUM
new O ADJ
demineralized B-outcome VERB
lesion I-outcome NOUN
(risk O NOUN
ratio,1.25; O NOUN
95% O NOUN
confidence O NOUN
interval, O ADP
0.74-2.13; O NOUN
P O NOUN
= O SYM
0.403) O NUM
or O CCONJ
first-time O NOUN
bracket O NOUN
failure O NOUN
(risk O NOUN
ratio,0.88; O ADV
95% O NOUN
confidence O NOUN
interval, O ADP
0.67-1.16; O NOUN
P O NOUN
= O SYM
0.35). O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal-Name:Brazilian O ADP
oral O ADJ
research O NOUN

Title: O NOUN
Efficacy O NOUN
of O ADP
different O ADJ
interaction O NOUN
devices O NOUN
using O VERB
non-immersive O ADJ
virtual O ADJ
tasks O NOUN
in O ADP
individuals O NOUN
with O ADP
Amyotrophic O ADJ
Lateral O ADJ
Sclerosis: O NOUN
a O DET
cross-sectional O ADJ
randomized O VERB
trial. O NOUN

Pain B-outcome NOUN
, O PUNCT
global B-outcome ADJ
quality I-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(GQoL) I-outcome NOUN
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
specific O ADJ
for O ADP
CD O NOUN
(QoLCD) O NOUN
were O VERB
assessed O VERB
before O ADP
and O CCONJ
after O ADP
the O DET
intervention. O NOUN

Title: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial O NOUN
of O ADP
neuromuscular O ADJ
electrical O ADJ
stimulation O NOUN
for O ADP
chronic O ADJ
urinary O ADJ
retention O NOUN
following O VERB
traumatic O ADJ
brain O NOUN
injury. O NOUN

Background O NOUN
& O CCONJ
objectives: O NOUN
: O PUNCT
Three O NUM
doses O NOUN
of O ADP
intermittent O ADJ
preventive O ADJ
treatment O NOUN
with O ADP
sulphadoxine-pyrimethamine O NOUN
(IPTp-SP) O NOUN
has O VERB
been O VERB
adopted O VERB
as O ADP
the O DET
new O ADJ
recommendation O NOUN
for O ADP
prevention O NOUN
of O ADP
malaria B-outcome NOUN
in O ADP
pregnancy. O NOUN

Publication O NOUN
date: O NOUN
2018/11/20 O ADJ
00:00 O NOUN
[accepted] O ADV

Journal-Name:JAMA O NOUN

BACKGROUND: O NOUN
Delayed-release O NOUN
dimethyl O NOUN
fumarate O NOUN
(DMF) O PUNCT
has O VERB
demonstrated O VERB
efficacy O NOUN
and O CCONJ
a O DET
favorable O ADJ
benefit-risk O NOUN
profile O NOUN
in O ADP
phase O NOUN
2 O NUM
and O CCONJ
3 O NUM
studies O NOUN
that O ADP
enrolled O VERB
predominantly O ADV
white O ADP
patients O NOUN
with O ADP
relapsing-remitting O VERB
multiple O ADJ
sclerosis O NOUN
(RRMS). O NOUN

Key O NOUN
exclusion O NOUN
criteria O NOUN
included O VERB
diagnosis O NOUN
of O ADP
neuromyelitis O NOUN
optica O ADV
spectrum O NOUN
disorder. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

There O PRON
were O VERB
no O DET
adverse B-outcome ADJ
effects I-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
There O PRON
is O VERB
no O DET
evidence O NOUN
that O ADP
the O DET
use O NOUN
of O ADP
resin O NOUN
modified O VERB
glass O NOUN
ionomer O NOUN
cement O NOUN
over O ADP
light-cured O VERB
composite O NOUN
for O ADP
bonding O VERB
brackets O NOUN
reduces O NOUN
the O DET
incidence O NOUN
of O ADP
new O ADJ
demineralized B-outcome VERB
lesions I-outcome NOUN
or O CCONJ
bond B-outcome NOUN
failures I-outcome NOUN
. O PUNCT
There O PRON
might O VERB
be O VERB
other O ADJ
reasons O NOUN
for O ADP
using O VERB
resin O NOUN
modified O VERB
glass O NOUN
ionomer O NOUN
cement. O NOUN

The O DET
median O ADJ
difference O NOUN
in O ADP
morphine B-outcome NOUN
consumption I-outcome NOUN
between O ADP
the O DET
PCM O NOUN
+ O SYM
IBU O NOUN
group O NOUN
vs O CCONJ
PCM O NOUN
alone O ADJ
was O VERB
16 O NUM
mg O NOUN
(99.6% O PUNCT
CI, O NOUN
6.5 O NUM
to O PART
24; O NUM
P O NOUN
< O SYM
.001); O NOUN
for O ADP
the O DET
PCM-alone O NOUN
group O NOUN
vs O CCONJ
HS-PCM O NOUN
+ O SYM
IBU, O NOUN
8 O NUM
mg O NOUN
(99.6% O PUNCT
CI, O NOUN
-1 O NUM
to O PART
14; O NUM
P O NOUN
= O SYM
.001); O NOUN
and O CCONJ
for O ADP
the O DET
PCM O NOUN
+ O SYM
IBU O NOUN
group O NOUN
vs O CCONJ
IBU O NOUN
alone, O NOUN
6 O NUM
mg O NOUN
(99.6% O PUNCT
CI, O NOUN
-2 O NUM
to O PART
16; O NUM
P O NOUN
= O SYM
.002). O PUNCT

BACKGROUND: O NOUN
E-cigarettes O NOUN
are O VERB
commonly O ADV
used O VERB
in O ADP
attempts O NOUN
to O PART
stop O NOUN
smoking, O NOUN
but O CCONJ
evidence O NOUN
is O VERB
limited O VERB
regarding O VERB
their O ADJ
effectiveness O NOUN
as O ADP
compared O VERB
with O ADP
that O ADP
of O ADP
nicotine O NOUN
products O NOUN
approved O VERB
as O ADP
smoking-cessation O NOUN
treatments. O NOUN

Journal O ADJ
ID: O NOUN
100968567 O NUM

The O DET
clinical O ADJ
and O CCONJ
radiographic O ADJ
twelve-month O NOUN
outcomes O NOUN
indicated O VERB
successful B-outcome ADJ
treatment I-outcome NOUN
, O PUNCT
independently O ADV
of O ADP
the O DET
root O NOUN
filling O VERB
material O ADJ
used. O NOUN

No O DET
protocol-related O VERB
serious B-outcome ADJ
adverse I-outcome ADJ
reactions I-outcome NOUN
were O VERB
confirmed. O NOUN

CONCLUSIONS: O NOUN
HP O NOUN
had O VERB
superior O ADJ
rates O NOUN
of O ADP
hemostasis B-outcome NOUN
, O PUNCT
shorter O ADJ
preparation B-outcome NOUN
time I-outcome NOUN
, O PUNCT
and O CCONJ
a O DET
similar O ADJ
safety O NOUN
profile O NOUN
compared O VERB
to O PART
G O NOUN
+ O SYM
T O NOUN
in O ADP
this O DET
prospective, O NOUN
randomized O VERB
trial O NOUN
using O VERB
quantitative O ADJ
bleeding B-outcome VERB
severity I-outcome NOUN
criteria. O NOUN

Journal O ADJ
ID: O NOUN
9113221 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
measures O NOUN
represent O NOUN
the O DET
exposure O NOUN
in O ADP
a O DET
normal O ADJ
workload O ADP
schedule O NOUN
of O ADP
ninety O NOUN
randomly O ADV
selected O VERB
workers O NOUN
over O ADP
a O DET
3-month O NOUN
period, O NOUN
extrapolated O VERB
to O PART
1 O NUM
year. O NOUN

Under O ADP
PCV O NOUN
mode, O NOUN
with O ADP
the O DET
increase O NOUN
in O ADP
atomized O VERB
oxygen O NOUN
flow, O NOUN
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
monitored O VERB
by O ADP
ventilator O NOUN
in O ADP
different O ADJ
preset O NOUN
suction O NOUN
pressure O NOUN
groups O NOUN
was O VERB
decreased O VERB
gradually, O NOUN
and O CCONJ
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
was O VERB
increased O VERB
gradually, O NOUN
but O CCONJ
peak B-outcome NOUN
airway I-outcome NOUN
pressure I-outcome NOUN
monitored O VERB
by O ADP
ventilator O NOUN
did O VERB
not O ADV
changed O VERB
significantly. O CCONJ

Improvement O NOUN
in O ADP
body B-outcome NOUN
composition I-outcome NOUN
was O VERB
achieved O NOUN
by O ADP
the O DET
intervention O NOUN
group O NOUN
(n O NOUN
= O SYM
13) O DET
with O ADP
a O DET
median O ADJ
decrease O NOUN
of O ADP
2.1% O NOUN
body O NOUN
fat O NOUN
compared O VERB
with O ADP
a O DET
non-exercising O VERB
group O NOUN
(n O NOUN
= O SYM
7) O NOUN
(0.1% O NOUN
increase; O NOUN
p O NOUN
= O SYM
0.022). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHODS: O NOUN
In O ADP
this O DET
multicentre, O NOUN
randomised, O NOUN
double-blind, O NOUN
placebo-controlled, O NOUN
parallel-group, O NOUN
phase O NOUN
2a O NOUN
study, O NOUN
we O PRON
recruited O VERB
adults O NOUN
(aged O PUNCT
21-75 O NUM
years) O NOUN
with O ADP
a O DET
body-mass O NOUN
index O NOUN
of O ADP
at O ADP
least O ADV
25 O NUM
kg/m(2), O NOUN
biopsy-confirmed O VERB
non-alcoholic O ADJ
steatohepatitis O NOUN
(fibrosis O PUNCT
stage O NOUN
1-3), O NOUN
and O CCONJ
a O DET
hepatic O ADJ
fat O NOUN
fraction O NOUN
of O ADP
at O ADP
least O ADV
10% O ADP
when O ADP
assessed O VERB
by O ADP
magnetic O ADJ
resonance O NOUN
imaging-proton O NOUN
density O NOUN
fat O NOUN
fraction. O NUM

RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
1773 O NUM
adult O NOUN
patients O NOUN
with O ADP
episodic O NOUN
migraine O NOUN
(n O NOUN
= O SYM
444 O NUM
for O ADP
galcanezumab O NOUN
120 O NUM
mg; O NOUN
n O NOUN
= O SYM
435 O NUM
for O ADP
galcanezumab O NOUN
240 O NUM
mg; O NOUN
n O NOUN
= O SYM
894 O NUM
for O ADP
placebo O NOUN
for O ADP
2 O NUM
studies O NOUN
pooled) O NOUN
and O CCONJ
1113 O NUM
patients O NOUN
with O ADP
chronic O ADJ
migraine O NOUN
(n O NOUN
= O SYM
278 O NUM
for O ADP
galcanezumab O NOUN
120 O NUM
mg; O NOUN
n O NOUN
= O SYM
277 O NUM
for O ADP
galcanezumab O NOUN
240 O NUM
mg; O NOUN
n O NOUN
= O SYM
558 O NUM
for O ADP
placebo) O NOUN
were O VERB
evaluated. O NOUN

The O DET
G1 O NOUN
presented O VERB
higher O ADJ
values O NOUN
of O ADP
CRP B-outcome NOUN
in O ADP
relation O NOUN
to O PART
the O DET
G2 O NOUN
significantly O ADV
(p O PUNCT
? O PUNCT

The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
investigate O NOUN
the O DET
immediate O ADJ
effectiveness O NOUN
of O ADP
2 O NUM
counterforce O NOUN
orthoses O NOUN
in O ADP
improving O VERB
the O DET
sensorimotor B-outcome NOUN
abilities O NOUN
of O ADP
the O DET
hand O NOUN
in O ADP
patients O NOUN
with O ADP
lateral O ADJ
elbow O NOUN
tendinopathy. O NOUN

Captured O PUNCT
drug O NOUN
was O VERB
quantified O VERB
using O VERB
Eu-labeled O VERB
protein O NOUN
A O DET
and O CCONJ
time-resolved O VERB
fluorescence. O NOUN

Main B-outcome ADJ
curve I-outcome NOUN
correction I-outcome NOUN
success O NOUN
rate O NOUN
was O VERB
in O ADP
association O NOUN
with O ADP
patients' O NOUN
age O NOUN
and O CCONJ
type O NOUN
of O ADP
rod O NOUN
(P-value=0.054, O PUNCT
r=-1.863 O NOUN
and O CCONJ
P-value=0.001, O NOUN
r=8.865 O NOUN
respectively). O NOUN

METHODS: O NOUN
Sixty-two O NUM
10- O NUM
to O PART
14-year-old O ADJ
patients O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
either O CCONJ
full-time O NOUN
(FT, O PUNCT
22 O NUM
hours O NOUN
daily) O CCONJ
or O CCONJ
part-time O NOUN
(PT, O NOUN
12 O NUM
hours O NOUN
daily) O CCONJ
wear O ADJ
of O ADP
a O DET
modified O VERB
Twin-block O NOUN
appliance. O NOUN

Journal-Name:BMC O NOUN
complementary O ADJ
and O CCONJ
alternative O ADJ
medicine O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

Title: O NOUN
[Effects O NOUN
of O ADP
propofol O NOUN
sedation O NOUN
on O ADP
psychological B-outcome ADJ
stress I-outcome NOUN
in O ADP
surgical O ADJ
patients O NOUN
under O ADP
epidural]. O NOUN

Journal-Name:Medicine O NOUN

Title: O NOUN
Plazomicin O NOUN
for O ADP
Infections O NOUN
Caused O VERB
by O ADP
Carbapenem-Resistant O NOUN
Enterobacteriaceae. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHOD: O NOUN
an O DET
experimental O ADJ
and O CCONJ
blind O PUNCT
study O NOUN
composed O VERB
of O ADP
120 O NUM
dyads O NOUN
of O ADP
first-time O NOUN
mothers O NOUN
and O CCONJ
full-term O NOUN
newborns, O NOUN
who O ADP
practiced O VERB
breastfeeding. O NOUN

Title: O NOUN
Effectiveness O NOUN
of O ADP
the O DET
Nutritional O ADJ
App O NOUN
"MyNutriCart" O NOUN
on O ADP
Food B-outcome NOUN
Choices I-outcome NOUN
Related O VERB
to O PART
Purchase B-outcome NOUN
and Seperator CCONJ
Dietary B-outcome ADJ
Behavior E1-outcome NOUN
: O PUNCT
A O DET
Pilot O NOUN
Randomized O VERB
Controlled O VERB
Trial. O NOUN

HR's O NOUN
for O ADP
levofloxacin O NOUN
and O CCONJ
moxifloxacin, O NOUN
compared O VERB
to O PART
beta-lactam O NOUN
monotherapy, O ADJ
on O ADP
any O DET
cardiac B-outcome ADJ
event I-outcome NOUN
were O VERB
0.40 O NUM
(95% O PUNCT
CI O NOUN
0.18;0.87)and O NUM
0.56 O NUM
(95% O PUNCT
CI O NOUN
0.36;0.87), O NUM
respectively. O NOUN

Journal-Name: O NOUN
Revista O NOUN
da O NOUN
Associacao O NOUN
Medica O NOUN
Brasileira O NOUN
(1992) O PUNCT

Intensive O ADJ
BP O NOUN
control O NOUN
significantly O ADV
reduced O VERB
the O DET
risk O NOUN
of O ADP
mild O ADJ
cognitive B-outcome ADJ
impairment I-outcome NOUN
(14.6 O ADV
vs O CCONJ
18.3 O NUM
cases O NOUN
per O ADP
1000 O NUM
person-years; O NOUN
HR, O NOUN
0.81; O NOUN
95% O NOUN
CI, O NOUN
0.69-0.95) O NOUN
and O CCONJ
the O DET
combined O VERB
rate O NOUN
of O ADP
mild O ADJ
cognitive B-outcome ADJ
impairment I-outcome NOUN
or Seperator CCONJ
probable I-outcome ADJ
dementia I-outcome NOUN
(20.2 O NUM
vs O CCONJ
24.1 O NUM
cases O NOUN
per O ADP
1000 O NUM
person-years; O NOUN
HR, O NOUN
0.85; O NOUN
95% O NOUN
CI, O NOUN
0.74-0.97). O NUM

This O DET
trial O NOUN
is O VERB
registered O VERB
with O ADP
ClinicalTrials.gov, O NOUN
number O NOUN
NCT02181413, O NOUN
and O CCONJ
follow-up O NOUN
is O VERB
ongoing. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

No O DET
trial-dependent O ADJ
differences O NOUN
were O VERB
observed O VERB
in O ADP
the O DET
Recovery O NOUN
period. O NOUN

Title: O NOUN
Are O VERB
(All) O PUNCT
Consumers O NOUN
Averse B-outcome NOUN
to I-outcome PART
Bitter I-outcome NOUN
Taste I-outcome NOUN
? O PUNCT

RESULTS: O NOUN
From O ADP
October O ADJ
2009 O NUM
through O ADP
April O NOUN
2012, O NUM
we O PRON
randomly O ADV
assigned O VERB
103 O NUM
patients O NOUN
to O PART
the O DET
hybrid-procedure O NOUN
group O NOUN
and O CCONJ
104 O NUM
to O PART
the O DET
open-procedure O NOUN
group. O VERB

Journal-Name: O NOUN
The O DET
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Title: O NOUN
Does O VERB
Doctor O NOUN
Race O NOUN
Affect O NOUN
the O DET
Health O NOUN
of O ADP
Black O NOUN
Men? O NOUN

There O PRON
were O VERB
no O DET
significantly O ADV
difference O NOUN
of O ADP
the O DET
numbers O NOUN
of O ADP
bucking B-outcome VERB
or O CCONJ
body B-outcome NOUN
moving I-outcome VERB
, O PUNCT
the O DET
satisfaction B-outcome NOUN
of O ADP
operators O NOUN
and O CCONJ
patients, O NOUN
and O CCONJ
adverse B-outcome ADJ
events I-outcome NOUN
(all O PUNCT
P>0.05). O NOUN

Between-group O ADJ
differences O NOUN
were O VERB
not O ADV
significant. O NOUN

The O DET
results O NOUN
of O ADP
this O DET
trial O NOUN
could O VERB
support O NOUN
decision-making O VERB
by O ADP
clinicians O NOUN
regarding O VERB
aPDT O NOUN
using O VERB
aPDT O NOUN
for O ADP
treating O VERB
halitosis. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Conclusion: O NOUN
Compared O VERB
with O ADP
the O DET
posterolateral O ADJ
approach, O NOUN
the O DET
SuperPATH O NOUN
approach O NOUN
can O VERB
reduce O VERB
muscle B-outcome NOUN
damage I-outcome NOUN
, O PUNCT
relieve O NOUN
early O ADJ
pain B-outcome NOUN
, O PUNCT
promote O VERB
recovery B-outcome NOUN
, O PUNCT
and O CCONJ
obtain O VERB
the O DET
similar O ADJ
short-term O NOUN
effectiveness. O NOUN

Publication O NOUN
date: O NOUN
['2019/10/16 O NOUN
06:00' O NUM

Publication O NOUN
date: O NOUN
2018/12/21 O NOUN
06:00 O ADP
[entrez] O ADP

Title: O NOUN
Comparing O VERB
the O DET
effect O NOUN
between O ADP
continuous O ADJ
infusion O NOUN
and O CCONJ
intermittent O ADJ
bolus O NOUN
of O ADP
rocuronium O NOUN
for O ADP
intraoperative O ADJ
neurophysiologic O ADJ
monitoring O VERB
of O ADP
neurointervention O NOUN
under O ADP
general O ADJ
anesthesia. O NOUN

Unhealthy O NOUN
food O NOUN
sponsorship O NOUN
also O ADV
led O VERB
to O PART
greater O ADJ
perceived O VERB
event-sponsor B-outcome NOUN
fit I-outcome NOUN
and Seperator CCONJ
transfer B-outcome NOUN
of I-outcome ADP
perceptions E1-outcome NOUN
of O ADP
the O DET
sporting O VERB
event O NOUN
to O PART
the O DET
unhealthy O NOUN
food O NOUN
sponsor O ADP
brands, O NOUN
relative O ADJ
to O PART
the O DET
control O NOUN
group. O VERB

BACKGROUND: O NOUN
To O PART
compare O NOUN
the O DET
superiority O NOUN
of O ADP
teaching O VERB
methods O NOUN
for O ADP
acquiring O VERB
a O DET
proficient O ADP
level O NOUN
of O ADP
surgical O ADJ
skill B-outcome ADV
in O ADP
a O DET
robotic O ADJ
surgery-naive O ADJ
individual O ADJ
using O VERB
a O DET
robotic O ADJ
virtual O ADJ
reality O NOUN
simulator. O NOUN

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[pubmed] O PUNCT

The O DET
intervention O NOUN
group O NOUN
received O VERB
additional O ADJ
individual O ADJ
pre-discharge O NOUN
pharmacotherapeutic O ADJ
education O NOUN
about O ADV
the O DET
discharge O NOUN
prescriptions. O NOUN

Physical B-outcome ADJ
activity-related I-outcome VERB
fear I-outcome ADJ
was O VERB
reduced O VERB
only O ADV
in O ADP
the O DET
Exercise-arm O NUM
(p O PUNCT
= O SYM
0.008). O NUM

Linear O ADJ
regressions O NOUN
examined O VERB
between-groups O NOUN
relationships O NOUN
for O ADP
foot O NOUN
and O CCONJ
ankle O NOUN
characteristics O NOUN
and O CCONJ
the O DET
FPPA. O NOUN

Title: O NOUN
Evaluation O NOUN
of O ADP
a O DET
Single O NOUN
Dose O NOUN
of O ADP
Azithromycin O NOUN
for O ADP
Trachoma O NOUN
in O ADP
Low-Prevalence O NOUN
Communities. O NOUN

Journal-Name:Zhonghua O NOUN
wei O NUM
zhong O PUNCT
bing O VERB
ji O ADP
jiu O NOUN
yi O ADP
xue O NOUN

The O DET
primary O ADJ
efficacy O NOUN
endpoint O NOUN
was O VERB
measured O VERB
by O ADP
the O DET
Tinnitus B-outcome NOUN
Severity I-outcome NOUN
Scale O NOUN
(TSS) O PUNCT
and O CCONJ
Tinnitus B-outcome NOUN
Questionnaire O PROPN
(TQ) O NOUN
sum O NOUN
score. O NOUN

To O PART
date, O VERB
no O DET
published O VERB
study O NOUN
has O VERB
examined O VERB
the O DET
effect O NOUN
of O ADP
an O DET
active, O ADJ
music-instruction O NOUN
intervention O NOUN
as O ADP
a O DET
complementary O ADJ
strategy O NOUN
to O PART
improve O VERB
the O DET
psychological O ADJ
well-being O VERB
of O ADP
veterans O NOUN
with O ADP
PTSD. O NOUN

In O ADP
third O ADJ
postoperative O ADJ
day, O ADP
mean O NOUN
was O VERB
3.18 O NUM
for O ADP
the O DET
first O ADV
group O NOUN
and O CCONJ
3.11 O NUM
for O ADP
the O DET
traditional O ADJ
group O NOUN
(p=0.937). O PUNCT

Baltimore O NOUN
Community-based O VERB
Organizations O NOUN
Neighborhood O NOUN
Network: O ADJ
Enhancing O VERB
Capacity O NOUN
Together O ADV
(CONNECT) O PUNCT
was O VERB
a O DET
randomized, O NOUN
controlled O VERB
trial O NOUN
based O VERB
on O ADP
the O DET
core O NOUN
tenets O NOUN
of O ADP
the O DET
World O NOUN
Health O NOUN
Organization's O NOUN
(WHO) O NOUN
African O ADV
Partnerships O NOUN
for O ADP
Patient O NOUN
Safety O NOUN
Community O NOUN
Engagement O NOUN
(ACE) O NOUN
approach. O NOUN

Registered O VERB
1 O NUM
February O ADJ
2013. O NUM

Publication O NOUN
date: O NOUN
2019/01/07 O NOUN
00:00 O NOUN
[accepted] O ADV

Title: O NOUN
Effectiveness O NOUN
and O CCONJ
cost-effectiveness O NOUN
of O ADP
neuromuscular O ADJ
exercise O NOUN
and O CCONJ
back O ADP
care O NOUN
counseling O VERB
in O ADP
female O NOUN
healthcare O NOUN
workers O NOUN
with O ADP
recurrent O ADP
non-specific O ADJ
low O ADJ
back O ADP
pain: O NOUN
a O DET
blinded O VERB
four-arm O NOUN
randomized O VERB
controlled O VERB
trial. O NOUN

Compared O VERB
to O PART
controls, O NOUN
elite O ADP
football O NOUN
players O NOUN
showed O VERB
lower O ADJ
antioxidant B-outcome NOUN
power I-outcome NOUN
and O CCONJ
higher O ADJ
oxidative B-outcome ADJ
stress I-outcome NOUN
paralleled O VERB
by O ADP
an O DET
increase O NOUN
in O ADP
muscle B-outcome NOUN
damage I-outcome NOUN
markers. O NOUN

There O PRON
were O VERB
30 O NUM
statistically O ADV
significant O ADJ
metabolite B-outcome NOUN
differences O NOUN
in O ADP
the O DET
stool O NOUN
of O ADP
participants O NOUN
that O ADP
consumed O VERB
navy O ADJ
bean O NOUN
at O ADP
day O NOUN
28 O NUM
compared O VERB
to O PART
the O DET
participants' O NOUN
baseline O NOUN
(p O PUNCT
</= O NOUN
0.05) O NUM
and O CCONJ
26 O NUM
significantly O ADV
different O ADJ
metabolites B-outcome NOUN
when O ADP
compared O VERB
to O PART
the O DET
control O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
9420934 O NUM

BACKGROUND: O NOUN
Studies O NOUN
have O VERB
reported O VERB
that O ADP
the O DET
ED50 O NOUN
of O ADP
intrathecal O ADJ
ropivacaine O NOUN
was O VERB
increased O VERB
when O ADP
using O VERB
prophylactic O ADJ
infusion O NOUN
of O ADP
phenylephrine O NOUN
to O PART
prevent O NOUN
spinal-induced O VERB
hypotension. O NOUN

A O DET
common O ADJ
approach O NOUN
to O PART
deliver O ADP
malaria O NOUN
services O NOUN
is O VERB
to O PART
assign O ADV
Village O NOUN
Health O NOUN
Volunteers O NOUN
(VHVs) O PUNCT
to O PART
villages, O NOUN
particularly O ADV
where O ADP
limited O VERB
or O CCONJ
no O DET
services O NOUN
exist. O ADJ

Results: O NOUN
The O DET
authors O NOUN
compared O VERB
the O DET
EG O NOUN
results O NOUN
at O ADP
the O DET
initial O ADJ
and O CCONJ
final O ADJ
assessments O NOUN
and O CCONJ
found O VERB
a O DET
statistically O ADV
significant O ADJ
improvement O NOUN
in O ADP
severity O NOUN
of O ADP
urinary B-outcome ADJ
incontinence I-outcome NOUN
(P=0.001) O ADV
and O CCONJ
depression B-outcome NOUN
severity O NOUN
(P=0.006), O NUM
and O CCONJ
a O DET
decrease O NOUN
in O ADP
myostatin B-outcome NOUN
concentration O NOUN
(P</=0.001). O NUM

Journal-Name:Ophthalmic O ADJ
epidemiology O NOUN

Objective: O NOUN
To O PART
investigate O NOUN
the O DET
efficacy O NOUN
of O ADP
cognitive-behavioral O ADJ
therapy O NOUN
for O ADP
insomnia O NOUN
(CBT-i) O NOUN
or O CCONJ
combination O NOUN
with O ADP
tapered O VERB
hypnotic O ADJ
agents. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
groups O NOUN
in O ADP
the O DET
median O ADJ
cumulative O ADJ
time O NOUN
with O ADP
mean O NOUN
arterial O ADJ
pressure O NOUN
below O ADP
60 O NUM
mm O NOUN
Hg O NOUN
(7 O NOUN
vs O CCONJ
7 O NUM
minutes; O NOUN
difference, O NOUN
0.0 O NUM
[95% O NOUN
CI, O NOUN
-1.7 O NOUN
to O PART
1.7]). O ADJ

METHODS: O NOUN
This O DET
is O VERB
a O DET
3-arm, O NUM
waitlist, O NOUN
single-blind O NOUN
randomised O VERB
controlled O VERB
trial O NOUN
testing O VERB
the O DET
efficacy O NOUN
of O ADP
the O DET
Stay O NOUN
Strong O ADJ
App O NOUN
in O ADP
improving O VERB
psychological B-outcome ADJ
distress I-outcome NOUN
, O PUNCT
depressive B-outcome ADJ
symptoms I-outcome NOUN
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
and O CCONJ
treatment B-outcome NOUN
adherence I-outcome NOUN
among O ADP
Indigenous O ADJ
clients O NOUN
undergoing O VERB
haemodialysis O NOUN
for O ADP
ESKD O NOUN
in O ADP
Alice O NOUN
Springs O NOUN
and O CCONJ
Darwin O ADP
with O ADP
follow O VERB
up O ADP
over O ADP
two O NUM
periods O NOUN
of O ADP
3 O NUM
months O NOUN
(total O ADJ
of O ADP
6 O NUM
months O NOUN
observation). O PUNCT

After O ADP
12 O NUM
months, O NOUN
the O DET
Combined-arm O NUM
showed O VERB
reduced O VERB
intensity B-outcome NOUN
of I-outcome ADP
low I-outcome ADJ
back I-outcome ADP
pain I-outcome NOUN
(p O PUNCT
= O SYM
0.006; O NOUN
effect O NOUN
size O NOUN
0.70, O NOUN
confidence O NOUN
interval O NOUN
0.23 O NUM
to O PART
1.17) O NUM
and O CCONJ
pain B-outcome NOUN
interfering I-outcome VERB
with Seperator ADP
work I-outcome NOUN
(p O PUNCT
= O SYM
0.011) O NUM
compared O VERB
with O ADP
the O DET
Control-arm. O NOUN

OBJECTIVE: O NOUN
To O PART
pilot O NOUN
test O NOUN
the O DET
effectiveness O NOUN
of O ADP
"MyNutriCart", O NOUN
a O DET
smartphone O NOUN
application O NOUN
(app) O NUM
that O ADP
generates O NOUN
healthy O ADJ
grocery O NOUN
lists, O NOUN
on O ADP
diet B-outcome NOUN
and O CCONJ
weight B-outcome NOUN
. O PUNCT
METHODS: O NOUN
A O DET
pilot O NOUN
randomized O VERB
trial O NOUN
was O VERB
conducted O VERB
to O PART
test O NOUN
the O DET
efficacy O NOUN
of O ADP
using O VERB
the O DET
"MyNutriCart" O NOUN
app O CCONJ
compared O VERB
to O PART
one O NUM
face-to-face O NUM
counseling O VERB
session O NOUN
(Traditional O ADJ
group) O ADJ
in O ADP
Hispanic O ADJ
overweight O NUM
and O CCONJ
obese O NOUN
adults. O NOUN

Wound B-outcome NOUN
complications I-outcome NOUN
in O ADP
the O DET
first O ADV
30 O NUM
days O NOUN
and O CCONJ
incisional B-outcome ADJ
hernia I-outcome NOUN
rates O NOUN
were O VERB
assessed. O NOUN

Both O CCONJ
techniques O NOUN
created O VERB
the O DET
same O ADJ
level O NOUN
of O ADP
epithelial B-outcome ADJ
thickness I-outcome NOUN
increase O NOUN
and O CCONJ
variation, O NOUN
with O ADP
a O DET
significantly O ADV
higher O ADJ
mid-peripheral B-outcome ADJ
epithelial I-outcome ADJ
thickness I-outcome NOUN
increase. O NOUN

Topical O ADJ
repellents O NOUN
are O VERB
an O DET
intervention O NOUN
that O ADP
can O VERB
be O VERB
used O VERB
to O PART
target O NOUN
residual O ADJ
malaria O NOUN
transmission O NOUN
not O ADV
covered O VERB
by O ADP
long O ADV
lasting O VERB
insecticide O NOUN
nets O NOUN
and O CCONJ
indoor O NOUN
residual O ADJ
spraying. O ADV

Objective: O NOUN
To O PART
investigate O NOUN
the O DET
effects O NOUN
of O ADP
dexmedetomidine O NOUN
on O ADP
perioperative O ADJ
stress B-outcome NOUN
and O CCONJ
postoperative O ADJ
pain B-outcome NOUN
in O ADP
patients O NOUN
with O ADP
radical O NOUN
resection O NOUN
of O ADP
esophageal O ADJ
cancer O NOUN
under O ADP
combined O VERB
thoracoscope O NOUN
and O CCONJ
laparoscope. O NOUN

The O DET
blood O NOUN
levels O NOUN
of O ADP
sICAM-1 B-outcome NOUN
, O PUNCT
sVCAM-1 B-outcome NOUN
, O PUNCT
endothelin-1 B-outcome NOUN
, O PUNCT
and O CCONJ
sE-selectin B-outcome NOUN
were O VERB
quantified; O NOUN
the O DET
activities O NOUN
of O ADP
catalase B-outcome NOUN
, O PUNCT
superoxide B-outcome NOUN
dismutase I-outcome NOUN
, O PUNCT
glutathione B-outcome NOUN
peroxidase I-outcome NOUN
, O PUNCT
glutathione B-outcome NOUN
reductase I-outcome NOUN
and O CCONJ
concentrations O NOUN
of O ADP
reduced O VERB
glutathione B-outcome NOUN
, O PUNCT
oxidized B-outcome VERB
glutathione I-outcome NOUN
, O PUNCT
and O CCONJ
thiobarbituric B-outcome ADJ
acid I-outcome NOUN
reactive O ADJ
substances, O NOUN
were O VERB
also O ADV
quantified O VERB
before O ADP
and O CCONJ
after O ADP
the O DET
treatment O NOUN
period. O NOUN
( O PUNCT

The O DET
total B-outcome ADJ
sleep I-outcome NOUN
time I-outcome NOUN
and O CCONJ
arousal B-outcome ADJ
time I-outcome NOUN
were O VERB
obtained O VERB
by O ADP
bispectral O ADJ
index O NOUN
(BIS) O PUNCT
monitoring O VERB
from O ADP
20: O NOUN
00 O NUM
(the O NOUN
first O ADV
day) O NOUN
to O PART
6: O ADP
00 O NUM
(the O NOUN
second O ADJ
day). O NOUN

The O DET
secondary O ADJ
objective O ADP
was O VERB
to O PART
investigate O NOUN
the O DET
postinduction O NOUN
levels O NOUN
of O ADP
serum O NOUN
neurohormones B-outcome NOUN
in O ADP
an O DET
attempt O NOUN
to O PART
explain O NOUN
the O DET
mechanisms O NOUN
involved. O NOUN

Importance: O NOUN
Abnormal O ADJ
peripheral O ADJ
perfusion O NOUN
after O ADP
septic O ADJ
shock O NOUN
resuscitation O NOUN
has O VERB
been O VERB
associated O VERB
with O ADP
organ O NOUN
dysfunction O NOUN
and O CCONJ
mortality. O NOUN

Journal-Name:Zhonghua O NOUN
lao O NOUN
dong O ADJ
wei O NUM
sheng O NOUN
zhi O NUM
ye O ADP
bing O VERB
za O ADP
zhi O NUM
= O SYM
Zhonghua O NOUN
laodong O ADV
weisheng O NOUN
zhiyebing O VERB
zazhi O NOUN
= O SYM
Chinese O NOUN
journal O ADJ
of O ADP
industrial O ADJ
hygiene O NOUN
and O CCONJ
occupational O ADJ
diseases O NOUN

Secondary O ADJ
outcomes O NOUN
were O VERB
from O ADP
start O NOUN
of O ADP
the O DET
propofol O NOUN
infusion O NOUN
time B-outcome NOUN
to I-outcome PART
loss I-outcome NOUN
of I-outcome ADP
consciousness I-outcome NOUN
(LOC) I-outcome NOUN
, O PUNCT
rocuronium B-outcome NOUN
onset I-outcome NOUN
time I-outcome NOUN
, O PUNCT
time B-outcome NOUN
to I-outcome PART
Bispectral I-outcome ADJ
index I-outcome NOUN
(BIS) I-outcome PUNCT
60 I-outcome NUM
, O PUNCT
and O CCONJ
hemodynamic B-outcome ADJ
variables. O NUM

RESULTS: O NOUN
The O DET
fentanyl O NOUN
level O NOUN
peaked O VERB
1 O NUM
h O NOUN
after O ADP
operation O NOUN
in O ADP
the O DET
TFP O NOUN
group O NOUN
(3.27 O NOUN
+/- O SYM
0.34 O NUM
ng/mL) O NOUN
and O CCONJ
24 O NUM
h O NOUN
postoperatively O ADV
in O ADP
the O DET
IV O NUM
group O NOUN
(2.9 O NUM
+/- O SYM
0.42 O NUM
ng/mL). O NOUN

CONCLUSIONS: O NOUN
Both O CCONJ
LASIK O NOUN
and O CCONJ
SMILE O NOUN
resulted O VERB
in O ADP
significant O ADJ
epithelial B-outcome ADJ
thickening I-outcome VERB
. O PUNCT
This O DET
response O NOUN
seemed O VERB
to O PART
be O VERB
surprisingly O ADV
quite O ADV
similar O ADJ
between O ADP
the O DET
2 O NUM
different O ADJ
techniques. O NUM

Two O NUM
clinical O ADJ
trials O NOUN
have O VERB
examined O VERB
this O DET
strategy O NOUN
and O CCONJ
reported O VERB
controversial O ADJ
results. O NOUN

For O ADP
the O DET
comparison O NOUN
of O ADP
the O DET
Ocular B-outcome ADJ
Surface I-outcome NOUN
Disease I-outcome NOUN
Index O NOUN
(OSDI)], O NOUN
subjective O ADJ
evaluation O NOUN
scores, O NOUN
tear B-outcome NUM
breakup I-outcome ADP
time I-outcome NOUN
(TBUT) I-outcome PUNCT
and O CCONJ
fluorescein B-outcome NOUN
staining I-outcome VERB
, O PUNCT
statistically O ADV
significant O ADJ
improvements O NOUN
were O VERB
noted O VERB
in O ADP
the O DET
BCL O NOUN
group, O NOUN
especially O ADV
on O ADP
days O NOUN
7 O NUM
and O CCONJ
14 O NUM
(P O NUM
< O SYM
0.001, O NUM
P O NOUN
< O SYM
0.001; O NOUN
P O NOUN
= O SYM
0.031, O NUM
P O NOUN
= O SYM
0.009; O NOUN
P O NOUN
= O SYM
0.021, O PUNCT
P O NOUN
= O SYM
0.028; O NOUN
and O CCONJ
P O NOUN
= O SYM
0.03, O NUM
P O NOUN
= O SYM
0.032, O NUM
respectively). O NOUN

RESULTS: O NOUN
HSS, O ADJ
KSS, O ADJ
NASS O NOUN
scores, O NOUN
and O CCONJ
ROM O NOUN
were O VERB
elevated O VERB
after O ADP
patients O NOUN
receiving O VERB
TKA. O NOUN

Journal O ADJ
ID: O NOUN
101160020 O NUM

The O DET
aim O ADP
of O ADP
the O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
if O ADP
Reproductive O ADJ
Life O NOUN
Plan O NOUN
(RLP)-based O VERB
counselling O VERB
during O ADP
a O DET
sexual O ADJ
health O NOUN
visit O NOUN
could O VERB
increase O NOUN
men's O NOUN
fertility B-outcome NOUN
awareness I-outcome ADV
. O PUNCT
MATERIAL O NOUN
AND O CCONJ
METHODS: O NOUN
The O DET
study O NOUN
was O VERB
a O DET
randomized O VERB
controlled O VERB
trial O NOUN
including O VERB
201 O NUM
men O NOUN
aged O VERB
18-50 O NUM
who O ADP
visited O VERB
either O CCONJ
of O ADP
two O NUM
participating O VERB
sexual O ADJ
health O NOUN
clinics O NOUN
in O ADP
Sweden O NOUN
for O ADP
sexually O ADV
transmitted O VERB
infection O NOUN
testing O VERB
during O ADP
2014-2016. O NOUN

The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
exploit O NOUN
the O DET
effect O NOUN
of O ADP
cocoa O NOUN
polyphenols O NOUN
on O ADP
oxidative B-outcome ADJ
stress I-outcome NOUN
and O CCONJ
muscular B-outcome ADJ
injuries I-outcome NOUN
induced O VERB
by O ADP
intensive O ADJ
physical O ADJ
exercise O NOUN
in O ADP
elite O ADP
football O NOUN
players. O NOUN

On O ADP
intention-to-treat O NOUN
analysis, O NOUN
Hp B-outcome NOUN
eradication I-outcome NOUN
rates O NOUN
in O ADP
FZD O NOUN
and O CCONJ
CLA O NOUN
groups O NOUN
were O VERB
90.22% O NOUN
and O CCONJ
86.02% O NUM
(P O NUM
= O SYM
.378); O PUNCT
in O ADP
per-protocol O NOUN
analysis, O NOUN
their O ADJ
eradication B-outcome NOUN
rates O NOUN
were O VERB
93.26% O NOUN
and O CCONJ
87.91%, O NUM
respectively O ADV
(P O NUM
= O SYM
.220). O NOUN

Journal-Name:Eye O NOUN
& O CCONJ
contact O NOUN
lens O NOUN

The O DET
exercise O NOUN
group O NOUN
performed O VERB
40 O NUM
min O NOUN
of O ADP
resistance O NOUN
exercises O NOUN
on O ADP
machines O NOUN
followed O VERB
by O ADP
30 O NUM
min O NOUN
of O ADP
aerobic O ADJ
training O VERB
on O ADP
a O DET
treadmill O ADV
3x/wk. O NOUN

PMID: O NOUN
31618328 O NUM

Secondary O ADJ
endpoints O NOUN
in O ADP
rank O NOUN
order O NOUN
included: O NOUN
superiority O NOUN
of O ADP
HP O NOUN
relative O ADJ
to O PART
G O NOUN
+ O SYM
T O NOUN
in O ADP
mean O NOUN
preparation B-outcome NOUN
time I-outcome NOUN
; O PUNCT
non-inferiority O NOUN
of O ADP
HP O NOUN
relative O ADJ
to O PART
G O NOUN
+ O SYM
T O NOUN
for O ADP
achieving O VERB
hemostasis B-outcome NOUN
within O ADP
3 O NUM
min; O NOUN
superiority O NOUN
of O ADP
HP O NOUN
relative O ADJ
to O PART
G O NOUN
+ O SYM
T O NOUN
for O ADP
achieving O VERB
hemostasis B-outcome NOUN
within O ADP
6 O NUM
min; O NOUN
and O CCONJ
superiority O NOUN
of O ADP
HP O NOUN
relative O ADJ
to O PART
G O NOUN
+ O SYM
T O NOUN
for O ADP
success O NOUN
for O ADP
achieving O VERB
hemostasis B-outcome NOUN
within O ADP
3 O NUM
min. O NOUN

The O DET
1st O ADJ
group O NOUN
contained O VERB
22 O NUM
patients O NOUN
and O CCONJ
surgery O NOUN
was O VERB
performed O VERB
using O VERB
a O DET
fascia O NOUN
lata O NOUN
allograft. O NOUN

Title: O NOUN
Pegbelfermin O NOUN
(BMS-986036), O PUNCT
a O DET
PEGylated O VERB
fibroblast O NOUN
growth O NOUN
factor O NOUN
21 O NUM
analogue, O NOUN
in O ADP
patients O NOUN
with O ADP
non-alcoholic O ADJ
steatohepatitis: O NOUN
a O DET
randomised, O NOUN
double-blind, O NOUN
placebo-controlled, O NOUN
phase O NOUN
2a O NOUN
trial. O NOUN

Discussion: O NOUN
Short-term O NOUN
use O NOUN
of O ADP
IQOS(TM) O NOUN
has O VERB
a O DET
minimal O ADJ
impact O NOUN
on O ADP
exhaled B-outcome VERB
CO I-outcome NOUN
, O PUNCT
is O VERB
equally O ADV
effective O ADJ
in O ADP
reducing O VERB
cigarette B-outcome NOUN
craving I-outcome VERB
and O CCONJ
withdrawal B-outcome NOUN
symptoms I-outcome NOUN
as O ADP
an O DET
e-cigarette, O PUNCT
and O CCONJ
is O VERB
slightly O ADV
preferred B-outcome VERB
. O PUNCT

Achaogen, O VERB
South O NOUN
San O NOUN
Francisco, O ADV
CA. O NOUN

Subjects O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
take O NOUN
either O CCONJ
50,000 O NUM
IU O NOUN
vitamin O NOUN
D O NOUN
every O DET
2 O NUM
weeks O NOUN
plus O CCONJ
8 O NUM
x O SYM
10(9) O NUM
CFU/day O NUM
probiotic O ADJ
(n O NOUN
= O SYM
30) O NOUN
or O CCONJ
placebo O NOUN
(n O NOUN
= O SYM
30) O NOUN
for O ADP
12 O NUM
weeks. O NOUN

Journal O ADJ
ID: O NOUN
100968547 O NUM

CONCLUSIONS: O NOUN
Among O ADP
patients O NOUN
with O ADP
TTP, O NOUN
treatment O NOUN
with O ADP
caplacizumab O NOUN
was O VERB
associated O VERB
with O ADP
faster O ADJ
normalization B-outcome NOUN
of I-outcome ADP
the Seperator DET
platelet I-outcome NOUN
count I-outcome NOUN
; O PUNCT
a O DET
lower O ADJ
incidence O NOUN
of O ADP
a O DET
composite O NOUN
of O ADP
TTP-related B-outcome VERB
death I-outcome NOUN
, O PUNCT
recurrence B-outcome NOUN
of O ADP
TTP, O NOUN
or O CCONJ
a O DET
thromboembolic B-outcome ADJ
event I-outcome NOUN
during O ADP
the O DET
trial O NOUN
treatment O NOUN
period; O NOUN
and O CCONJ
a O DET
lower O ADJ
rate O NOUN
of O ADP
recurrence B-outcome NOUN
of O ADP
TTP O NOUN
during O ADP
the O DET
trial O NOUN
than O ADP
placebo. O NOUN
( O PUNCT

The O DET
corresponding O VERB
rates O NOUN
between O ADP
weeks O NOUN
44 O NUM
and O CCONJ
80 O NUM
were O VERB
0.10+/-0.25 O NUM
and O CCONJ
0.03+/-0.28 O NUM
(difference, O ADV
0.07; O NOUN
two-sided O ADP
90% O VERB
CI, O NOUN
0.03 O NUM
to O PART
0.10); O NUM
the O DET
difference O NOUN
in O ADP
the O DET
rate O NOUN
of O ADP
progression B-outcome NOUN
between O ADP
weeks O NOUN
44 O NUM
and O CCONJ
80 O NUM
did O VERB
not O ADV
meet O NOUN
the O DET
criterion O NOUN
for O ADP
noninferiority O NOUN
of O ADP
early O ADJ
receipt O NOUN
of O ADP
levodopa O NOUN
to O PART
delayed O VERB
receipt. O ADP

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Follow-up O NOUN
period O NOUN
was O VERB
2 O NUM
years. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

RESULTS: O NOUN
At O ADP
T2, O NOUN
the O DET
intervention O NOUN
group O NOUN
reported O VERB
significantly O ADV
higher O ADJ
self-efficacy B-outcome NOUN
to O PART
cope O NOUN
with O ADP
stress O NOUN
(effect O NOUN
size O NOUN
[Cohen's O NOUN
d O NOUN
= O SYM
0.53), O NUM
better O ADJ
emotional O ADJ
coping B-outcome VERB
response O NOUN
(d O NOUN
= O SYM
0.38), O NUM
less O ADV
stress B-outcome NOUN
(d O NOUN
= O SYM
0.34), O NUM
fewer O ADJ
depressive B-outcome ADJ
symptoms I-outcome NOUN
(d O NOUN
= O SYM
- O PUNCT
0.27), O NUM
and O CCONJ
more O ADV
positive B-outcome ADJ
affect I-outcome NOUN
(d O NOUN
= O SYM
0.31) O NUM
than O ADP
the O DET
comparison O NOUN
group. O VERB

Results: O NOUN
The O DET
self-assessment O ADJ
scores O NOUN
of O ADP
WDCs' O NOUN
capacity O NOUN
to O PART
fulfil O NOUN
their O ADJ
roles O NOUN
improved O VERB
more O ADV
in O ADP
the O DET
intervention O NOUN
than O ADP
in O ADP
the O DET
comparison O NOUN
area O NOUN
for O ADP
all O DET
six O NUM
components, O NOUN
but O CCONJ
for O ADP
only O ADV
1 O NUM
of O ADP
the O DET
6 O NUM
was O VERB
the O DET
improvement O NOUN
statistically O ADV
significant O ADJ
(monthly O NUM
and O CCONJ
quarterly O ADV
meetings O NOUN
in O ADP
which O ADP
Peer O NOUN
Supervisor O NOUN
and/or O CCONJ
CHW O NOUN
supervision O NOUN
was O VERB
an O DET
agenda O NOUN
item). O NOUN

Data O NOUN
were O VERB
analysed O VERB
using O VERB
Systematic O ADJ
Text O VERB
Condensation. O NOUN

Publication O NOUN
date: O NOUN
2018/11/04 O PUNCT
00:00 O NOUN
[accepted] O ADV

Results: O NOUN
Twenty-four O NUM
children O NOUN
with O ADP
HIV O NOUN
and/or O CCONJ
PHE O NOUN
were O VERB
randomized O VERB
into O ADP
one O NUM
of O ADP
the O DET
two O NUM
intervention O NOUN
groups. O NOUN

Journal-Name:JAMA O NOUN

Participants O NOUN
were O VERB
followed O VERB
for O ADP
1 O NUM
year. O NOUN

BACKGROUND: O NOUN
Ambulatory O ADJ
patients O NOUN
receiving O VERB
systemic O ADJ
cancer O NOUN
therapy O NOUN
are O VERB
at O ADP
varying O VERB
risk O NOUN
for O ADP
venous O ADJ
thromboembolism. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[entrez] O ADP

Dental B-outcome ADJ
, O PUNCT
skeletal B-outcome ADJ
, O PUNCT
and O CCONJ
soft B-outcome NOUN
tissue I-outcome NOUN
measurements O NOUN
were O VERB
performed O VERB
on O ADP
lateral O ADJ
cephalograms O NOUN
taken O VERB
just O ADV
before O ADP
and O CCONJ
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
Herbst O NOUN
appliance O NOUN
therapy. O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

RESULTS: O NOUN
Seventy-one O NUM
patients O NOUN
(45% O PUNCT
PAH, O NOUN
55% O NOUN
CTEPH; O NOUN
53.5% O NOUN
female; O NOUN
60 O NUM
+/- O SYM
13 O NUM
years, O NOUN
mean O NOUN
pulmonary O ADJ
arterial O ADJ
pressure O NOUN
46 O NUM
+/- O SYM
10 O NUM
mmHg, O NOUN
mean O NOUN
PVR O NOUN
700 O NUM
+/- O SYM
282dynes.sec.cm-5) O NUM
were O VERB
included. O NOUN

Five O NUM
of O ADP
7 O NUM
household O NOUN
behaviors O NOUN
judged O VERB
to O PART
be O VERB
amenable O ADJ
to O PART
promotion O NOUN
by O ADP
CHWs O NOUN
improved O VERB
more O ADV
in O ADP
the O DET
intervention O NOUN
area O NOUN
than O ADP
in O ADP
the O DET
comparison O NOUN
area, O NOUN
and O CCONJ
2 O NUM
out O ADP
of O ADP
the O DET
5 O NUM
were O VERB
statistically O ADV
significant O ADJ
(feeding O VERB
colostrum O NOUN
and O CCONJ
appropriate O ADJ
infant O NOUN
and O CCONJ
young O ADJ
child O NOUN
feeding). O NUM

We O PRON
measured O VERB
and O CCONJ
compare O NOUN
the O DET
knowledge B-outcome NOUN
of I-outcome ADP
and Seperator CCONJ
incidences X NOUN
of X NOUN
hand B-outcome NOUN
food I-outcome NOUN
mouth I-outcome NOUN
disease E4-outcome NOUN
between O ADP
2 O NUM
groups. O NOUN

Outcomes O NOUN
will O VERB
be O VERB
assessed O VERB
at O ADP
baseline O NOUN
and O CCONJ
at O ADP
3, O NOUN
6, O NOUN
and O CCONJ
10 O NUM
weeks O NOUN
after O ADP
screening. O NOUN

Trial O NOUN
Registration: O NOUN
ISRCTN53448131. O NOUN

Compared O VERB
with O ADP
SFC, O ADP
IND/GLY O NOUN
treatment O NOUN
was O VERB
associated O VERB
with O ADP
reductions O NOUN
in O ADP
the O DET
annualized O VERB
rates O NOUN
of O ADP
moderate/severe O ADV
exacerbations B-outcome NOUN
(rate O NOUN
ratio O NOUN
[95% O NOUN
CI]: O ADP
0.81 O NUM
[0.73-0.91], O NUM
0.89 O NUM
[0.74-1.07] O NOUN
in O ADP
men O NOUN
and O CCONJ
women, O NOUN
respectively). O NOUN

Electromyographic O ADJ
analysis O NOUN
of O ADP
the O DET
pectoralis O NOUN
major O ADJ
and O CCONJ
triceps O ADP
brachii O ADJ
were O VERB
monitored O VERB
during O ADP
3 O NUM
maximal O ADJ
isometric O ADJ
contractions O NOUN
and O CCONJ
a O DET
fatiguing O VERB
endurance O NOUN
task. O NOUN

OBJECTIVE: O NOUN
The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
compare O NOUN
enhancement B-outcome NOUN
of O ADP
the O DET
aorta O NOUN
and O CCONJ
liver O NOUN
on O ADP
hepatic O ADJ
dynamic O ADJ
computed O VERB
tomography O NOUN
scans O NOUN
acquired O VERB
with O ADP
contrast O NOUN
material O ADJ
doses O NOUN
based O VERB
on O ADP
the O DET
lean O ADJ
body O NOUN
weight O NOUN
(LBW) O NUM
or O CCONJ
the O DET
total O ADJ
body O NOUN
weight O NOUN
(TBW). O PUNCT

Does O VERB
the O DET
timing O VERB
of O ADP
hCG O NOUN
support O NOUN
make O VERB
a O DET
difference? O NOUN

Cumulative O ADJ
incidence O NOUN
and O CCONJ
relative O ADJ
risks O NOUN
with O ADP
95% O NOUN
confidence O NOUN
intervals O NOUN
for O ADP
death B-outcome NOUN
from I-outcome ADP
any Seperator DET
cause I-outcome ADP
, O PUNCT
death B-outcome NOUN
from I-outcome ADP
prostate I-outcome NOUN
cancer I-outcome NOUN
, O PUNCT
and O CCONJ
metastasis B-outcome NOUN
were O VERB
estimated O VERB
in O ADP
intention-to-treat O NOUN
and O CCONJ
per-protocol O NOUN
analyses, O NOUN
and O CCONJ
numbers O NOUN
of O ADP
years O NOUN
of O ADP
life O NOUN
gained O VERB
were O VERB
estimated. O NOUN

Title: O NOUN
Impact O NOUN
of O ADP
a O DET
Local O ADJ
Vision O NOUN
Care O NOUN
Center O NOUN
on O ADP
Glasses B-outcome NOUN
Ownership I-outcome NOUN
and O CCONJ
Wearing B-outcome VERB
Behavior I-outcome NOUN
in O ADP
Northwestern O ADJ
Rural O ADJ
China: O NOUN
A O DET
Cluster-Randomized O VERB
Controlled O VERB
Trial. O NOUN

CONCLUSION: O NOUN
This O DET
study O NOUN
does O VERB
not O ADV
support O NOUN
the O DET
use O NOUN
of O ADP
TENS O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
patients O NOUN
with O ADP
chronic O ADJ
LBP O NOUN
even O ADV
though O ADP
patients O NOUN
benefited O VERB
from O ADP
a O DET
therapeutic O ADJ
education O NOUN
program O NOUN
by O ADP
a O DET
pain O NOUN
resource O NOUN
nurse. O NOUN

Trial O NOUN
registered O VERB
with O ADP
Current O ADJ
Controlled O VERB
Trials, O NOUN
number O NOUN
ISRCTN17975376. O NOUN

Journal-Name:Zhonghua O NOUN
yi O ADP
xue O NOUN
za O ADP
zhi O NUM

Publication O NOUN
date: O NOUN
2019/01/31 O NOUN
06:00 O ADP
[medline] O NOUN

Contours O NOUN
were O VERB
analysed O VERB
with O ADP
Monaco O ADJ
ADMIRE O ADV
(research O NUM
v. O ADP
2.0) O NUM
to O PART
assess O NOUN
interobserver O ADV
variability O NOUN
and O CCONJ
accuracy O NOUN
by O ADP
comparison O NOUN
with O ADP
a O DET
gold O NOUN
standard O ADJ
clinician O NOUN
contour. O NOUN

The O DET
mean O NOUN
number O NOUN
of O ADP
accurate O ADJ
lifestyle B-outcome NOUN
factors I-outcome NOUN
(that O PUNCT
could O VERB
affect O NOUN
fertility) O ADV
mentioned O VERB
increased O VERB
from O ADP
3.6 O NUM
to O PART
4.4 O NUM
(P O NUM
< O SYM
0.001) O NUM
in O ADP
the O DET
IG. O NOUN

BACKGROUND/AIM: O NOUN
The O DET
analysis O NOUN
of O ADP
prognostic O ADJ
factors O NOUN
is O VERB
important O ADJ
to O PART
identify O NOUN
determinants O NOUN
of O ADP
disease-free O ADJ
survival O NOUN
(DFS) O NOUN
and O CCONJ
overall O ADJ
survival O NOUN
(OS) O NOUN
in O ADP
resected O VERB
non-small-cell O NOUN
lung O NOUN
cancer O NOUN
(NSCLC). O PUNCT

Funded O VERB
by O ADP
the O DET
British O NOUN
Heath O NOUN
Foundation O NOUN
and O CCONJ
others; O NOUN
Current O ADJ
Controlled O VERB
Trials O NOUN
number, O ADV
ISRCTN46552265 O NOUN
.). O NOUN

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
82 O NUM
patients O NOUN
with O ADP
UIAS O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
2 O NUM
groups O NOUN
that O ADP
received O VERB
NMES O NOUN
therapy O NOUN
(NMES O PUNCT
group) O ADJ
or O CCONJ
sham O NOUN
NMES O NOUN
(sham O PUNCT
group) O ADJ
for O ADP
10 O NUM
weeks. O NOUN

POC O NOUN
patients O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
group O NOUN
A O DET
(n=40) O NOUN
and O CCONJ
group O NOUN
B O NOUN
(n=39). O NOUN

Belatacept O NOUN
serum O NOUN
concentrations O NOUN
were O VERB
determined O VERB
at O ADP
several O ADJ
time O NOUN
points O NOUN
between O ADP
belatacept O ADV
infusions. O NOUN

Publication O NOUN
date: O NOUN
2019/01/12 O ADJ
06:00 O ADP
[medline] O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Participants O NOUN
were O VERB
randomly O ADV
administered O VERB
loading O VERB
doses O NOUN
of O ADP
prasugrel O NOUN
60 O NUM
mg O NOUN
(group O PUNCT
A, O NOUN
n O NOUN
= O SYM
166) O NOUN
or O CCONJ
30 O NUM
mg O NOUN
(group O PUNCT
B, O NOUN
n O NOUN
= O SYM
166) O NOUN
before O ADP
undergoing O VERB
elective O ADJ
PCI O NOUN
in O ADP
a O DET
1:1 O ADJ
manner. O NOUN

Conclusions: O NOUN
Tretinoin O NOUN
0.05% O NUM
lotion O NOUN
was O VERB
significantly O ADV
more O ADV
effective O ADJ
than O ADP
its O ADJ
vehicle O NOUN
in O ADP
achieving O VERB
treatment B-outcome NOUN
success I-outcome NOUN
and O CCONJ
reducing O VERB
inflammatory O ADJ
and O CCONJ
noninflammatory O ADJ
acne O NOUN
lesions B-outcome NOUN
in O ADP
a O DET
Hispanic O ADJ
population. O ADV

A O DET
significance O NOUN
level O NOUN
of O ADP
p O NOUN
< O SYM
0.05 O NUM
was O VERB
established. O NOUN

Journal O ADJ
ID: O NOUN
8208604 O NUM

Furthermore, O NOUN
we O PRON
identified O VERB
two O NUM
different O ADJ
pathways O NOUN
characterizing O VERB
ways O NOUN
to O PART
success O NOUN
(consistency: O NOUN
81%, O NUM
coverage: O NOUN
52%). O NOUN

lacrimal O ADJ
duct O NOUN
probing O VERB
is O VERB
the O DET
major O ADJ
treatment. O NOUN

CONCLUSIONS: O NOUN
Both O CCONJ
techniques O NOUN
were O VERB
effective O ADJ
in O ADP
the O DET
short-term O NOUN
(18-30 O NOUN
months) O NOUN
in O ADP
treatment O NOUN
of O ADP
recurrent O ADP
patellar O ADJ
dislocation. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Eligible O ADJ
patients O NOUN
were O VERB
stratified O VERB
by O ADP
type O NOUN
2 O NUM
diabetes O NOUN
status O NOUN
and O CCONJ
they O PRON
were O VERB
randomly O ADV
assigned O VERB
(1:1:1) O NUM
by O ADP
a O DET
computer-based O VERB
system O NOUN
to O PART
receive O VERB
subcutaneous O ADJ
injections O NOUN
of O ADP
placebo O NOUN
once O ADP
a O DET
day, O ADP
10 O NUM
mg O NOUN
pegbelfermin O NOUN
once O ADP
a O DET
day, O ADP
or O CCONJ
20 O NUM
mg O NOUN
pegbelfermin O NOUN
once O ADP
a O DET
week, O NOUN
all O DET
for O ADP
16 O NUM
weeks. O NOUN

In O ADP
as-treated O VERB
analyses, O NOUN
participants O NOUN
in O ADP
the O DET
decolonization O NOUN
group O NOUN
who O ADP
adhered O VERB
fully O ADV
to O PART
the O DET
regimen O NOUN
had O VERB
44% O NOUN
fewer O ADJ
MRSA B-outcome NOUN
infections I-outcome NOUN
than O ADP
the O DET
education O NOUN
group O NOUN
(hazard O PUNCT
ratio, O NOUN
0.56; O NOUN
95% O NOUN
CI, O NOUN
0.36 O NUM
to O PART
0.86) O NUM
and O CCONJ
had O VERB
40% O NUM
fewer O ADJ
infections B-outcome NOUN
from O ADP
any O DET
cause O ADP
(hazard O PUNCT
ratio, O NOUN
0.60; O NOUN
95% O NOUN
CI, O NOUN
0.46 O NUM
to O PART
0.78). O NUM

30 O NUM
individuals O NOUN
with O ADP
CD O NOUN
were O VERB
divided O VERB
into O ADP
2 O NUM
groups: O NOUN
16 O NUM
in O ADP
the O DET
experimental O ADJ
group O NOUN
(EG) O NOUN
and O CCONJ
14 O NUM
in O ADP
the O DET
control O NOUN
group O NOUN
(CG). O NUM

The O DET
chi O NOUN
independent O ADJ
test O NOUN
or O CCONJ
2-tailed O VERB
paired O VERB
t O NOUN
test O NOUN
were O VERB
performed O VERB
for O ADP
statistical O ADJ
analysis. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

BACKGROUND: O NOUN
Medical O ADJ
researchers O NOUN
have O VERB
been O VERB
reluctant O NOUN
to O PART
use O NOUN
neuromuscular O ADJ
blocking O VERB
drugs O NOUN
(NMBD) O NUM
during O ADP
the O DET
use O NOUN
of O ADP
intraoperative O ADJ
motor O NOUN
evoked O VERB
potential O ADJ
(MEP) O PUNCT
monitoring O VERB
despite O ADP
the O DET
possibility O NOUN
of O ADP
patient O NOUN
movement. O NOUN

Additional O ADJ
analyses O NOUN
showed O VERB
that O ADP
changes O NOUN
in O ADP
active B-outcome ADJ
B12 I-outcome NOUN
, O PUNCT
HcY B-outcome NOUN
and O CCONJ
folate B-outcome NOUN
measures O NOUN
during O ADP
WPI O NOUN
treatment O NOUN
correlated O VERB
with O ADP
improvements O NOUN
in O ADP
cognitive B-outcome ADJ
function I-outcome NOUN
(all O PUNCT
p O NOUN
< O SYM
0.05). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Clinical O ADJ
assessments, O NOUN
including O VERB
neurological O ADJ
examination O NOUN
and O CCONJ
EDSS O NOUN
scoring, O NOUN
were O VERB
conducted O VERB
at O ADP
baseline O NOUN
and O CCONJ
at O ADP
weeks O NOUN
12 O NUM
and O CCONJ
24. O NUM

The O DET
patients O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
were O VERB
given O VERB
routine O ADJ
treatment O NOUN
and O CCONJ
respiratory O ADJ
function O NOUN
exercise, O NOUN
and O CCONJ
those O DET
in O ADP
the O DET
observation O NOUN
group O NOUN
were O VERB
given O VERB
nursing O VERB
intervention O NOUN
in O ADP
addition O NOUN
to O PART
the O DET
treatment O NOUN
in O ADP
the O DET
control O NOUN
group. O VERB

The O DET
original O ADJ
trial O NOUN
(number, O NOUN
NCT00678275) O NOUN
and O CCONJ
follow-up O NOUN
extension O NOUN
(number, O NOUN
NCT03042676) O NOUN
are O VERB
registered O VERB
at O ADP
ClinicalTrials.gov. O NOUN

Title: O NOUN
A O DET
dose-finding O VERB
randomized O VERB
Phase O NOUN
II O NUM
study O NOUN
of O ADP
oral O ADJ
netupitant O ADJ
in O ADP
combination O NOUN
with O ADP
palonosetron O NOUN
.75 O NUM
mg O NOUN
intravenous O ADJ
for O ADP
the O DET
prevention O NOUN
of O ADP
chemotherapy-induced O VERB
nausea B-outcome NOUN
and O CCONJ
vomiting B-outcome VERB
in O ADP
Japanese O NOUN
patients O NOUN
receiving O VERB
highly O ADV
emetogenic O ADJ
chemotherapy. O NOUN

PE O NOUN
teachers O NOUN
(n O NOUN
= O SYM
29) O NOUN
from O ADP
eleven O NUM
schools O NOUN
will O VERB
apply O NOUN
the O DET
intervention O NOUN
program O NOUN
to O PART
students O NOUN
(n O NOUN
= O SYM
502) O NOUN
in O ADP
PE O NOUN
classes O NOUN
for O ADP
one O NUM
month. O NOUN

Title: O NOUN
Prognostic O ADJ
Factors O NOUN
in O ADP
Early-stage O NOUN
NSCLC: O NOUN
Analysis O NOUN
of O ADP
the O DET
Placebo O NOUN
Group O NOUN
in O ADP
the O DET
MAGRIT O NOUN
Study. O NOUN

CONCLUSIONS: O NOUN
Findings O NOUN
highlight O NOUN
the O DET
complexity O NOUN
of O ADP
implementing O VERB
a O DET
mhGAP-based O VERB
training O VERB
given O VERB
its O ADJ
interaction O NOUN
with O ADP
contextual O ADJ
factors O NOUN
to O PART
influence O NOUN
the O DET
attainment O NOUN
of O ADP
expected O VERB
outcomes. O ADJ

Conclusion:Compared O VERB
with O ADP
CHOP+IMRT O NOUN
regimen, O NOUN
the O DET
LOP+IMRT O NOUN
regimen O NOUN
for O ADP
nasal O ADJ
NK/T-cell O NOUN
lymphoma O NOUN
patients O NOUN
resulted O VERB
in O ADP
higher O ADJ
overall O ADJ
remission B-outcome NOUN
rate, O NOUN
survival B-outcome NOUN
rate O NOUN
and O CCONJ
lower O ADJ
adverse B-outcome ADJ
reactions I-outcome NOUN
, O PUNCT
so O ADV
it O PRON
is O VERB
worth O ADP
in O ADP
clinical O ADJ
promotion. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Patient O NOUN
follow-up O NOUN
to O PART
3 O NUM
months O NOUN
was O VERB
completed O VERB
on O ADP
April O NOUN
12, O NUM
2018. O NUM

Journal-Name:Journal O ADJ
of O ADP
foot O NOUN
and O CCONJ
ankle O NOUN
research O NOUN

Under O ADP
VCV O NOUN
mode, O NOUN
the O DET
levels O NOUN
of O ADP
peak B-outcome NOUN
airway I-outcome NOUN
pressure I-outcome NOUN
and O CCONJ
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
were O VERB
increased O VERB
with O ADP
the O DET
increase O NOUN
in O ADP
atomized O VERB
oxygen O NOUN
flow, O NOUN
and O CCONJ
there O PRON
was O VERB
significant O ADJ
difference O NOUN
at O ADP
9 O NUM
L/min O NOUN
as O ADP
compared O VERB
with O ADP
those O DET
before O ADP
atomization O NOUN
[ O PUNCT
peak B-outcome NOUN
airway I-outcome NOUN
pressure I-outcome NOUN
(cmH2O): O PUNCT
29.44+/-4.58 O NUM
vs. O CCONJ
24.39+/-4.64, O PUNCT
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
(mL): O NOUN
896.26+/-24.91 O NUM
vs. O CCONJ
497.61+/-8.67, O NOUN
both O CCONJ
P O NOUN
< O SYM
0.05]. O NUM
There O PRON
was O VERB
no O DET
significant O ADJ
change O NOUN
in O ADP
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
, O PUNCT
and O CCONJ
no O DET
significant O ADJ
difference O NOUN
at O ADP
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow O NOUN
as O ADP
compared O VERB
with O ADP
that O ADP
before O ADP
atomization O NOUN
(mL: O PUNCT
494.67+/-3.07 O NOUN
vs. O CCONJ
492.61+/-6.05, O NOUN
P O NOUN
> O SYM
0.05). O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
Pittsburgh O NOUN
Sleep B-outcome NOUN
Quality I-outcome NOUN
Index O NOUN
(PSQI) O NOUN
score O NOUN
and O CCONJ
Treatment O NOUN
Emergent O ADJ
Symptom O NOUN
Scale O NOUN
(TESS) O ADP
score O NOUN
between O ADP
the O DET
two O NUM
groups. O NOUN

BACKGROUND: O NOUN
Systematic O ADJ
pelvic O ADJ
and O CCONJ
paraaortic O ADJ
lymphadenectomy O NOUN
has O VERB
been O VERB
widely O ADV
used O VERB
in O ADP
the O DET
surgical O ADJ
treatment O NOUN
of O ADP
patients O NOUN
with O ADP
advanced O VERB
ovarian O ADJ
cancer, O NOUN
although O ADP
supporting O VERB
evidence O NOUN
from O ADP
randomized O VERB
clinical O ADJ
trials O NOUN
has O VERB
been O VERB
limited. O NOUN

One O NUM
hundred O NUM
and O CCONJ
thirty O NUM
adult O NOUN
patients O NOUN
with O ADP
T2DM O NOUN
who O ADP
were O VERB
discharged O VERB
to O PART
the O DET
community O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
either O CCONJ
the O DET
intervention O NOUN
or O CCONJ
the O DET
control O NOUN
group. O VERB

STUDY O NOUN
IDENTIFICATION O NOUN
AND O CCONJ
TRIAL O NOUN
REGISTRATION: O NOUN
Study O NOUN
Identification: O NOUN
EVOLVE-1 O NOUN
(I5Q-MC-CGAG); O NUM
EVOLVE-2 O NOUN
(I5Q-MC-CGAH); O NUM
REGAIN O NOUN
(I5Q-MC-CGAI) O NOUN
TRIAL O NOUN
REGISTRATION: O NOUN
ClinicalTrials.gov O NOUN
; O PUNCT
NCT02614183 O NOUN
(EVOLVE-1); O NOUN
NCT02614196 O NOUN
(EVOLVE-2); O PUNCT
NCT02614261 O NOUN
(REGAIN). O NOUN

Before O ADP
and O CCONJ
after O ADP
supplementation, O NOUN
we O PRON
determined O VERB
plasma O NOUN
fatty B-outcome ADJ
acid I-outcome NOUN
concentrations, O NOUN
latencies O NOUN
of O ADP
visually B-outcome ADV
evoked I-outcome VERB
potentials I-outcome NOUN
, O PUNCT
fine B-outcome ADV
and Seperator CCONJ
gross B-outcome ADJ
motor I-outcome NOUN
behaviour E2-outcome NOUN
, O PUNCT
and O CCONJ
IQ B-outcome NOUN
. O PUNCT
Fatty O ADJ
acid O NOUN
desaturase O NOUN
genotypes O NOUN
were O VERB
also O ADV
determined. O NOUN

We O PRON
also O ADV
examined O VERB
how O ADP
health O NOUN
warning O VERB
severity O NOUN
influences O NOUN
these O DET
reactions B-outcome NOUN
and O CCONJ
whether O ADP
there O PRON
is O VERB
an O DET
interaction O NOUN
between O ADP
self-affirmation O NOUN
and O CCONJ
severity. O DET

PARTICIPANTS: O NOUN
13 O NUM
046 O NUM
women O NOUN
aged O VERB
16 O NUM
years O NOUN
or O CCONJ
older O ADJ
with O ADP
a O DET
low O ADJ
risk O NOUN
singleton O NOUN
pregnancy. O NOUN

After O ADP
baseline O NOUN
competency O NOUN
assessment, O NOUN
parents O NOUN
received O VERB
instruction O NOUN
according O ADJ
to O PART
their O ADJ
group. O VERB

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
98 O NUM
dyslipidemic O ADJ
patients O NOUN
were O VERB
enrolled O VERB
and O CCONJ
divided O VERB
into O ADP
amla O NOUN
and O CCONJ
placebo O NOUN
groups. O NOUN

Journal O ADJ
ID: O NOUN
8200894 O NUM

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

However, O ADV
we O PRON
found O VERB
that O ADP
using O VERB
the O DET
motion O NOUN
tracking O VERB
device O NOUN
led O VERB
to O PART
transfer B-outcome NOUN
of O ADP
performance O NOUN
to O PART
the O DET
touchscreen. O NOUN

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
sufentanil-midazolam O NOUN
and O CCONJ
sevoflurane O NOUN
for O ADP
anesthesia O NOUN
induction O NOUN
in O ADP
children O NOUN
undergoing O VERB
cardiac O ADJ
surgery O NOUN
by O ADP
real-time O NOUN
hemodynamic B-outcome ADJ
and O CCONJ
cardiac B-outcome ADJ
efficiency O NOUN
monitoring: O NOUN
A O DET
prospective O ADJ
randomized O VERB
study. O NOUN

In O ADP
addition, O NOUN
gene O NOUN
expression O NOUN
analysis O NOUN
in O ADP
PBMC O NOUN
showed O VERB
subtle O ADJ
changes O NOUN
in O ADP
superoxide B-outcome NOUN
metabolic I-outcome ADJ
processes. O NOUN

Compared O VERB
with O ADP
the O DET
preoperative O ADJ
levels, O NOUN
serum O NOUN
cortisol B-outcome NOUN
level O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
operation O NOUN
was O VERB
increased O VERB
in O ADP
the O DET
sedation O NOUN
group O NOUN
but O CCONJ
lowered O VERB
in O ADP
the O DET
control O NOUN
group, O NOUN
and O CCONJ
the O DET
variations O NOUN
of O ADP
serum O NOUN
cortisol B-outcome NOUN
level O NOUN
differed O VERB
significantly O ADV
between O ADP
the O DET
two O NUM
groups O NOUN
(t=4.75, O ADV
P O NOUN
&lt; O NOUN
0.01). O NOUN

The O DET
clinical O ADJ
examination O NOUN
included O VERB
hematology B-outcome NOUN
and O CCONJ
blood B-outcome NOUN
chemistry I-outcome NOUN
tests, O NOUN
urinalysis B-outcome ADV
, O PUNCT
vital B-outcome ADJ
signs I-outcome NOUN
, O PUNCT
body B-outcome NOUN
weight I-outcome NOUN
, O PUNCT
and O CCONJ
electrocardiogram B-outcome NOUN
(ECG) I-outcome PUNCT
. O PUNCT
RESULTS: O NOUN
Eleven O NUM
adverse B-outcome ADJ
reactions I-outcome NOUN
were O VERB
observed O VERB
in O ADP
ten O NUM
subjects O NOUN
receiving O VERB
BT-11 O NOUN
while O ADP
seven O NUM
adverse B-outcome ADJ
reactions I-outcome NOUN
in O ADP
six O NUM
subjects O NOUN
receiving O VERB
placebo. O NOUN

The O DET
tendency O NOUN
to O PART
use O NOUN
different O ADJ
methods O NOUN
of O ADP
complementary O ADJ
medicine O NOUN
to O PART
control O NOUN
menopausal O ADJ
symptoms O NOUN
is O VERB
increasing. O NOUN

HR's O NOUN
for O ADP
erythromycin, O NOUN
compared O VERB
to O PART
beta-lactam O NOUN
monotherapy, O ADJ
on O ADP
any O DET
cardiac B-outcome ADJ
event I-outcome NOUN
and O CCONJ
heart B-outcome NOUN
failure I-outcome NOUN
were O VERB
1.60 O NUM
(95% O PUNCT
CI O NOUN
1.09;2.36) O NOUN
and O CCONJ
1.89 O NUM
(95% O PUNCT
CI O NOUN
1.22;2.91), O NUM
respectively. O NOUN

Journal-Name:Medicine O NOUN

More O ADV
interestingly, O NOUN
preoperative O ADJ
analgesia O NOUN
group O NOUN
patients O NOUN
consumed O VERB
less O ADV
patient-controlled O VERB
analgesia B-outcome NOUN
compared O VERB
to O PART
postoperative O ADJ
analgesia O NOUN
group O NOUN
patients O NOUN
at O ADP
72 O NUM
hours O NOUN
post O ADV
operation. O ADV

Results O NOUN
were O VERB
extrapolated O VERB
to O PART
two O NUM
years O NOUN
after O ADP
randomization. O NOUN

Whether O ADP
L-valine O NOUN
affects O NOUN
energy O NOUN
intake, O NOUN
and O CCONJ
the O DET
gastrointestinal O ADJ
functions O NOUN
involved O VERB
in O ADP
the O DET
regulation O NOUN
of O ADP
energy O NOUN
intake, O NOUN
as O ADP
well O ADV
as O ADP
blood O NOUN
glucose, O NOUN
in O ADP
humans, O NOUN
is O VERB
currently O ADV
unknown. O NOUN

However, O ADV
ED95 O NOUN
is O VERB
more O ADV
meaningful O ADJ
to O PART
clinical O ADJ
practice O NOUN
than O ADP
ED50. O NOUN

PURPOSE: O NOUN
To O PART
determine O NOUN
the O DET
effects O NOUN
of O ADP
botulinum O NOUN
toxin O NOUN
type O NOUN
A O DET
(BTX-A) O PUNCT
injection O NOUN
on O ADP
dry B-outcome ADJ
eye I-outcome NOUN
signs I-outcome NOUN
, Seperator PUNCT
symptoms S2-outcome NOUN
, O PUNCT
and O CCONJ
tear O NUM
cytokine B-outcome NOUN
levels O NOUN
in O ADP
patients O NOUN
with O ADP
intractable O ADJ
dry O ADJ
eye O NOUN
disease O NOUN
(DED). O NUM

Journal-Name:British O NOUN
journal O ADJ
of O ADP
anaesthesia O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

Journal-Name:Medicine O NOUN

Withdrawal B-outcome NOUN
symptoms I-outcome NOUN
declined O VERB
immediately O ADV
after O ADP
smoking O VERB
or O CCONJ
using O VERB
IQOS(TM), O NUM
and O CCONJ
with O ADP
some O DET
delay O NOUN
after O ADP
vaping. O NOUN

There O PRON
are O VERB
also O ADV
no O DET
studies O NOUN
that O ADP
establish O NOUN
a O DET
clear O ADJ
relationship O NOUN
between O ADP
EEN O NOUN
in O ADP
MAP O NOUN
and O CCONJ
levels O NOUN
of O ADP
albuminemia O NOUN
and O CCONJ
CRP. O NOUN

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

Patients O NOUN
who O ADP
received O VERB
Ahmed O VERB
glaucoma O NOUN
valve O NOUN
implantation O NOUN
surgery O NOUN
from O ADP
August O NOUN
2015 O NUM
to O PART
January O NOUN
2017 O NUM
at O ADP
the O DET
Xiamen O NOUN
Eye O NOUN
Center O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
2 O NUM
groups. O NOUN

Adult O NOUN
mothers O NOUN
of O ADP
children O NOUN
born O VERB
in O ADP
participating O VERB
maternity O NOUN
wards O NOUN
were O VERB
recruited O VERB
between O ADP
March O NOUN
2014 O NUM
and O CCONJ
February O ADJ
2015. O NUM

No O DET
statistical O ADJ
difference O NOUN
was O VERB
also O ADV
observed O VERB
in O ADP
safety O NOUN
laboratory O NOUN
tests, O NOUN
vital B-outcome ADJ
signs I-outcome NOUN
, O PUNCT
and O CCONJ
electrocardiogram B-outcome NOUN
(ECG) I-outcome PUNCT
between O ADP
two O NUM
groups. O NOUN

Journal-Name:Radiation O NOUN
oncology O NOUN
(London, O PUNCT
England) O NOUN

Logistic O ADJ
regression O NOUN
analyses O NOUN
were O VERB
used O VERB
for O ADP
between O ADP
treatment O NOUN
comparisons. O NOUN

Statistically O ADV
significant O ADJ
differences O NOUN
in O ADP
cumulative O ADJ
QALYs O NOUN
and O CCONJ
costs B-outcome NOUN
were O VERB
found O VERB
at O ADP
six O NUM
and O CCONJ
12 O NUM
months O NOUN
for O ADP
the O DET
decompression O NOUN
versus O CCONJ
no O DET
treatment O NOUN
comparison O NOUN
only. O NOUN

Refractory B-outcome ADJ
disease I-outcome NOUN
developed O VERB
in O ADP
no O DET
patients O NOUN
in O ADP
the O DET
caplacizumab O NOUN
group O NOUN
and O CCONJ
in O ADP
three O NUM
patients O NOUN
in O ADP
the O DET
placebo O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2018/12/04 O ADP
00:00 O NOUN
[accepted] O ADV

BACKGROUND: O NOUN
Transcutaneous O ADJ
electrical O ADJ
nerve O NOUN
stimulation O NOUN
(TENS) O PUNCT
is O VERB
often O ADV
used O VERB
for O ADP
the O DET
treatment O NOUN
of O ADP
low-back O NOUN
pain O NOUN
(LBP). O NOUN

They O PRON
were O VERB
randomly O ADV
assigned O VERB
to O PART
an O DET
intervention O NOUN
group O NOUN
(410 O NUM
participants) O NOUN
or O CCONJ
comparison O NOUN
group O NOUN
(202 O NOUN
participants). O NOUN

Journal O ADJ
ID: O NOUN
0414003 O NUM

We O PRON
assessed O VERB
the O DET
effectiveness O NOUN
of O ADP
the O DET
interventions O NOUN
on O ADP
intensity B-outcome NOUN
of I-outcome ADP
low I-outcome ADJ
back I-outcome ADP
pain I-outcome NOUN
, O PUNCT
pain B-outcome NOUN
interfering I-outcome VERB
with Seperator ADP
work I-outcome NOUN
and O CCONJ
fear O ADJ
avoidance O NOUN
beliefs B-outcome NOUN
against O ADP
the O DET
Control, O NOUN
and O CCONJ
calculated O VERB
the O DET
incremental O ADJ
cost-effectiveness O NOUN
ratios O NOUN
for O ADP
sickness B-outcome NOUN
absence I-outcome NOUN
and O CCONJ
QALY. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
0417355 O NUM

CONCLUSIONS: O NOUN
Endometrial O ADJ
scratching O VERB
did O VERB
not O ADV
result O VERB
in O ADP
a O DET
higher O ADJ
rate O NOUN
of O ADP
live B-outcome ADJ
birth I-outcome NOUN
than O ADP
no O DET
intervention O NOUN
among O ADP
women O NOUN
undergoing O VERB
IVF. O NUM
( O PUNCT

Fatal B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
occurred O VERB
in O ADP
seven O NUM
(3%) O ADV
patients O NOUN
in O ADP
the O DET
A+CHP O ADV
group O NOUN
and O CCONJ
nine O NUM
(4%) O NUM
in O ADP
the O DET
CHOP O VERB
group. O VERB

Each O DET
group O NOUN
was O VERB
subdivided O VERB
into O ADP
the O DET
3 O NUM
classes O NOUN
based O VERB
on O ADP
the O DET
body O NOUN
mass O NOUN
index O NOUN
(BMI; O NUM
low, O PUNCT
normal, O ADJ
high). O NOUN

Twelve O NUM
patients O NOUN
were O VERB
treated O VERB
with O ADP
SuperPATH O NOUN
approach O NOUN
(SuperPATH O NOUN
group) O ADJ
and O CCONJ
12 O NUM
patients O NOUN
with O ADP
posterolateral O ADJ
approach O NOUN
(control O PUNCT
group). O NOUN

Serum O NOUN
epinephrine B-outcome NOUN
in O ADP
group O NOUN
D O NOUN
were O VERB
significantly O ADV
lower O ADJ
than O ADP
them O PRON
in O ADP
group O NOUN
C O NOUN
at O ADP
T(2), O NOUN
T(3), O NOUN
T(4), O NOUN
T(5) O ADJ
(t=6.153, O NOUN
8.774, O NOUN
9.127, O CCONJ
8.409, O NOUN
respectively; O NOUN
all O DET
P<0.05), O NOUN
but O CCONJ
there O PRON
were O VERB
no O DET
difference O NOUN
between O ADP
these O DET
two O NUM
groups O NOUN
at O ADP
T(0), O NOUN
T(1), O NOUN
T(6), O NOUN
T(7), O NOUN
T(8)(all O NOUN
P>0.05). O NOUN

During O ADP
the O DET
follow-up, O ADP
no O DET
loosening B-outcome VERB
or O CCONJ
migration B-outcome NOUN
was O VERB
observed. O NOUN

Title: O NOUN
A O DET
Randomized O VERB
Trial O NOUN
of O ADP
E-Cigarettes O NOUN
versus O CCONJ
Nicotine-Replacement O ADJ
Therapy. O NOUN

Journal O ADJ
ID: O NOUN
7511141 O NUM

Group O NOUN
A O DET
(n O NOUN
= O SYM
53) O NOUN
was O VERB
the O DET
single-shot O NOUN
group O NOUN
(16 O NOUN
female O NOUN
patients O NOUN
and O CCONJ
37 O NUM
male O NOUN
patients O NOUN
with O ADP
a O DET
mean O NOUN
age O NOUN
of O ADP
63.9 O NUM
years O NOUN
(sd O PUNCT
9.6)), O NOUN
group O NOUN
B O NOUN
(n O NOUN
= O SYM
51) O NOUN
was O VERB
the O DET
24-hour O NOUN
infusion O NOUN
group O NOUN
(22 O NOUN
female O NOUN
patients O NOUN
and O CCONJ
29 O NUM
male O NOUN
patients O NOUN
with O ADP
a O DET
mean O NOUN
age O NOUN
of O ADP
66.5 O NUM
years O NOUN
(sd O PUNCT
8.5)), O NOUN
and O CCONJ
group O NOUN
C O NOUN
(n O NOUN
= O SYM
52) O NOUN
was O VERB
the O DET
48-hour O NOUN
infusion O NOUN
group O NOUN
(18 O NOUN
female O NOUN
patients O NOUN
and O CCONJ
34 O NUM
male O NOUN
patients O NOUN
with O ADP
a O DET
mean O NOUN
age O NOUN
of O ADP
62.2 O NUM
years O NOUN
(sd O PUNCT
8.7)). O NOUN

The O DET
efficacy O NOUN
of O ADP
short- O NOUN
and O CCONJ
long-TXA O NOUN
protocols O NOUN
in O ADP
the O DET
reduction O NOUN
of O ADP
perioperative O ADJ
real O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
(RBL) O PUNCT
was O VERB
compared O VERB
with O ADP
a O DET
placebo O NOUN
group. O VERB

National O ADJ
and O CCONJ
Kapodistrian O ADJ
University O NOUN
of O ADP
Athens, O NOUN
Athens, O NOUN
Greece. O NOUN

Were O VERB
used O VERB
highly B-outcome ADV
sensitive I-outcome ADJ
troponin I-outcome NOUN
(HF-Tr) I-outcome PUNCT
and O CCONJ
creatine B-outcome NOUN
phosphokinase-MB I-outcome NOUN
as O ADP
an O DET
irreversible O ADJ
myocardial O ADJ
damage O NOUN
biomarkers. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

In O ADP
this O DET
study, O NOUN
we O PRON
investigated O VERB
mtDNA B-outcome ADJ
, O PUNCT
mitochondrial B-outcome ADJ
dynamics I-outcome NOUN
, Seperator PUNCT
function S1-outcome NOUN
and O CCONJ
metabolic O ADJ
pathways O NOUN
to O PART
determine O NOUN
if O ADP
mitochondrial O ADJ
damage O NOUN
plays O NOUN
a O DET
critical O ADJ
role O NOUN
in O ADP
the O DET
development O NOUN
of O ADP
tubular O ADJ
injury O NOUN
in O ADP
DKD O NOUN
patients. O NOUN

Title: O NOUN
[Effects O NOUN
of O ADP
early O ADJ
enteral O ADJ
nutrition O NOUN
in O ADP
patients O NOUN
with O ADP
mild O ADJ
acute O ADJ
pancreatitis. O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
prostate O NOUN
delineation O NOUN
on O ADP
multimodality O NOUN
imaging O VERB
for O ADP
MR-guided O VERB
radiotherapy. O NOUN

BACKGROUND: O NOUN
The O DET
onset O NOUN
of O ADP
puberty O NOUN
and O CCONJ
menarche O NOUN
is O VERB
a O DET
specifically O ADV
vulnerable O ADJ
time O NOUN
for O ADP
girls, O ADJ
during O ADP
which O ADP
they O PRON
begin O ADP
to O PART
show O VERB
interest O NOUN
in O ADP
the O DET
opposite O ADJ
sex, O NOUN
while O ADP
becoming O VERB
exposed O VERB
to O PART
a O DET
myriad O ADJ
of O ADP
external O ADJ
pressures, O ADP
including O VERB
sexual O ADJ
coercion O NOUN
or O CCONJ
harassment O ADV
from O ADP
boys O NOUN
and O CCONJ
men, O NOUN
expectations O NOUN
to O PART
marry O NOUN
from O ADP
their O ADJ
families, O NOUN
and O CCONJ
the O DET
need O NOUN
to O PART
perform O NOUN
well O ADV
in O ADP
primary O ADJ
school O NOUN
in O ADP
order O NOUN
to O PART
qualify O NOUN
for O ADP
secondary O ADJ
school. O NOUN

All O DET
patients O NOUN
were O VERB
anaesthetized O VERB
(induced O NUM
and O CCONJ
maintained) O NOUN
with O ADP
intravenous O ADJ
target-controlled O VERB
infusion(TCl) O NOUN
of O ADP
propofol O NOUN
and O CCONJ
remifentanil, O ADV
and O CCONJ
intermittent O ADJ
intravenous O ADJ
injection O NOUN
of O ADP
cisatracuriumbesylate. O ADJ

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

BACKGROUND: O NOUN
Proprietary O ADJ
spearmint O NOUN
extract O NOUN
(PSE) O NOUN
containing O VERB
a O DET
minimum O NOUN
14.5% O NOUN
rosmarinic O ADJ
acid O NOUN
and O CCONJ
24% O NOUN
total O ADJ
phenolic O NOUN
content, O NOUN
has O VERB
evinced O VERB
positive O ADJ
effects O NOUN
on O ADP
cognition O NOUN
in O ADP
individuals O NOUN
aged O VERB
50-70 O NUM
with O ADP
memory O NOUN
impairment O NOUN
after O ADP
chronic O ADJ
supplementation. O NOUN

A O DET
single O ADJ
agent O NOUN
to O PART
reduce O VERB
cholesterol O NOUN
as O ADP
well O ADV
as O ADP
TG O NOUN
is O VERB
rare. O NOUN

All O DET
participants O NOUN
were O VERB
tested O VERB
(test-1) O PUNCT
following O VERB
an O DET
introductory O ADJ
course O NOUN
of O ADP
basic O ADJ
ultrasonography. O NOUN

The O DET
3-year O NOUN
survival B-outcome NOUN
rate O NOUN
of O ADP
group O NOUN
A O DET
was O VERB
higher O ADJ
than O ADP
that O ADP
of O ADP
group O NOUN
BP<0.05. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

The O DET
forearm O NOUN
band O NOUN
showed O VERB
better O ADJ
scores O NOUN
on O ADP
joint B-outcome NOUN
position I-outcome NOUN
reproduction I-outcome NOUN
at O ADP
70 O NUM
degrees O NOUN
compared O VERB
with O ADP
the O DET
elbow O NOUN
sleeve O NOUN
(P O NUM
= O SYM
.006), O PUNCT
whereas O ADP
the O DET
elbow O NOUN
sleeve O NOUN
showed O VERB
better O ADJ
scores O NOUN
at O ADP
110 O NUM
degrees O NOUN
(P O NUM
< O SYM
.001). O PUNCT

We O PRON
aimed O VERB
to O PART
determine O NOUN
if O ADP
a O DET
program O NOUN
of O ADP
aerobic O ADJ
and O CCONJ
resistance O NOUN
exercise O NOUN
could O VERB
safely O ADV
achieve O NOUN
body B-outcome NOUN
composition I-outcome NOUN
changes O NOUN
in O ADP
patients O NOUN
with O ADP
Inflammatory O ADJ
Bowel O NOUN
Disease. O NOUN

It O PRON
builds O NOUN
on O ADP
an O DET
existing O VERB
program O NOUN
of O ADP
mental O ADJ
health O NOUN
research O NOUN
with O ADP
demonstrated O VERB
efficacy O NOUN
- O PUNCT
the O DET
Aboriginal O ADJ
and O CCONJ
Islander O ADP
Mental O ADJ
Health O NOUN
Initiative O NOUN
(AIMhi) O NOUN
- O PUNCT
to O PART
test O NOUN
the O DET
newly O ADV
developed O VERB
electronic O ADJ
motivational O ADJ
care O NOUN
planning O VERB
(MCP) O NOUN
therapy O NOUN
- O PUNCT
the O DET
AIMhi O NOUN
Stay O NOUN
Strong O ADJ
App. O NOUN

It O PRON
was O VERB
found O VERB
that O ADP
exhausted O VERB
terminal O ADJ
programmed O VERB
cell O NOUN
death O NOUN
1 O NUM
(PD1)+ O PUNCT
CD8+ O NOUN
T O NOUN
cells O NOUN
in O ADP
the O DET
peripheral O ADJ
blood O NOUN
are O VERB
independently O ADV
associated O VERB
with O ADP
worse O NOUN
progression B-outcome NOUN
free I-outcome ADJ
survival I-outcome NOUN
(PFS) I-outcome NOUN
and O CCONJ
overall B-outcome ADJ
survival I-outcome NOUN
(OS) I-outcome NOUN
. O PUNCT
Notably, O NOUN
hydrogen O NOUN
gas O NOUN
decreased O VERB
the O DET
abundance O NOUN
of O ADP
exhausted O VERB
terminal O ADJ
PD1+ B-outcome NOUN
CD8+ I-outcome NOUN
T I-outcome NOUN
cells I-outcome NOUN
, O PUNCT
increased O VERB
that O ADP
of O ADP
active O ADJ
terminal O ADJ
PD1 B-outcome NOUN
CD8+ I-outcome NOUN
T I-outcome NOUN
cells I-outcome NOUN
, O PUNCT
and O CCONJ
improved O VERB
progression B-outcome NOUN
free I-outcome ADJ
survival I-outcome NOUN
(PFS) I-outcome NOUN
and O CCONJ
overall B-outcome ADJ
survival I-outcome NOUN
(OS) I-outcome NOUN
times, O NOUN
suggesting O VERB
that O ADP
the O DET
balance O NOUN
between O ADP
terminal O ADJ
PD1+ B-outcome NOUN
and Seperator CCONJ
PD1 B-outcome NOUN
CD8+ I-outcome NOUN
cells E3-outcome NOUN
is O VERB
critical O ADJ
for O ADP
cancer O NOUN
prognosis. O NOUN

The O DET
OSTAP O NOUN
group O NOUN
showed O VERB
a O DET
statistically O ADV
significant O ADJ
reduction O NOUN
at O ADP
the O DET
postoperative O ADJ
24th O ADJ
hour O NOUN
tramadol B-outcome NOUN
consumption O NOUN
(mean O NUM
difference O NOUN
22 O NUM
mg, O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
-38.4 O NUM
to O PART
-5.6 O VERB
mL; O NOUN
P O NOUN
= O SYM
.009). O ADP

Title: O NOUN
Wellbeing O VERB
intervention O NOUN
for O ADP
chronic O ADJ
kidney O NOUN
disease O NOUN
(WICKD): O NOUN
a O DET
randomised O VERB
controlled O VERB
trial O NOUN
study O NOUN
protocol. O NOUN

No O DET
statistically O ADV
significant O ADJ
difference O NOUN
was O VERB
found O VERB
between O ADP
the O DET
orthoses' O NOUN
effects O NOUN
on O ADP
pain B-outcome NOUN
reduction O NOUN
and O CCONJ
grip B-outcome NOUN
strength I-outcome NOUN
(P O NUM
> O SYM
.05). O NUM

Journal-Name:American O NOUN
journal O ADJ
of O ADP
orthodontics O NOUN
and O CCONJ
dentofacial O ADJ
orthopedics O NOUN
: O PUNCT
official O ADJ
publication O NOUN
of O ADP
the O DET
American O ADJ
Association O NOUN
of O ADP
Orthodontists, O NOUN
its O ADJ
constituent O ADP
societies, O NOUN
and O CCONJ
the O DET
American O ADJ
Board O NOUN
of O ADP
Orthodontics O NOUN

RESULTS: O NOUN
We O PRON
conducted O VERB
three O NUM
sub-studies O NOUN
in O ADP
consecutive O ADJ
years O NOUN
of O ADP
2011, O NUM
2012, O NUM
and O CCONJ
2013 O NUM
to O PART
reach O NOUN
an O DET
adequate O ADJ
sample O NOUN
size. O NOUN

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name: O NOUN
Revista O NOUN
latino-americana O NOUN
de O ADP
enfermagem O NOUN

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
00:00 O NOUN
[accepted] O ADV

CONCLUSIONS: O NOUN
Once-monthly O ADV
injections O NOUN
of O ADP
givosiran O NOUN
in O ADP
patients O NOUN
who O ADP
had O VERB
recurrent O ADP
porphyria B-outcome NOUN
attacks O NOUN
resulted O VERB
in O ADP
mainly O ADV
low-grade O NOUN
adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
reductions O NOUN
in O ADP
induced O VERB
ALAS1 B-outcome NOUN
mRNA I-outcome NOUN
levels, O NOUN
nearly O ADV
normalized O VERB
levels O NOUN
of O ADP
the O DET
neurotoxic O ADJ
intermediates O NOUN
delta B-outcome NOUN
aminolevulinic I-outcome ADJ
acid I-outcome NOUN
and O CCONJ
porphobilinogen B-outcome NOUN
, O PUNCT
and O CCONJ
a O DET
lower O ADJ
attack B-outcome NOUN
rate O NOUN
than O ADP
that O ADP
observed O VERB
with O ADP
placebo. O NOUN
( O PUNCT

In O ADP
addition, O NOUN
22 O NUM
patients O NOUN
treated O VERB
by O ADP
monthly O ADV
regimen O NOUN
were O VERB
evaluated O VERB
after O ADP
18 O NUM
months O NOUN
of O ADP
treatment. O NOUN

Participants O NOUN
were O VERB
randomly-assigned O VERB
to O PART
receive O VERB
either O CCONJ
CM O NOUN
or O CCONJ
CHO O NOUN
immediately O ADV
post-exercise. O NOUN

Conclusion: O NOUN
High-fidelity O NOUN
simulation O NOUN
training O VERB
is O VERB
superior O ADJ
to O PART
low-fidelity O NOUN
CPR O NOUN
manikin O NOUN
training O VERB
for O ADP
teaching O VERB
fourth-year O NOUN
medical O ADJ
students O NOUN
implementation O NOUN
of O ADP
high-quality O NOUN
CPR O NOUN
for O ADP
chest B-outcome NOUN
compression I-outcome NOUN
depth I-outcome NOUN
and O CCONJ
compression B-outcome NOUN
fraction I-outcome NOUN
. O PUNCT

Follow O VERB
up O ADP
of O ADP
the O DET
participants' O NOUN
outcomes O NOUN
was O VERB
conducted O VERB
via O ADP
electronic O ADJ
medical O ADJ
records. O NOUN

Publication O NOUN
date: O NOUN
2019/02/17 O NOUN
06:00 O ADP
[entrez] O ADP

Journal O ADJ
ID: O NOUN
8912748 O NUM

BACKGROUPD: O NOUN
This O DET
study O NOUN
investigated O VERB
the O DET
plasma O NOUN
fentanyl O NOUN
concentration O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
transdermal O ADJ
fentanyl O NOUN
patch O NOUN
(TFP) O NUM
(25 O NOUN
mug/h) O NOUN
in O ADP
the O DET
management O NOUN
of O ADP
acute O ADJ
postoperative O ADJ
pain B-outcome NOUN
. O PUNCT
METHODS: O NOUN
Patients O NOUN
undergoing O VERB
laparoscopic O ADJ
cholecystectomy O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
2 O NUM
groups. O NOUN

In O ADP
multivariate O ADJ
analysis O NOUN
of O ADP
disease-free B-outcome ADJ
survival I-outcome NOUN
, O PUNCT
SPC-prognosis O NOUN
[hazard O PUNCT
ratio O NOUN
(HR): O NOUN
1.879 O NUM
(1.101-3.205), O NOUN
2.399 O NUM
(1.415-4.067), O NOUN
p=0.003 O NOUN
and O CCONJ
MSI O NOUN
status O NOUN
(HR: O NOUN
0.363, O NUM
95% O NOUN
confidence O NOUN
interval: O NOUN
0.161-0.820, O NUM
p=0.015) O NOUN
were O VERB
independent O ADJ
prognostic O ADJ
factors O NOUN
along O ADV
with O ADP
age, O NOUN
Lauren O NOUN
classification, O NOUN
TNM O NOUN
stage, O VERB
and O CCONJ
chemotherapy. O NOUN

Haematology O NOUN

Knee B-outcome NOUN
function I-outcome NOUN
was O VERB
assessed O VERB
using O VERB
HSS, O ADJ
KSS, O ADJ
NASS, O ADJ
and O CCONJ
ROM. O NOUN

At O ADP
3 O NUM
years, O NOUN
overall B-outcome ADJ
survival I-outcome NOUN
was O VERB
67% O ADJ
(95% O PUNCT
CI, O NOUN
57 O NUM
to O PART
75) O NOUN
in O ADP
the O DET
hybrid-procedure O NOUN
group, O NOUN
as O ADP
compared O VERB
with O ADP
55% O NOUN
(95% O PUNCT
CI, O NOUN
45 O NUM
to O PART
64) O NOUN
in O ADP
the O DET
open-procedure O NOUN
group; O ADJ
disease-free B-outcome ADJ
Survival I-outcome NOUN
was O VERB
57% O NUM
(95% O PUNCT
CI, O NOUN
47 O NUM
to O PART
66) O NOUN
and O CCONJ
48% O ADP
(95% O PUNCT
CI, O NOUN
38 O NUM
to O PART
57), O NOUN
respectively. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Clinical O ADJ
trials, O NOUN
NCT01949558 O NOUN
, O PUNCT
2013-09-24. O NUM

PMID: O NOUN
31613945 O NUM

CLINICAL O ADJ
TRIAL O NOUN
REGISTRATION: O NOUN
NCT00788398. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[entrez] O ADP

DESIGN: O NOUN
Open O ADJ
randomized O VERB
monocentric O ADP
study. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
['2019/10/15 O NOUN
06:00' O NUM

After O ADP
144 O NUM
weeks O NOUN
of O ADP
treatment, O NOUN
HBV B-outcome NOUN
DNA I-outcome NOUN
levels O NOUN
were O VERB
similarly O ADV
suppressed O VERB
in O ADP
both O CCONJ
groups O NOUN
(ETV O NUM
vs O CCONJ
TDF; O ADJ
-6.6485 O SYM
vs O CCONJ
-6.692 O NOUN
log10IU/mL, O NOUN
P O NOUN
= O SYM
.807). O PUNCT

Conclusion: O NOUN
The O DET
results O NOUN
suggest O VERB
that O ADP
it O PRON
is O VERB
feasible O ADJ
to O PART
use O NOUN
the O DET
Borg O ADJ
rating O VERB
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
scale O NOUN
to O PART
adjust O NOUN
FT O NOUN
intensity. O NOUN

Parents O NOUN
were O VERB
taught O NOUN
the O DET
same O ADJ
3 O NUM
infant-handling O VERB
techniques O NOUN
after O ADP
random O NOUN
assignment O NOUN
to O PART
the O DET
(1) O PUNCT
direct, O NOUN
(2) O PUNCT
video, O ADV
or O CCONJ
(3) O PUNCT
written-pictorial O ADJ
instructional O ADJ
groups. O NOUN

The O DET
incidence O NOUN
of O ADP
hand B-outcome NOUN
food I-outcome NOUN
mouth I-outcome NOUN
disease I-outcome NOUN
(2.1%) O PUNCT
in O ADP
intervention O NOUN
group O NOUN
was O VERB
significantly O ADV
lower O ADJ
than O ADP
that O ADP
in O ADP
control O NOUN
group O NOUN
(4.2%) O PUNCT
at O ADP
year O NOUN
2 O NUM
(chi O PUNCT
= O SYM
22.138, O NUM
P O NOUN
<.001). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

On O ADP
the O DET
basis O NOUN
of O ADP
traditional O ADJ
treatment, O NOUN
the O DET
children O NOUN
in O ADP
the O DET
SBH O NOUN
treatment O NOUN
group O NOUN
were O VERB
given O VERB
SBH O NOUN
treatment O NOUN
within O ADP
6 O NUM
hours O NOUN
after O ADP
birth. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

A O DET
net O ADJ
cost B-outcome NOUN
analysis O NOUN
from O ADP
an O DET
employer O NOUN
perspective O ADJ
demonstrated O VERB
the O DET
intervention O NOUN
group O NOUN
was O VERB
associated O VERB
with O ADP
a O DET
mean O NOUN
of O ADP
2.97 O NUM
h O NOUN
less O ADV
absenteeism B-outcome NOUN
over O ADP
a O DET
4 O NUM
week O NOUN
period O NOUN
(p O PUNCT
= O SYM
0.62), O NUM
which O ADP
could O VERB
result O VERB
in O ADP
net O ADJ
savings O NOUN
ranging O VERB
from O ADP
pound66 O ADJ
to O PART
pound735 O NOUN
depending O VERB
on O ADP
the O DET
wage O NOUN
rate O NOUN
employed. O NOUN

The O DET
primary O ADJ
efficacy O NOUN
endpoint O NOUN
was O VERB
non-inferiority O NOUN
of O ADP
HP O NOUN
relative O ADJ
to O PART
G O NOUN
+ O SYM
T O NOUN
for O ADP
success O NOUN
at O ADP
achieving O VERB
hemostasis B-outcome NOUN
within O ADP
6 O NUM
minutes. O ADJ

Full-mouth O NOUN
scaling O VERB
and O CCONJ
root O NOUN
planing O VERB
(SRP) O NOUN
was O VERB
performed O VERB
followed O VERB
by O ADP
the O DET
application O NOUN
of O ADP
curcumin O NOUN
gel O NOUN
on O ADP
a O DET
single O ADJ
side. O NOUN

There O PRON
was O VERB
a O DET
minor O ADJ
change O NOUN
(0.0 O PUNCT
to O PART
0.3 O NUM
mm) O NOUN
in O ADP
peri-implant B-outcome ADJ
mucosal I-outcome ADJ
zenith I-outcome ADP
positions I-outcome NOUN
over O ADP
time O NOUN
and O CCONJ
between O ADP
groups. O NOUN

Publication O NOUN
date: O NOUN
2019/03/01 O NOUN
06:00 O ADP
[entrez] O ADP

Introduction: O NOUN
Videoconferencing O VERB
has O VERB
been O VERB
employed O VERB
in O ADP
numerous O ADJ
medical O ADJ
education O NOUN
settings O NOUN
ranging O VERB
from O ADP
remote O ADV
supervision O NOUN
of O ADP
medical O ADJ
trainees O NOUN
to O PART
conducting O VERB
residency O NOUN
interviews. O NOUN

METHODS: O NOUN
The O DET
study O NOUN
included O VERB
20 O NUM
men O NOUN
(20-31 O PUNCT
yrs., O ADP

BACKGROUND: O NOUN
Based O VERB
on O ADP
epidemiological O ADJ
and O CCONJ
clinical O ADJ
data O NOUN
acute O ADJ
appendicitis O NOUN
can O VERB
present O ADJ
either O CCONJ
as O ADP
uncomplicated O VERB
(70-80%) O PUNCT
or O CCONJ
complicated O VERB
(20-30%) O NOUN
disease. O NOUN

METHODS: O NOUN
50 O NUM
patients O NOUN
with O ADP
chronic O ADJ
low O ADJ
back O ADP
pain O NOUN
(78% O PUNCT
female, O NOUN
49.7+/-10.0 O NOUN
years) O NOUN
were O VERB
randomized O VERB
to O PART
two O NUM
Gua O NOUN
Sha O NOUN
treatments O NOUN
(n=25) O PUNCT
or O CCONJ
waitlist O ADJ
control O NOUN
(n=25). O NOUN

The O DET
OR O CCONJ
Study O NOUN
intervention O NOUN
was O VERB
delayed O VERB
because O ADP
of O ADP
interruptions O NOUN
in O ADP
finalizing O VERB
the O DET
national O ADJ
CHW O NOUN
policy, O NOUN
two O NUM
separate O ADJ
cholera O NOUN
epidemics, O ADJ
and O CCONJ
the O DET
Ebola O NOUN
epidemic O ADJ
lasting O VERB
more O ADV
than O ADP
2 O NUM
years. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

BACKGROUND: O NOUN
Tafenoquine, O NOUN
a O DET
single-dose O NOUN
therapy O NOUN
for O ADP
Plasmodium O NOUN
vivax O NOUN
malaria, O NOUN
has O VERB
been O VERB
associated O VERB
with O ADP
relapse O NOUN
prevention O NOUN
through O ADP
the O DET
clearance O NOUN
of O ADP
P. O NOUN
vivax O NOUN
parasitemia O NOUN
and O CCONJ
hypnozoites, O NOUN
termed O VERB
"radical O ADJ
cure." O NOUN

Protrusion B-outcome NOUN
and Seperator CCONJ
proclination B-outcome NOUN
of I-outcome ADP
mandibular I-outcome ADJ
incisors E3-outcome NOUN
were O VERB
greater O ADJ
in O ADP
the O DET
IA O NOUN
group O NOUN
(95.90 O ADV
degrees O NOUN
+/- O SYM
5.34 O NUM
degrees O NOUN
) O PUNCT
compared O VERB
with O ADP
the O DET
MA O NOUN
group O NOUN
(92.04 O PUNCT
degrees O NOUN
+/- O SYM
7.92 O NUM
degrees O NOUN
). O NOUN

BACKGROUND: O NOUN
Many O ADJ
surgical O ADJ
procedures O NOUN
have O VERB
been O VERB
described O VERB
to O PART
treat O NOUN
recurrent O ADP
patellar O ADJ
dislocation, O NOUN
but O CCONJ
none O NUM
of O ADP
these O DET
techniques O NOUN
has O VERB
been O VERB
successful O ADJ
in O ADP
all O DET
patients. O NOUN

Title: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial O NOUN
of O ADP
ultrasound-guided O VERB
pulsed O VERB
radiofrequency O NOUN
for O ADP
patients O NOUN
with O ADP
frozen O NOUN
shoulder. O NOUN

After O ADP
further O ADV
exclusions, O NOUN
75 O NUM
(94%) O NUM
patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
groups, O NOUN
received O VERB
at O ADP
least O ADV
one O NUM
dose O NOUN
of O ADP
treatment O NOUN
(25 O NOUN
patients O NOUN
to O PART
receive O VERB
10 O NUM
mg O NOUN
pegbelfermin O NOUN
once O ADP
a O DET
day; O NOUN
24 O NUM
patients O NOUN
to O PART
receive O VERB
20 O NUM
mg O NOUN
pegbelfermin O NOUN
once O ADP
a O DET
week, O NOUN
and O CCONJ
26 O NUM
patients O NOUN
to O PART
receive O VERB
placebo), O NOUN
and O CCONJ
were O VERB
included O VERB
in O ADP
the O DET
primary O ADJ
analysis. O NOUN

At O ADP
day O NOUN
5, O ADJ
composite O NOUN
cure B-outcome NOUN
was O VERB
observed O VERB
in O ADP
88.0% O NUM
of O ADP
the O DET
patients O NOUN
(168 O NUM
of O ADP
191 O NUM
patients) O NOUN
in O ADP
the O DET
plazomicin O NOUN
group O NOUN
and O CCONJ
in O ADP
91.4% O NOUN
(180 O PUNCT
of O ADP
197 O NUM
patients) O NOUN
in O ADP
the O DET
meropenem O NOUN
group O NOUN
(difference, O ADV
-3.4 O NUM
percentage O NOUN
points; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
-10.0 O NUM
to O PART
3.1). O NOUN

RESULTS: O NOUN
After O ADP
followed O VERB
up O ADP
for O ADP
6 O NUM
to O PART
20 O NUM
months, O NOUN
a O DET
thinner O NOUN
appearance B-outcome NOUN
was O VERB
seen O VERB
in O ADP
3 O NUM
eyes O NOUN
(2.2%) O PUNCT
in O ADP
the O DET
corneal O ADJ
graft O NOUN
group O NOUN
and O CCONJ
7 O NUM
eyes O NOUN
(5.5%) O NOUN
in O ADP
the O DET
scleral O ADJ
group. O VERB

OBJECTIVE: O NOUN
To O PART
reduce O VERB
the O DET
inappropriate O ADJ
identification O NOUN
of O ADP
eye O NOUN
drops, O NOUN
through O ADP
the O DET
use O NOUN
of O ADP
different O ADJ
colors. O NOUN

A O DET
prespecified O VERB
interim O ADJ
analysis O NOUN
at O ADP
week O NOUN
8 O NUM
showed O VERB
a O DET
greater O ADJ
than O ADP
expected O VERB
change O NOUN
in O ADP
the O DET
primary O ADJ
outcome O NOUN
and O CCONJ
supported O VERB
early O ADJ
closing O VERB
of O ADP
patient O NOUN
enrolment, O NOUN
since O ADP
this O DET
analysis O NOUN
indicated O VERB
that O ADP
the O DET
full O ADJ
planned O VERB
sample O NOUN
size O NOUN
was O VERB
not O ADV
needed. O NOUN

A O DET
total O ADJ
of O ADP
55 O NUM
patients O NOUN
with O ADP
histologically O ADV
and O CCONJ
clinically O ADV
diagnosed O VERB
stage O NOUN
IV O NUM
colorectal O ADJ
carcinoma O NOUN
were O VERB
enrolled O VERB
between O ADP
July O NOUN
2014 O NUM
and O CCONJ
July O NOUN
2017. O NUM

The O DET
study O NOUN
consisted O VERB
of O ADP
a O DET
pre-screening, O NOUN
screening, O NOUN
day O NOUN
0 O NUM
baseline O NOUN
(randomization O NOUN
visit) O NOUN
and O CCONJ
three O NUM
follow-up O NOUN
visits O NOUN
on O ADP
days O NOUN
14, O NUM
28 O NUM
and O CCONJ
56. O PART

RESULTS: O NOUN
Of O ADP
131 O NUM
subjects O NOUN
who O ADP
underwent O VERB
routine O ADJ
phacoemulsification, O NOUN
analyzable O ADJ
endothelial O ADJ
images O NOUN
at O ADP
24 O NUM
months O NOUN
were O VERB
available O ADJ
for O ADP
126 O NUM
subjects O NOUN
(96.2%). O PUNCT

AIMS O NOUN
OF O ADP
THE O DET
STUDY: O NOUN
The O DET
safety O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
a O DET
hemostatic O ADJ
powder O NOUN
(HP) O NOUN
versus O CCONJ
a O DET
control O NOUN
agent, O NOUN
absorbable O ADJ
gelatin O NOUN
sponge O NOUN
and O CCONJ
thrombin O NOUN
(G O NUM
+ O SYM
T), O NOUN
were O VERB
assessed, O NOUN
using O VERB
a O DET
validated, O NOUN
quantitative O ADJ
bleeding B-outcome VERB
severity I-outcome NOUN
scale. O ADJ

PROTOCOL: O NOUN
The O DET
protocol O NOUN
was O VERB
not O ADV
published O VERB
before O ADP
trial O NOUN
commencement. O NOUN

METHODS: O NOUN
The O DET
study O NOUN
was O VERB
a O DET
randomised, O NOUN
double-blinded, O NOUN
placebo-controlled O VERB
intervention O NOUN
study O NOUN
with O ADP
35 O NUM
overweight O NUM
subjects O NOUN
with O ADP
mildly O ADV
or O CCONJ
moderately O ADV
elevated O VERB
blood O NOUN
pressure, O NOUN
who O ADP
took O VERB
4 O NUM
g O NOUN
krill O NOUN
oil O NOUN
powder O NOUN
or O CCONJ
4 O NUM
g O NOUN
of O ADP
placebo O NOUN
during O ADP
an O DET
8-week O NOUN
follow-up O NOUN
period. O NOUN

Title: O NOUN
Effectiveness O NOUN
of O ADP
routine O ADJ
third O ADJ
trimester O NOUN
ultrasonography O NOUN
to O PART
reduce O VERB
adverse B-outcome ADJ
perinatal I-outcome ADJ
outcomes I-outcome NOUN
in O ADP
low O ADJ
risk O NOUN
pregnancy O NOUN
(the O NOUN
IRIS O NOUN
study): O NUM
nationwide, O NOUN
pragmatic, O NOUN
multicentre, O NOUN
stepped O VERB
wedge O NOUN
cluster O NOUN
randomised O VERB
trial. O NOUN

Results O NOUN
The O DET
TC O NOUN
had O VERB
produced O VERB
significant O ADJ
positive O ADJ
chances O NOUN
in O ADP
depression B-outcome NOUN
and O CCONJ
some O DET
heart B-outcome NOUN
rate I-outcome NOUN
variability I-outcome NOUN
parameters O NOUN
(mean O NUM
heart B-outcome NOUN
rate I-outcome NOUN
, O PUNCT
RMSSD B-outcome NOUN
, O PUNCT
HF B-outcome NOUN
, O PUNCT
LFnorm B-outcome NOUN
, O PUNCT
and O CCONJ
HFnorm B-outcome NOUN
) O PUNCT
(p O PUNCT
< O SYM
0.05), O NUM
whereas O ADP
these O DET
positive O ADJ
results O NOUN
were O VERB
not O ADV
observed O VERB
in O ADP
the O DET
control O NOUN
group. O VERB

Twelve O NUM
deaths B-outcome NOUN
(8 O NOUN
in O ADP
the O DET
omadacycline O NOUN
group O NOUN
and O CCONJ
4 O NUM
in O ADP
the O DET
moxifloxacin O NOUN
group) O ADJ
occurred O VERB
during O ADP
the O DET
trial. O NOUN

Title: O NOUN
Does O VERB
L-Methylfolate O NOUN
Supplement O NOUN
Methylphenidate O NOUN
Pharmacotherapy O NOUN
in O ADP
Attention-Deficit/Hyperactivity O NOUN
Disorder?: O NOUN

Publication O NOUN
date: O NOUN
2018/05/09 O NOUN
00:00 O NOUN
[accepted] O ADV

BACKGROUND: O NOUN
Maintenance O NOUN
of O ADP
effect O NOUN
following O VERB
treatment O NOUN
with O ADP
galcanezumab O NOUN
compared O VERB
to O PART
placebo O NOUN
in O ADP
adult O NOUN
patients O NOUN
with O ADP
episodic O NOUN
or O CCONJ
chronic O ADJ
migraine O NOUN
was O VERB
evaluated. O NOUN

min(-1); O NOUN
CON O NOUN
= O SYM
0.19 O NUM
+/- O SYM
0.05 O NUM
degrees O NOUN
C O NOUN
. O PUNCT

Publication O NOUN
date: O NOUN
2019/02/15 O NOUN
06:00 O ADP
[medline] O NOUN

We O PRON
aimed O VERB
to O PART
compare O NOUN
the O DET
immunogenicity B-outcome NOUN
and O CCONJ
safety O NOUN
of O ADP
the O DET
most O DET
commonly O ADV
used O VERB
HA O NOUN
vaccines O NOUN
in O ADP
ethnic O ADJ
Korean O NOUN
children O NOUN
aged O VERB
12 O NUM
to O PART
18 O NUM
months. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

The O DET
initial O ADJ
3 O NUM
mg O NOUN
dose O NOUN
was O VERB
increased O VERB
to O PART
4 O NUM
mg O NOUN
from O ADP
cycle O NOUN
5 O NUM
if O ADP
tolerated O VERB
during O ADP
cycles O NOUN
1-4. O ADP

It O PRON
may O VERB
be O VERB
used O VERB
as O ADP
an O DET
alternative O ADJ
drug O NOUN
for O ADP
fentanyl O NOUN
in O ADP
pain O NOUN
control O NOUN
after O ADP
orthopedic O ADJ
surgery. O VERB

Our O ADJ
purpose O NOUN
was O VERB
to O PART
investigate O NOUN
the O DET
effectiveness O NOUN
and O CCONJ
cost-effectiveness O NOUN
of O ADP
three O NUM
intervention-arms O NOUN
(combined O PUNCT
neuromuscular O ADJ
exercise O NOUN
and O CCONJ
back O ADP
care O NOUN
counselling O VERB
or O CCONJ
either O CCONJ
alone) O NOUN
compared O VERB
with O ADP
non-treatment. O NOUN

Journal-Name:Nutrients O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

METHODS: O NOUN
In O ADP
this O DET
randomized O VERB
controlled O VERB
trial, O NOUN
we O PRON
compared O VERB
the O DET
efficacy O NOUN
of O ADP
DR O NOUN
versus O CCONJ
EODR O NOUN
by O ADP
measuring O VERB
lipid B-outcome NOUN
indices O NOUN
and O CCONJ
serum O NOUN
HMGCR B-outcome ADV
levels O NOUN
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
12 O NUM
weeks O NOUN
of O ADP
10mg O NUM
atorvastatin O NOUN
therapy. O NOUN

A O DET
sequential O ADJ
design O NOUN
was O VERB
used O VERB
with O ADP
a O DET
triangular O ADJ
continuation O NOUN
region. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

L(- O NOUN
1); O NOUN
PL: O NOUN
8.7 O NUM
+/- O SYM
0.9 O NUM
mmol. O NOUN

They O PRON
were O VERB
randomly O ADV
treated O VERB
by O ADP
endoscopic O ADJ
sclerotherapy O NOUN
or O CCONJ
cyanoacrylate O VERB
injection O NOUN
as O ADP
banding O VERB
was O VERB
not O ADV
suitable O ADJ
for O ADP
those O DET
patients O NOUN
due O ADJ
to O PART
profuse O NOUN
bleeding O VERB
making O VERB
unclear O ADJ
endoscopic O ADJ
visual O ADJ
field. O NOUN

Aim: O NOUN
To O PART
clinically O ADV
assess O NOUN
the O DET
efficacy O NOUN
of O ADP
resin O NOUN
infiltration O NOUN
versus O CCONJ
fluoride O NOUN
varnish O NOUN
for O ADP
arresting O VERB
white B-outcome ADP
spot I-outcome NOUN
lesions I-outcome NOUN
(WSLs) I-outcome NOUN
on O ADP
permanent O ADJ
teeth O NOUN
in O ADP
children. O NOUN

METHODS: O NOUN
A O DET
cross-sectional O ADJ
study O NOUN
was O VERB
carried O VERB
out O ADP
among O ADP
healthy O ADJ
controls O NOUN
(HCs, O NOUN
n O NOUN
= O SYM
65), O NUM
diabetes O NOUN
patients O NOUN
without O ADP
kidney O NOUN
disease O NOUN
(DCs, O NOUN
n O NOUN
= O SYM
48) O NOUN
and O CCONJ
DKD O NOUN
patients O NOUN
(n O NOUN
= O SYM
60). O NOUN

PATIENTS: O NOUN
A O DET
total O ADJ
of O ADP
288 O NUM
patients O NOUN
with O ADP
clinically O ADV
confirmed O VERB
uncontrolled O VERB
chronic O ADJ
rhinosinusitis O NOUN
were O VERB
subjected O VERB
to O PART
randomization O NOUN
(1:1 O NUM
ratio). O ADP

METHODS: O NOUN
This O DET
prospective O ADJ
study O NOUN
included O VERB
113 O NUM
cirrhotic O ADJ
patients O NOUN
with O ADP
actively O ADV
bleeding O VERB
esophageal O ADJ
varices. O NOUN

Children O NOUN
with O ADP
phenylketonuria O NOUN
(PKU) O PUNCT
follow O VERB
a O DET
protein O NOUN
restricted O VERB
diet O NOUN
with O ADP
negligible O ADJ
amounts O NOUN
of O ADP
docosahexaenoic O VERB
acid O NOUN
(DHA). O PUNCT

Publication O NOUN
date: O NOUN
2019/01/31 O NOUN
06:00 O ADP
[entrez] O ADP

Journal O ADJ
ID: O NOUN
7511141 O NUM

Belatacept O NOUN
concentrations O NOUN
were O VERB
determined O VERB
in O ADP
a O DET
total O ADJ
of O ADP
203 O NUM
serum O NOUN
samples O NOUN
collected O VERB
during O ADP
26 O NUM
infusion O NOUN
intervals O NOUN
from O ADP
5 O NUM
renal O ADJ
transplant O NOUN
recipients. O NOUN

The O DET
selection O NOUN
of O ADP
proper O ADJ
respirators O NOUN
and O CCONJ
training O VERB
would O VERB
be O VERB
beneficial O ADJ
to O PART
the O DET
safety O NOUN
of O ADP
healthcare O NOUN
providers. O ADP

Undoubtedly, O NOUN
further O ADV
in O ADP
vitro O ADV
and O CCONJ
in O ADP
vivo O ADV
studies O NOUN
need O NOUN
to O PART
be O VERB
performed O VERB
in O ADP
order O NOUN
to O PART
elucidate O NOUN
possible O ADJ
mechanisms O NOUN
of O ADP
action O NOUN
and O CCONJ
corroborate O VERB
our O ADJ
preliminary O ADJ
results. O NOUN

Obesity O NOUN
prevention O NOUN
campaign O ADV
sponsorship O NOUN
promoted O VERB
higher O ADJ
campaign O ADV
awareness B-outcome ADV
and O CCONJ
perceived B-outcome VERB
event-sponsor I-outcome NOUN
fit I-outcome NOUN
, O PUNCT
but O CCONJ
did O VERB
not O ADV
impact O NOUN
food O NOUN
attitudes B-outcome NOUN
or O CCONJ
preference B-outcome NOUN
for O ADP
unhealthy O NOUN
versus O CCONJ
healthier O ADJ
foods. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
BRPE O NOUN
could O VERB
be O VERB
a O DET
valuable O ADJ
tool O NOUN
for O ADP
clinicians O NOUN
to O PART
dose O NOUN
FT O NOUN
intensity O NOUN
after O ADP
a O DET
stroke, O NOUN
but O CCONJ
this O DET
remains O NOUN
to O PART
be O VERB
tested. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Journal O ADJ
ID: O NOUN
101234168 O NUM

Four-hundred O VERB
twenty-four O NOUN
patients O NOUN
with O ADP
septic O ADJ
shock O NOUN
were O VERB
included O VERB
between O ADP
March O NOUN
2017 O NUM
and O CCONJ
March O NOUN
2018. O NUM

Title: O NOUN
Does O VERB
all O DET
single O ADJ
infarction O NOUN
have O VERB
lower O ADJ
risk O NOUN
of O ADP
stroke B-outcome NOUN
recurrence O NOUN
than O ADP
multiple O ADJ
infarctions O NOUN
in O ADP
minor O ADJ
stroke? O NOUN

However, O ADV
this O DET
needs O NOUN
reconfirmation O NOUN
in O ADP
a O DET
larger O ADJ
study. O NOUN

Journal-Name:Nutrients O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
This O DET
trial O NOUN
was O VERB
registered O VERB
prior O ADJ
to O PART
enrollment O NOUN
at O ADP
the O DET
Registry O NOUN
for O ADP
International O ADJ
Impact O NOUN
Evaluations O NOUN
(RIDIE O PUNCT
STUDY O NOUN
ID: O NOUN
582a2462ae2ab): O NOUN
http://ridie.3ieimpact.org/index.php?r=search/detailView&id=492 O NOUN
. O PUNCT

RESULTS: O NOUN
Despite O ADP
similar O ADJ
fluoroscopy O NOUN
times O NOUN
(20.4+/-9.4min O NOUN
with O ADP
RADPAD O NOUN
vs. O CCONJ
19.4+/-9.2min O NOUN
without O ADP
RADPAD, O NOUN
P=0.871) O NOUN
and O CCONJ
total O ADJ
radiation O NOUN
dose O NOUN
(3.4+/-4.3 O PUNCT
Gy O NOUN
with O ADP
RADPAD O NOUN
vs. O CCONJ
2.3+/-1.4 O NOUN
Gy, O NOUN
P=0.198), O NOUN
the O DET
relative B-outcome ADJ
operator I-outcome NOUN
exposure I-outcome NOUN
was O VERB
significantly O ADV
less O ADV
with O ADP
RADPAD O NOUN
(1.39+/-0.95) O PUNCT
as O ADP
compared O VERB
to O PART
no O DET
RADPAD O NOUN
group O NOUN
(2.27+/-1.4) O NUM
(p=0.004) O ADV
amounting O VERB
to O PART
a O DET
39% O NUM
reduction. O NOUN

Results: O NOUN
After O ADP
the O DET
treatment, O NOUN
the O DET
improvement O NOUN
of O ADP
glycosylated B-outcome VERB
hemoglobin I-outcome NOUN
(HbA1c) I-outcome NOUN
, O PUNCT
blood B-outcome NOUN
urea I-outcome NOUN
nitrogen I-outcome NOUN
(BUN) I-outcome PUNCT
, O PUNCT
systolic B-outcome ADJ
pressure I-outcome NOUN
(SP), O PUNCT
high B-outcome ADJ
sensitive I-outcome ADJ
C-reactive I-outcome ADJ
protein I-outcome NOUN
(hs-CRP) I-outcome NOUN
, O PUNCT
erythrocyte B-outcome NOUN
sedimentation I-outcome NOUN
rate I-outcome NOUN
(ESR) I-outcome NOUN
, O PUNCT
estimated B-outcome VERB
glomerular I-outcome ADJ
filtration I-outcome NOUN
rate I-outcome NOUN
(eGFR) I-outcome NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
were O VERB
significantly O ADV
better O ADJ
than O ADP
those O DET
in O ADP
the O DET
control O NOUN
group O NOUN
(all O PUNCT
P<0.05), O NOUN
as O ADP
well O ADV
as O ADP
the O DET
urine O NOUN
albumin/creatine B-outcome NOUN
ratio I-outcome NOUN
[47(26, O VERB
120) O NOUN
mg/g O ADV
vs O CCONJ
103(42, O NOUN
267) O NOUN
mg/g, O VERB
P<0.001]and O NOUN
serum O NOUN
cystatin B-outcome NOUN
C I-outcome NOUN
[(0.83+/-0.30) O NOUN
mg/L O NOUN
vs O CCONJ
(0.98+/-0.25) O PUNCT
mg/L, O NOUN
P=0.031]. O NOUN
However, O ADV
there O PRON
was O VERB
no O DET
statistically O ADV
significant O ADJ
difference O NOUN
of O ADP
urine O NOUN
albumin/creatine B-outcome NOUN
ratio I-outcome NOUN
and O CCONJ
cystatin B-outcome NOUN
C I-outcome NOUN
between O ADP
before O ADP
and O CCONJ
after O ADP
treatment O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
(all O PUNCT
P>0.05). O NOUN

Training O VERB
was O VERB
performed O VERB
by O ADP
lecture, O NOUN
real-time O NOUN
feedback, O NUM
and O CCONJ
fit O NOUN
check. O NOUN

Freedom O NOUN
from O ADP
recurrence B-outcome NOUN
of O ADP
P. O NOUN
vivax O NOUN
parasitemia O NOUN
at O ADP
6 O NUM
months O NOUN
was O VERB
the O DET
primary O ADJ
efficacy O NOUN
outcome O NOUN
in O ADP
a O DET
planned O VERB
patient-level O NOUN
meta-analysis O NOUN
of O ADP
the O DET
current O ADJ
trial O NOUN
and O CCONJ
another O DET
phase O NOUN
3 O NUM
trial O NOUN
of O ADP
tafenoquine O NOUN
and O CCONJ
primaquine O NOUN
(per-protocol O NOUN
populations), O NOUN
and O CCONJ
an O DET
odds O NOUN
ratio O NOUN
for O ADP
recurrence B-outcome NOUN
of O ADP
1.45 O NUM
(tafenoquine O NUM
vs. O CCONJ
primaquine) O NOUN
was O VERB
used O VERB
as O ADP
a O DET
noninferiority O NOUN
margin. O NOUN

RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
366 O NUM
patients O NOUN
(mean O NUM
age, O NOUN
48.5 O NUM
years; O NOUN
280 O NUM
men) O NOUN
were O VERB
enrolled. O NOUN

Exploratory O ADJ
analyses O NOUN
suggested O VERB
that O ADP
variation O NOUN
in O ADP
a O DET
guanosine O NOUN
triphosphate O NOUN
cyclohydrolase O NOUN
gene O NOUN
predicted O VERB
association O NOUN
with O ADP
higher O ADJ
doses B-outcome NOUN
of I-outcome ADP
methylphenidate I-outcome NOUN
(P O NUM
< O SYM
0.001). O NUM

Title: O NOUN
Comparison O NOUN
of O ADP
analgesic B-outcome ADP
efficacy O NOUN
of O ADP
oxycodone O NOUN
and O CCONJ
fentanyl O NOUN
after O ADP
total O ADJ
hip O NOUN
replacement O NOUN
surgery: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

BACKGROUND: O NOUN
Postoperative O ADJ
complications B-outcome NOUN
, O PUNCT
especially O ADV
pulmonary B-outcome ADJ
complications I-outcome NOUN
, O PUNCT
affect O NOUN
more O ADV
than O ADP
half O NOUN
the O DET
patients O NOUN
who O ADP
undergo O NOUN
open O ADJ
esophagectomy O NOUN
for O ADP
esophageal O ADJ
cancer. O NOUN

Cry B-outcome NOUN
and Seperator CCONJ
fuss B-outcome NOUN
time E1-outcome NOUN
were O VERB
measured O VERB
with O ADP
validated O VERB
Baby's O NOUN
Day O NOUN
Diary O NOUN
on O ADP
days O NOUN
0 O NUM
and O CCONJ
28. O NUM

The O DET
primary O ADJ
outcome O NOUN
included O VERB
bacteriological B-outcome ADJ
cure I-outcome NOUN
. O PUNCT
It O PRON
was O VERB
assessed O VERB
by O ADP
the O DET
eradication O NOUN
of O ADP
urogenital O ADJ
gonorrhea O ADJ
at O ADP
any O DET
site O NOUN
cultured O VERB
after O ADP
taken O VERB
the O DET
study O NOUN
medications. O NOUN

Journal-Name:Occupational O ADJ
therapy O NOUN
international O ADJ

Furthermore, O NOUN
the O DET
100-mm O NOUN
VAS O NOUN
for O ADP
radiating B-outcome VERB
pain I-outcome NOUN
, O PUNCT
Oswestry O NOUN
disability B-outcome NOUN
index O NOUN
(ODI)], O NOUN
Roland-Morris O NOUN
disability B-outcome NOUN
questionnaire O NOUN
(RMDQ)], O NOUN
EuroQol O NOUN
5 O NUM
Dimensions O NOUN
5 O NUM
Levels O NOUN
(EQ-5D-5L)], O NOUN
global B-outcome ADJ
perceived I-outcome VERB
effect O NOUN
(GPE), O NUM
and O CCONJ
deficiency B-outcome NOUN
syndrome I-outcome NOUN
of I-outcome ADP
kidney I-outcome NOUN
index O NOUN
(DSKI) O NOUN
will O VERB
be O VERB
used O VERB
to O PART
evaluate O VERB
secondary O ADJ
outcomes. O ADJ

Publication O NOUN
date: O NOUN
2018/06/12 O ADJ
00:00 O NOUN
[accepted] O ADV

There O PRON
were O VERB
significant O ADJ
differences O NOUN
favoring O VERB
acetaminophen O ADV
vs O CCONJ
placebo O NOUN
for O ADP
3 O NUM
prespecified O VERB
secondary O ADJ
outcomes: O NOUN
delirium B-outcome NOUN
duration I-outcome NOUN
(median, O NOUN
1 O NUM
vs O CCONJ
2 O NUM
days; O NOUN
difference, O NOUN
-1 O NUM
[95% O NOUN
CI, O NOUN
-2 O NUM
to O PART
0]), O NOUN
ICU B-outcome NOUN
length I-outcome NOUN
of I-outcome ADP
stay I-outcome NOUN
(median, O NOUN
29.5 O NUM
vs O CCONJ
46.7 O NUM
hours; O ADV
difference, O NOUN
-16.7 O NUM
[95% O NOUN
CI, O NOUN
-20.3 O NUM
to O PART
-0.8]), O NUM
and O CCONJ
breakthrough O NOUN
analgesia B-outcome NOUN
(median, O NOUN
322.5 O NUM
vs O CCONJ
405.3 O NUM
microg O NOUN
morphine O NOUN
equivalents; O ADJ
difference, O NOUN
-83 O NUM
[95% O NOUN
CI, O NOUN
-154 O NUM
to O PART
-14]). O NOUN

Respiratory O ADJ
muscle O NOUN
training O VERB
of O ADP
the O DET
experiment O NOUN
group O NOUN
was O VERB
performed O VERB
using O VERB
the O DET
respiratory O ADJ
endurance O NOUN
training O VERB
device O NOUN
combined O VERB
with O ADP
traditional O ADJ
techniques. O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Publication O NOUN
date: O NOUN
2018/12/19 O NOUN
06:00 O ADP
[entrez] O ADP

Journal O ADJ
ID: O NOUN
101521595 O NUM

The O DET
administration O NOUN
of O ADP
gonadotrophin-releasing O VERB
hormone O NOUN
(GnRH) O NUM
agonists O NOUN
prior O ADJ
to O PART
IVF/ICSI O NOUN
can O VERB
improve O VERB
the O DET
successful O ADJ
pregnancy O NOUN
rate. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Pain B-outcome NOUN
is O VERB
an O DET
important O ADJ
factor O NOUN
that O ADP
inversely O ADV
correlates O NOUN
with O ADP
the O DET
improvements O NOUN
in O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
. O PUNCT

BACKGROUND: O NOUN
This O DET
study O NOUN
assessed O VERB
the O DET
feasibility B-outcome NOUN
and O CCONJ
acceptability B-outcome NOUN
of O ADP
two O NUM
common O ADJ
types O NOUN
of O ADP
exercise O NOUN
training-high-intensity O NOUN
interval O NOUN
training O VERB
(HIIT) O NOUN
and O CCONJ
moderate-intensity O NOUN
continuous O ADJ
training O VERB
(MICT)-in O NOUN
adults O NOUN
with O ADP
Crohn's O NOUN
disease O NOUN
(CD). O NUM

Further O ADV
investigation O NOUN
would O VERB
be O VERB
required O VERB
to O PART
confirm O NOUN
this O DET
effect O NOUN
and O CCONJ
its O ADJ
mechanism O NOUN
and O CCONJ
the O DET
genotype O NOUN
prediction O NOUN
of O ADP
effects O NOUN
on O ADP
dosing. O NOUN

RESULTS: O NOUN
After O ADP
4-week O NOUN
treatment, O NOUN
the O DET
patients O NOUN
undergoing O VERB
verum O NOUN
TENS O NOUN
showed O VERB
statistically O ADV
efficacy O NOUN
of O ADP
symptoms B-outcome NOUN
relief, O NOUN
as O ADP
measured O VERB
by O ADP
the O DET
scales O NOUN
of O ADP
Tinnitus B-outcome NOUN
Severity I-outcome NOUN
Scale O NOUN
(TSS) O PUNCT
(P O NUM
< O SYM
.01), O PUNCT
Tinnitus B-outcome NOUN
Questionnaire O PROPN
(TQ) O NOUN
(P O NUM
< O SYM
.01), O PUNCT
and O CCONJ
Tinnitus B-outcome NOUN
Handicap I-outcome NOUN
Inventory O ADJ
(THI)], O NOUN
(P O NUM
< O SYM
.01), O PUNCT
and O CCONJ
improvement O NOUN
of O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
as O ADP
assessed O VERB
by O ADP
the O DET
SF-12 O NOUN
(P O NUM
< O SYM
.01), O PUNCT
compared O VERB
with O ADP
patients O NOUN
receiving O VERB
sham O NOUN
TENS. O NOUN

In O ADP
the O DET
conventional O ADJ
group, O NOUN
the O DET
treatment O NOUN
goal O NOUN
was O VERB
clinical B-outcome ADJ
remission I-outcome NOUN
. O PUNCT
Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
Co-primary O ADJ
outcomes O NOUN
were O VERB
proportions O NOUN
of O ADP
patients O NOUN
achieving O VERB
DAS28-CRP B-outcome NOUN
remission I-outcome NOUN
(DAS28-CRP O NUM
<2.6) O NOUN
and O CCONJ
with O ADP
no O DET
radiographic B-outcome ADJ
progression I-outcome NOUN
(no O PUNCT
increase O NOUN
in O ADP
total O ADJ
van O NOUN
der O NOUN
Heijde-modified O VERB
Sharp O NOUN
score) O NOUN
at O ADP
24 O NUM
months. O NOUN

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
investigator-assessed O VERB
progression-free B-outcome ADJ
survival I-outcome NOUN
; O PUNCT
rates O NOUN
of O ADP
objective B-outcome ADP
response I-outcome NOUN
and O CCONJ
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
also O ADV
evaluated. O NOUN

Title: O NOUN
[Randomized O VERB
controlled O VERB
trial O NOUN
of O ADP
comparison O NOUN
between O ADP
the O DET
SuperPATH O NOUN
and O CCONJ
posterolateral O ADJ
approaches O NOUN
in O ADP
total O ADJ
hip O NOUN
arthroplasty]. O NOUN

Functional B-outcome ADJ
outcomes O NOUN
were O VERB
similar O ADJ
in O ADP
all O DET
three O NUM
groups O NOUN
in O ADP
POD O NOUN
1 O NUM
and O CCONJ
POD O NOUN
2. O NUM

Methods: O NOUN
Seventy-five O NUM
patients O NOUN
were O VERB
randomized O VERB
into O ADP
either O CCONJ
CBT-i O NOUN
group O NOUN
(n=37) O NOUN
or O CCONJ
combination O NOUN
group O NOUN
(n=38). O NUM

RESULTS: O NOUN
In O ADP
the O DET
dry O ADJ
needling O VERB
group, O NOUN
intensity B-outcome NOUN
of, I-outcome NOUN
frequency X NOUN
and X NOUN
duration B-outcome NOUN
of I-outcome ADP
headache B-outcome NOUN
, O PUNCT
and O CCONJ
the O DET
scores O NOUN
of O ADP
Short O NOUN
Form-36 O NOUN
subscales O NOUN
were O VERB
significantly O ADV
improved O VERB
after O ADP
treatment O NOUN
(P O NUM
< O SYM
.05). O NUM

RESULTS: O NOUN
After O ADP
6 O NUM
weeks O NOUN
treatment, O NOUN
lactulose O ADV
showed O VERB
better O ADJ
outcomes O NOUN
in O ADP
daily O ADJ
stool B-outcome NOUN
frequency I-outcome NOUN
(P O NUM
< O SYM
.01), O PUNCT
and O CCONJ
stool B-outcome NOUN
consistency I-outcome NOUN
(P O NUM
< O SYM
.01), O PUNCT
except O ADP
the O DET
abdominal B-outcome ADJ
pain I-outcome NOUN
(P O NUM
= O SYM
.24), O PUNCT
and O CCONJ
flatulence B-outcome NOUN
(P O NUM
= O SYM
.44), O NOUN
compared O VERB
with O ADP
the O DET
placebo. O NOUN

At O ADP
the O DET
test-of-cure O NOUN
visit, O NOUN
a O DET
higher O ADJ
percentage O NOUN
of O ADP
patients O NOUN
in O ADP
the O DET
plazomicin O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
meropenem O NOUN
group O NOUN
were O VERB
found O VERB
to O PART
have O VERB
microbiologic B-outcome ADJ
eradication I-outcome NOUN
, O PUNCT
including O VERB
eradication O NOUN
of O ADP
Enterobacteriaceae O NOUN
that O ADP
were O VERB
not O ADV
susceptible O ADJ
to O PART
aminoglycosides O NOUN
(78.8% O PUNCT
vs. O CCONJ
68.6%) O ADP
and O CCONJ
Enterobacteriaceae O NOUN
that O ADP
produce O VERB
extended-spectrum O NOUN
beta-lactamases O NOUN
(82.4% O NUM
vs. O CCONJ
75.0%). O NUM

BACKGROUND: O NOUN
Endometrial O ADJ
scratching O VERB
(with O PUNCT
the O DET
use O NOUN
of O ADP
a O DET
pipelle O ADJ
biopsy) O NOUN
is O VERB
a O DET
technique O NOUN
proposed O VERB
to O PART
facilitate O VERB
embryo B-outcome NOUN
implantation I-outcome NOUN
and O CCONJ
increase O NOUN
the O DET
probability O NOUN
of O ADP
pregnancy B-outcome NOUN
in O ADP
women O NOUN
undergoing O VERB
in O ADP
vitro O ADV
fertilization O NOUN
(IVF). O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
older O ADJ
adults O NOUN
undergoing O VERB
major O ADJ
surgery, O NOUN
EEG-guided O VERB
anesthetic O ADJ
administration, O NOUN
compared O VERB
with O ADP
usual O ADJ
care, O NOUN
did O VERB
not O ADV
decrease O NOUN
the O DET
incidence O NOUN
of O ADP
postoperative O ADJ
delirium B-outcome NOUN
. O PUNCT
This O DET
finding O VERB
does O VERB
not O ADV
support O NOUN
the O DET
use O NOUN
of O ADP
EEG-guided O VERB
anesthetic O ADJ
administration O NOUN
for O ADP
this O DET
indication. O ADV

Significant O ADJ
survival O NOUN
benefit O NUM
from O ADP
adjuvant O NOUN
chemotherapy O NOUN
was O VERB
observed O VERB
by O ADP
SPC-Prediction O NOUN
in O ADP
MSS O NOUN
and O CCONJ
EBV-negative O ADJ
gastric O ADJ
cancer. O NOUN

There O PRON
is O VERB
evidence O NOUN
that O ADP
supplementation O NOUN
with O ADP
L-methylfolate O NOUN
augments O NOUN
antidepressant O NOUN
agent O NOUN
effects O NOUN
and O CCONJ
thus O ADV
might O VERB
also O ADV
augment O ADP
ADHD O NOUN
treatment O NOUN
effects O NOUN
by O ADP
a O DET
common O ADJ
catecholaminergic O ADJ
mechanism. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Funded O VERB
by O ADP
the O DET
University O NOUN
of O ADP
Auckland O CCONJ
and O CCONJ
others; O NOUN
PIP O NOUN
Australian O ADJ
New O ADJ
Zealand O NOUN
Clinical O ADJ
Trials O NOUN
Registry O NOUN
number, O ADV
ACTRN12614000626662 O NOUN
.). O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

The O DET
ratio B-outcome NOUN
of I-outcome ADP
Apo I-outcome NOUN
B I-outcome NOUN
to I-outcome PART
Apo I-outcome NOUN
A1 I-outcome NOUN
was O VERB
reduced O VERB
more O ADV
(p O PUNCT
= O SYM
0.0866) O NUM
in O ADP
the O DET
amla O NOUN
group O NOUN
as O ADP
compared O VERB
to O PART
the O DET
placebo. O NOUN

None O NUM
of O ADP
the O DET
intervention-arms O NOUN
was O VERB
cost-effective O ADJ
for O ADP
sickness B-outcome NOUN
absence I-outcome NOUN
. O PUNCT
There O PRON
was O VERB
85% O NOUN
probability O NOUN
of O ADP
exercise-arm O NOUN
being O VERB
cost-effective O ADJ
if O ADP
willing O VERB
to O PART
pay O NOUN
euro3550 O NOUN
for O ADP
QALY O NOUN
gained. O NOUN

The O DET
preventive, O ADJ
complex O NOUN
psychological O ADJ
intervention O NOUN
comprised O VERB
promotion O NOUN
of O ADP
a O DET
therapeutic O ADJ
ICU O NOUN
environment O NOUN
plus O CCONJ
3 O NUM
stress O NOUN
support O NOUN
sessions O NOUN
and O CCONJ
a O DET
relaxation O NOUN
and O CCONJ
recovery O NOUN
program O NOUN
delivered O VERB
by O ADP
trained O VERB
ICU O NOUN
nurses O NOUN
to O PART
high-risk O NOUN
(acutely O ADV
stressed) O NOUN
patients. O NOUN

We O PRON
measured O VERB
the O DET
correct O ADJ
index O NOUN
in O ADP
the O DET
identification B-outcome NOUN
of O ADP
the O DET
eye O NOUN
drops O NOUN
of O ADP
the O DET
two O NUM
groups. O NOUN

Journal-Name:Revista O NOUN
medica O NOUN
de O ADP
Chile O NOUN

All O DET
other O ADJ
adverse B-outcome ADJ
reactions I-outcome NOUN
observed O VERB
during O ADP
the O DET
test O NOUN
period O NOUN
were O VERB
resolved O VERB
completely O ADV
without O ADP
special O ADJ
treatment. O NOUN

During O ADP
clinically O ADV
apparent O ADJ
infection, O NOUN
a O DET
reduction O NOUN
in O ADP
the O DET
diversity O NOUN
of O ADP
micro-organisms O NOUN
in O ADP
a O DET
DFU O NOUN
was O VERB
often O ADV
observed O VERB
due O ADJ
to O PART
expansion O NOUN
of O ADP
one O NUM
or O CCONJ
two O NUM
taxa, O NOUN
with O ADP
recovery O NOUN
in O ADP
diversity O NOUN
at O ADP
resolution. O NOUN

Trimethylamine O NOUN
N-oxide O NOUN
(TMAO) O NOUN
is O VERB
considered O VERB
a O DET
novel O ADJ
risk O NOUN
factor O NOUN
for O ADP
cardiovascular O ADJ
diseases. O NOUN

Side B-outcome NOUN
effects I-outcome NOUN
(all O PUNCT
mild) O NOUN
occurred O VERB
in O ADP
4.2% O NOUN
of O ADP
the O DET
participants. O NOUN

Periprosthetic B-outcome ADJ
fracture I-outcome NOUN
occurred O VERB
in O ADP
1 O NUM
case O NOUN
of O ADP
the O DET
SuperPATH O NOUN
group. O VERB

Pain B-outcome NOUN
scores, O NOUN
opioid B-outcome NOUN
requirements I-outcome NOUN
, O PUNCT
PT O NOUN
test O NOUN
results, O NOUN
and O CCONJ
patient-reported O VERB
outcome O NOUN
instruments O NOUN
were O VERB
compared O VERB
between O ADP
the O DET
three O NUM
groups. O NOUN

2019; O NOUN
90(1):12-17. O NOUN

Journal-Name:Graefe's O NOUN
archive O ADJ
for O ADP
clinical O ADJ
and O CCONJ
experimental O ADJ
ophthalmology O NOUN
= O SYM
Albrecht O NOUN
von O ADP
Graefes O NOUN
Archiv O NOUN
fur O NUM
klinische O NOUN
und O NOUN
experimentelle O NOUN
Ophthalmologie O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
101160941 O NUM

The O DET
combination O NOUN
of O ADP
an O DET
unsatisfying O VERB
quality B-outcome NOUN
of I-outcome ADP
implementing I-outcome VERB
the Seperator DET
intervention I-outcome NOUN
and O CCONJ
a O DET
low O ADJ
previous O ADJ
knowledge B-outcome NOUN
about O ADV
the O DET
intervention O NOUN
showed O VERB
the O DET
highest O ADP
empirical O ADJ
relevance. O NOUN

Title: O NOUN
A O DET
High O ADJ
Adherence O NOUN
to O PART
Six O NUM
Food O NOUN
Targets O NOUN
of O ADP
the O DET
Mediterranean O NOUN
Diet O NOUN
in O ADP
the O DET
Late O ADJ
First O ADV
Trimester O NOUN
is O VERB
Associated O VERB
with O ADP
a O DET
Reduction O NOUN
in O ADP
the O DET
Risk O NOUN
of O ADP
Materno-Foetal O ADJ
Outcomes: O NOUN
The O DET
St. O NOUN
Carlos O NOUN
Gestational O ADJ
Diabetes O NOUN
Mellitus O NOUN
Prevention O NOUN
Study. O NOUN

RESULTS: O NOUN
Twenty-two O NUM
patients O NOUN
(44%) O PUNCT
were O VERB
still O ADV
assessable O ADJ
at O ADP
the O DET
end-of-study O NOUN
visit, O NOUN
whereas O ADP
33 O NUM
(70%) O NOUN
were O VERB
assessable O ADJ
at O ADP
the O DET
same O ADJ
time O NOUN
point O NOUN
in O ADP
the O DET
TENS-TEP O ADV
group O NOUN
(P O NUM
= O SYM
.013). O PUNCT

Journal O ADJ
ID: O NOUN
101521595 O NUM

Group O NOUN
A O DET
consisted O VERB
of O ADP
66 O NUM
patients O NOUN
who O ADP
received O VERB
dexmedetomidine, O ADP
and O CCONJ
Group O NOUN
B O NOUN
included O VERB
66 O NUM
patients O NOUN
with O ADP
paracetamol O NOUN
administration. O ADV

Journal O ADJ
ID: O NOUN
2985248R O NOUN

RESULTS: O NOUN
At O ADP
3 O NUM
and O CCONJ
6 O NUM
month O NOUN
follow O VERB
up, O NOUN
Atorvastatin O ADP
40mg O NOUN
leads O NOUN
to O PART
mean O NOUN
LDL B-outcome NOUN
cholesterol I-outcome NOUN
reduction O NOUN
of O ADP
47.18+/-20.81 O NUM
& O CCONJ
50.03+/-18.06 O NUM
respectively. O NOUN

Thirty O NUM
minutes O NOUN
before O ADP
operation, O NOUN
control O NOUN
group O NOUN
received O VERB
intranasal O ADJ
placebo O NOUN
(0.9% O NOUN
saline) O NOUN
0.02 O NUM
mL/kg, O NOUN
and O CCONJ
DEX O NOUN
group O NOUN
received O VERB
intranasal O ADJ
DEX O NOUN
2 O NUM
mug/kg. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Twelve O NUM
(9.5%) O NOUN
and O CCONJ
10 O NUM
(7.9%) O PUNCT
subjects O NOUN
experienced O VERB
>30% O NOUN
endothelial B-outcome ADJ
cell I-outcome NOUN
loss O NOUN
(ECL) O ADV
at O ADP
12 O NUM
and O CCONJ
24 O NUM
months, O NOUN
respectively. O NOUN

OBJECTIVE: O NOUN
To O PART
investigate O NOUN
the O DET
use O NOUN
of O ADP
Bilevel O NOUN
Positive O ADJ
Airway O NOUN
Pressure O NOUN
(BiPAP) O NOUN
in O ADP
morbidly O ADV
obese O NOUN
individuals O NOUN
in O ADP
two O NUM
moments O NOUN
following O VERB
bariatric O ADJ
surgery O NOUN
(Roux-en-Y O NUM
gastric O ADJ
bypass): O NOUN
post-anesthetic O ADJ
recovery O NOUN
(PAR) O NOUN
and O CCONJ
first O ADV
postoperative O ADJ
day O NOUN
(1PO). O NUM

Title: O NOUN
[Effects O NOUN
of O ADP
intranasal O ADJ
dexmedetomidine O NOUN
for O ADP
children O NOUN
undergoing O VERB
dental O ADJ
rehabilitation O NOUN
under O ADP
general O ADJ
anesthesia: O NOUN
a O DET
double-blinded O VERB
randomized O VERB
controlled O VERB
trial]. O ADV

Only O ADV
one O NUM
tooth O NOUN
of O ADP
G1 O NOUN
was O VERB
unsuccessful B-outcome ADJ
; O PUNCT
hence, O NOUN
pulpectomy B-outcome NOUN
performance I-outcome NOUN
in O ADP
both O CCONJ
groups O NOUN
was O VERB
not O ADV
influenced O VERB
by O ADP
the O DET
filling O VERB
material, O NOUN
nor O CCONJ
by O ADP
any O DET
other O ADJ
analyzed O VERB
variable. O NOUN

C-group O NOUN
received O VERB
a O DET
brochure. O NOUN

The O DET
frequency O NOUN
of O ADP
live B-outcome ADJ
birth I-outcome NOUN
was O VERB
180 O NUM
of O ADP
690 O NUM
women O NOUN
(26.1%) O NUM
in O ADP
the O DET
endometrial-scratch O NOUN
group O NOUN
and O CCONJ
176 O NUM
of O ADP
674 O NUM
women O NOUN
(26.1%) O NUM
in O ADP
the O DET
control O NOUN
group O NOUN
(adjusted O PUNCT
odds O NOUN
ratio, O NOUN
1.00; O NOUN
95% O NOUN
confidence O NOUN
interval, O ADP
0.78 O NUM
to O PART
1.27). O NOUN

FUNDING: O NOUN
National O ADJ
Institute O NOUN
for O ADP
Health O NOUN
Research O NOUN
Efficacy O NOUN
and O CCONJ
Mechanism O NOUN
Evaluation O NOUN
Programme. O NOUN

The O DET
results O NOUN
of O ADP
nine-gene O NOUN
based O VERB
SPC O NOUN
assay O NOUN
were O VERB
classified O VERB
as O ADP
prognostication O NOUN
(SPC-prognosis) O PUNCT
and O CCONJ
prediction O NOUN
of O ADP
chemotherapy O NOUN
benefit O NUM
(SPC-prediction). O PUNCT

Title: O NOUN
Chocolate O NOUN
Milk O NOUN
versus O CCONJ
carbohydrate O NOUN
supplements O NOUN
in O ADP
adolescent O NOUN
athletes: O ADJ
a O DET
field O NOUN
based O VERB
study. O NOUN

Results O NOUN
were O VERB
similar O ADJ
for O ADP
all O DET
(mild/moderate/severe) O PUNCT
exacerbations B-outcome NOUN
. O PUNCT
Improvements O NOUN
in O ADP
lung B-outcome NOUN
function I-outcome NOUN
, O PUNCT
health B-outcome NOUN
status O NOUN
and O CCONJ
rescue B-outcome NOUN
medication I-outcome NOUN
use I-outcome NOUN
with O ADP
IND/GLY O NOUN
vs O CCONJ
SFC O NOUN
were O VERB
comparable O ADJ
between O ADP
men O NOUN
and O CCONJ
women. O NOUN

Participants O NOUN
are O VERB
randomised O VERB
to O PART
receive O VERB
MCP O NOUN
either O CCONJ
at O ADP
baseline O NOUN
(early O ADV
treatment) O NOUN
or O CCONJ
after O ADP
3 O NUM
months O NOUN
(delayed O PUNCT
treatment). O NOUN

The O DET
positive O ADJ
percent O NOUN
of O ADP
coli-form B-outcome NOUN
on O ADP
the O DET
hand O NOUN
swabs O NOUN
in O ADP
intervention O NOUN
group O NOUN
(2.00%) O NUM
were O VERB
significantly O ADV
lower O ADJ
than O ADP
that O ADP
in O ADP
control O NOUN
group O NOUN
(9.45%) O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
year O NOUN
2.The O NUM
intervention O NOUN
of O ADP
intensive O ADJ
education O NOUN
on O ADP
hand O NOUN
hygiene O NOUN
effectively O ADV
improved O VERB
the O DET
personal B-outcome ADJ
hygiene I-outcome NOUN
both O CCONJ
of O ADP
children O NOUN
and O CCONJ
parents, O NOUN
as O ADP
well O ADV
as O ADP
reduced O VERB
the O DET
incidence O NOUN
of O ADP
hand B-outcome NOUN
food I-outcome NOUN
mouth I-outcome NOUN
disease I-outcome NOUN
. O PUNCT
We O PRON
suggested O VERB
expanding O VERB
the O DET
intervention O NOUN
measures O NOUN
in O ADP
community O NOUN
to O PART
prevent O NOUN
HFMD. O NOUN

Publication O NOUN
date: O NOUN
2019/02/12 O ADJ
06:00 O ADP
[medline] O NOUN

The O DET
data O NOUN
were O VERB
analyzed O VERB
using O VERB
repeated O VERB
measures O NOUN
MANOVA. O NOUN

Whey O NOUN
protein O NOUN
isolate O VERB
(WPI) O ADV
is O VERB
high O ADJ
in O ADP
vitamin O NOUN
B12 O NOUN
and O CCONJ
folate. O NOUN

Such O ADJ
guidelines O NOUN
are O VERB
made O VERB
available O ADJ
for O ADP
strength O NOUN
training O VERB
(ST) O NOUN
using O VERB
the O DET
1 O NUM
repetition O NOUN
maximum O NOUN
(1RM), O NOUN
which O ADP
has O VERB
been O VERB
linked O VERB
to O PART
individuals' O NOUN
self-rated O VERB
level O NOUN
of O ADP
exertion O NOUN
using O VERB
the O DET
Borg O ADJ
rating O VERB
of O ADP
perceived O VERB
exertion O NOUN
(BRPE) O ADV
scale. O ADJ

Patients O NOUN
in O ADP
the O DET
routine O ADJ
chemotherapy O NOUN
group O NOUN
(n O NOUN
= O SYM
30, O NUM
RC O NOUN
group) O ADJ
received O VERB
cisplatin O NOUN
infusion O NOUN
within O ADP
1 O NUM
h O NOUN
and O CCONJ
5-FU O NOUN
infusion O NOUN
for O ADP
about O ADV
24 O NUM
h. O NOUN
The O DET
dose O NOUN
in O ADP
the O DET
RC O NOUN
group O NOUN
was O VERB
the O DET
same O ADJ
as O ADP
that O ADP
in O ADP
the O DET
CC O NOUN
group. O VERB

METHODS: O NOUN
A O DET
sample O NOUN
of O ADP
37 O NUM
patients O NOUN
poststroke O NOUN
(29 O NOUN
males) O NOUN
was O VERB
randomly O ADV
allocated O VERB
to O PART
either O CCONJ
SPT O NOUN
control O NOUN
group O NOUN
(n O NOUN
= O SYM
18) O NOUN
or O CCONJ
SPT O NOUN
and O CCONJ
SMV O NOUN
(SPT-SMV) O NOUN
experimental O ADJ
group O NOUN
(n O NOUN
= O SYM
19). O ADJ

RESULTS: O NOUN
Participants O NOUN
identified O VERB
more O ADV
barriers O NOUN
than O ADP
facilitators O NOUN
when O ADP
describing O VERB
contextual O ADJ
factors O NOUN
influencing O VERB
the O DET
mhGAP-based O VERB
training's O NOUN
expected O VERB
outcomes. O ADJ

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

min(-1)). O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Registered O VERB
with O ADP
Clinical O ADJ
Trials O NOUN
Registry- O NOUN
India O PROPN
at O ADP
www.ctri.nic.in O NOUN
(Registration O NOUN
number: O NOUN
CTRI/2015/04/005682 O NOUN
) O PUNCT
on O ADP
8 O NUM
April O NOUN
2015 O NUM
(retrospectively O ADV
registered). O ADP

Whether O ADP
a O DET
briefer O VERB
treatment O NOUN
interval O NOUN
would O VERB
be O VERB
efficacious O ADJ
has O VERB
not O ADV
been O VERB
studied. O NOUN

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

Serum O NOUN
levels O NOUN
of O ADP
AdipoR1 O VERB
were O VERB
positively O ADV
correlated O VERB
with O ADP
APN O NOUN
(r O NUM
= O SYM
0.726, O PUNCT
P<0.01), O NOUN
and O CCONJ
negatively O ADV
correlated O VERB
with O ADP
BMI, O NUM
SBP, O NOUN
DBP, O NOUN
FBG, O NOUN
TC O NOUN
and O CCONJ
LDL-C O NOUN
(r O NUM
= O SYM
-0.440, O NOUN
-0.446, O NUM
-0.374, O NUM
-0.444, O NOUN
-0.344, O NOUN
-0.709, O NOUN
respectively; O NOUN
all O DET
P<0.01). O NOUN

Statistical O ADJ
significance O NOUN
was O VERB
set O NOUN
at O ADP
P O NOUN
</= O NOUN
0.05. O PUNCT

Publication O NOUN
date: O NOUN
2019/03/12 O NOUN
06:00 O ADP
[medline] O NOUN

Single-arm O NUM
studies O NOUN
have O VERB
suggested O VERB
that O ADP
a O DET
10-day O NOUN
schedule O NOUN
of O ADP
decitabine O NOUN
cycles O NOUN
leads O NOUN
to O PART
better O ADJ
outcomes O NOUN
than O ADP
the O DET
usual O ADJ
5-day O NOUN
schedule. O NOUN

The O DET
interruption O NOUN
of O ADP
the O DET
blood O NOUN
supply O NOUN
to O PART
the O DET
donor O NOUN
liver O NOUN
during O ADP
cold O NOUN
storage O NOUN
damages O NOUN
the O DET
liver, O NOUN
affecting O VERB
how O ADP
well O ADV
the O DET
liver O NOUN
will O VERB
function O NOUN
after O ADP
transplant. O NOUN

METHODS: O NOUN
In O ADP
this O DET
randomised O VERB
placebo-controlled O VERB
trial, O NOUN
we O PRON
recruited O VERB
very O ADV
preterm O NOUN
infants O NOUN
born O VERB
before O ADP
32 O NUM
weeks' O ADP
gestation O NOUN
in O ADP
37 O NUM
UK O PROPN
hospitals O NOUN
and O CCONJ
younger O ADJ
than O ADP
72 O NUM
h O NOUN
at O ADP
randomisation. O ADV

Journal O ADJ
ID: O NOUN
101224380 O NUM

CONCLUSION: O NOUN
The O DET
findings O NOUN
of O ADP
this O DET
study O NOUN
showed O VERB
that O ADP
BZSF O NOUN
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
ceftriaxone O NOUN
may O VERB
be O VERB
not O ADV
superior O ADJ
to O PART
the O DET
ceftriaxone O NOUN
alone O ADJ
for O ADP
Chinese O NOUN
female O NOUN
patients O NOUN
with O ADP
uncomplicated O VERB
gonorrhea O ADJ
after O ADP
10 O NUM
days O NOUN
treatment. O NOUN

Publication O NOUN
date: O NOUN
2018/11/30 O NOUN
00:00 O NOUN
[accepted] O ADV

Based O VERB
on O ADP
the O DET
benefit O NUM
of O ADP
polyphenolic O ADJ
compounds O NOUN
on O ADP
osteoporosis, O PRON
we O PRON
hypothesized O VERB
that O ADP
the O DET
polyphenol-rich O ADJ
herbal O ADJ
congee O ADP
containing O VERB
the O DET
combined O VERB
extract O NOUN
of O ADP
Morus O NOUN
alba O NOUN
and O CCONJ
Polygonum O NOUN
odoratum O NOUN
leaves O NOUN
should O VERB
improve O VERB
bone B-outcome NOUN
turnover I-outcome ADV
markers O NOUN
in O ADP
menopausal O ADJ
women. O NOUN

The O DET
secondary O ADJ
outcome O NOUN
was O VERB
the O DET
incidence O NOUN
of O ADP
severe B-outcome ADJ
hypoxemia I-outcome NOUN
, O PUNCT
defined O VERB
as O ADP
an O DET
oxygen O NOUN
saturation O NOUN
of O ADP
less O ADV
than O ADP
80%. O NUM

After O ADP
the O DET
exercise, O NOUN
improvement O NOUN
was O VERB
noted O VERB
in O ADP
Ober O NOUN
test O NOUN
(P O NUM
= O SYM
.005; O PUNCT
d O NOUN
= O SYM
0.75 O NUM
on O ADP
the O DET
right O ADJ
side, O NOUN
P O NOUN
= O SYM
.005; O PUNCT
d O NOUN
= O SYM
0.78 O NUM
on O ADP
the O DET
left O ADV
side) O NOUN
and O CCONJ
in O ADP
the O DET
Thomas O NOUN
test O NOUN
(P O NUM
= O SYM
.005; O PUNCT
d O NOUN
= O SYM
0.66 O NUM
on O ADP
the O DET
right O ADJ
side, O NOUN
P O NOUN
= O SYM
.005; O PUNCT
d O NOUN
= O SYM
0.67 O NUM
on O ADP
the O DET
left O ADV
side). O ADJ

Title: O NOUN
Bilevel O NOUN
positive O ADJ
airway O NOUN
pressure O NOUN
in O ADP
two O NUM
moments O NOUN
after O ADP
bariatric O ADJ
surgery. O VERB

Title: O NOUN
A O DET
Phase O NOUN
II O NUM
Study O NOUN
Alternating O VERB
Erlotinib O NOUN
With O ADP
Second-line O NOUN
mFOLFOX6 O NOUN
or O CCONJ
FOLFIRI O NOUN
for O ADP
Metastatic O ADJ
Colorectal O ADJ
Cancer. O ADV

Both O CCONJ
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
and O CCONJ
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
monitored O VERB
by O ADP
ventilator O NOUN
could O VERB
not O ADV
reflect O NOUN
the O DET
patient's O NOUN
tidal B-outcome DET
volume I-outcome NOUN
under O ADP
either O CCONJ
VCV O NOUN
or O CCONJ
PCV O NOUN
mode. O VERB

AIM: O NOUN
To O PART
assess O NOUN
the O DET
effectiveness O NOUN
of O ADP
a O DET
self-administered O VERB
rehabilitation O NOUN
program O NOUN
in O ADP
adults O NOUN
with O ADP
shoulder O NOUN
pain O NOUN
syndrome O NOUN
in O ADP
primary O ADJ
care. O NOUN

The O DET
preoperative O ADJ
sedation B-outcome NOUN
score, O NOUN
the O DET
status B-outcome NOUN
of I-outcome ADP
separation I-outcome NOUN
from I-outcome ADP
parents I-outcome NOUN
, O PUNCT
compliance B-outcome NOUN
with O ADP
the O DET
mask O NOUN
and O CCONJ
hemodynamic B-outcome ADJ
parameters O NOUN
were O VERB
recorded O VERB
by O ADP
an O DET
anesthesiologists O NOUN
until O ADP
anesthesia O NOUN
induction. O NOUN

Journal-Name:Journal O ADJ
of O ADP
drugs O NOUN
in O ADP
dermatology O NOUN
: O PUNCT
JDD O NOUN

RESULTS: O NOUN
The O DET
incidence O NOUN
of O ADP
involuntary B-outcome ADJ
movement I-outcome NOUN
and O CCONJ
spontaneous B-outcome ADJ
movement I-outcome NOUN
were O VERB
measured O VERB
as O ADP
significantly O ADV
lower O ADJ
in O ADP
group O NOUN
I O NUM
(P O NUM
< O SYM
.05). O NUM

RESULTS: O NOUN
Among O ADP
42 O NUM
HIE O NOUN
children, O NOUN
1 O NUM
child O NOUN
of O ADP
severe O ADJ
congenital O ADJ
malformation O NOUN
and O CCONJ
1 O NUM
child O NOUN
of O ADP
platelet O NOUN
count O NOUN
(PLT) O PUNCT
< O SYM
50x10(9)/L O NOUN
were O VERB
excluded, O VERB
and O CCONJ
40 O NUM
children O NOUN
were O VERB
enrolled O VERB
in O ADP
the O DET
study O NOUN
group. O VERB

Overall, O NOUN
the O DET
study O NOUN
demonstrated O VERB
the O DET
acceptability B-outcome NOUN
of O ADP
an O DET
adapted O VERB
version O NOUN
of O ADP
the O DET
WHO O NOUN
Moments O NOUN
for O ADP
Hand O NOUN
Hygiene O NOUN
poster O NOUN
in O ADP
the O DET
introduction O NOUN
of O ADP
an O DET
intervention O NOUN
in O ADP
the O DET
community. O ADJ

OBJECTIVE: O NOUN
To O PART
investigate O NOUN
the O DET
effects O NOUN
of O ADP
aerosol O NOUN
inhalation O NOUN
on O ADP
respiratory B-outcome ADJ
mechanical I-outcome ADJ
parameters O NOUN
under O ADP
different O ADJ
ventilation O NOUN
patterns O NOUN
and O CCONJ
ventilator O NOUN
parameters O NOUN
in O ADP
patients O NOUN
on O ADP
mechanical O ADJ
ventilation O NOUN
and O CCONJ
simulated O VERB
model O NOUN
of O ADP
aqualung O NOUN
in O ADP
vitro. O NOUN

The O DET
secondary O ADJ
outcomes O NOUN
consisted O VERB
of O ADP
stool B-outcome NOUN
consistency I-outcome NOUN
, O PUNCT
measured O VERB
by O ADP
the O DET
Bristol O NOUN
Stool O NOUN
Form O NOUN
Scale, O NOUN
abdominal B-outcome ADJ
pain I-outcome NOUN
, O PUNCT
flatulence B-outcome NOUN
, O PUNCT
as O ADP
well O ADV
as O ADP
the O DET
adverse B-outcome ADJ
events I-outcome NOUN
. O PUNCT
All O DET
outcomes O NOUN
were O VERB
measured O VERB
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
6-weeks O NOUN
treatment. O NOUN

CONCLUSIONS: O NOUN
Among O ADP
patients O NOUN
with O ADP
early O ADJ
Parkinson's O NOUN
disease O NOUN
who O ADP
were O VERB
evaluated O VERB
over O ADP
the O DET
course O NOUN
of O ADP
80 O NUM
weeks, O NOUN
treatment O NOUN
with O ADP
levodopa O NOUN
in O ADP
combination O NOUN
with O ADP
carbidopa O NOUN
had O VERB
no O DET
disease-modifying O VERB
effect. O NOUN
( O PUNCT

The O DET
mean O NOUN
age O NOUN
of O ADP
the O DET
patients O NOUN
was O VERB
14.9 O NUM
years O NOUN
and O CCONJ
the O DET
mean O NOUN
follow-up O NOUN
was O VERB
24 O NUM
months. O NOUN

Background O NOUN
Intravenous O ADJ
sufentanil-midazolam O NOUN
and O CCONJ
inhalational O ADJ
sevoflurane O NOUN
are O VERB
widely O ADV
used O VERB
for O ADP
anesthetic O ADJ
induction O NOUN
in O ADP
children O NOUN
undergoing O VERB
cardiac O ADJ
surgery. O VERB
